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ABSTRACT 
 
 Legionella pneumophila is a Gram-negative intracellular pathogen that causes 
Legionnaires’ disease and Pontiac fever in elderly or immunocompromised humans. The ability 
of Legionella to thrive within host cells depends on the Legionella-containing vacuole (LCV) 
which, in turn, relies on the activity of secreted effector proteins for its formation. Effectors are 
highly variable in structure and function, and functional redundancy is prevalent among them. 
Consequently, relating structural data to function provides an attractive avenue of research into 
molecules which are unlikely to exhibit a phenotype upon gene deletion. Our lab relies on X-ray 
crystallography for macromolecular structure determination. Structural data may point to a 
function for the protein of interest, which can be verified using mutagenesis, biochemical assays 
or some combination thereof. This dissertation explores the structure and putative function of 
effectors LpnE(lpg2222), MavE(lpg2344) and MavL(lpg2526).  
LpnE (Legionella pneumophila Entry) is a Sel1-like repeat (SLR) protein implicated in 
host cell invasion. During infection, a eukaryotic polyphosphate 5-phosphatase, called 
Oculocerebrorenal syndrome of Lowe protein 1 (OCRL1), is recruited to the LCV by an interaction 
with LpnE and restricts bacterial replication by an unknown mechanism. The crystal structure of 
His-LpnE(73-375) reveals a typical SLR super-helix with a concave surface implicated in protein-
protein interactions. Herein, critical residues promoting the LpnE-OCRL interaction are uncovered 
using size exclusion chromatography with multi-angle light scattering (SEC-MALS). In addition, 
we show that LpnE localizes to cis-Golgi using its signal peptide. These findings are compiled into 
a mechanistic hypothesis where: (1) LpnE localizes to the LCV by its predicted signal peptide. (2) 
OCRL binding prevents liberation of LpnE from the LCV and (3) renders LpnE unable to promote 
infection by mediating protein-protein interactions in the cytosol. 
MavE is one of many proteins identified as a secreted effector based on its ability to rescue 
LCV localization of a translocation deficient SidC (SidCΔ100). Our collaborator, Dr. Yousef Abu-
Kwaik, has obtained a unique phenotype for Δlpg2344 (MavE) mutants, in which the LCV fuses 
with lysosomes (unpublished data). He suggests that MavE interacts with proteins harbouring 
phosphotyrosine-binding domains (PTBs) using its NPxY motif. The recruitment of these binding 
  
 
 
iii 
partners may impede autophagic trafficking. The crystal structure of MavE(39-172) presented in 
this dissertation has an overall structure reminiscent of the grass pollen allergen, Phlp 5b, with the 
NPxY motif located on a loop of poorly defined electron density. This loop has no counterpart in 
Phlp 5b and has flexibility that may accommodate protein-protein interactions. These structural 
data corroborate the proposed role of the NPxY motif while revealing a scaffold domain previously 
seen in the grass pollen allergen, Phlp 5b. 
MavL is another secreted effector identified in the same manner as MavE. Presently, there 
is little published data available on the function of MavL. Elizabeth Hartland et al. have found by 
yeast two-hybrid that an E2 ubiquitin conjugating enzyme called Ube2q1 interacts directly with 
MavL, although we were unable to reproduce this interaction in vitro. The crystal structure of 
MavL(42-435) reveals an ADP-ribose binding macrodomain with homology to those that 
recognize mono-ADP-ribosylated targets. We confirmed the interaction of MavL and ADP-ribose 
by isothermal titration calorimetry (ITC), giving a dissociation constant of 13µM. Intriguingly, 
MavL contains a pair of neighboring aspartate residues in the same location as the catalytic 
glutamates of poly-ADP-ribose glycohydrolase (PARG) enzymes. We propose that MavL exhibits 
either ADP-ribose reader or eraser activity. Further studies are needed to investigate the role of 
ADP-ribosylation in MavL functionality. 
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1. Introduction 
Legionella pneumophila is the causative agent of Legionnaire’s disease and a milder illness 
known as Pontiac fever. It is a Gram-negative intracellular pathogen that infects a large 
spectrum of freshwater amoeba as its primary hosts. Once transmitted to the human lung by 
contaminated aerosols, L. pneumophila replicates within alveolar macrophages and gives rise 
to disease in elderly or immunocompromised individuals. The ability of L. pneumophila to 
replicate in human cells stems from its strategy for infecting lower eukaryotes, but Legionella 
does not efficiently mediate disease transmission in humans. Consequently, L. pneumophila 
has been named an “accidental pathogen” and humans are a dead-end host for this organism.  
L. pneumophila depends on successful formation and maturation of the so-called 
“Legionella-containing vacuole” (LCV) for survival within host cells. This compartment is 
derived initially from the host cell membrane, but later acquires components of the 
endoplasmic reticulum (ER) and mitochondrial membranes. Formation of the LCV depends 
on an arsenal of effector proteins, which are secreted by a membrane-spanning complex called 
the Type IVB (Dot/Icm) secretion system. These secreted effectors are highly variable in 
structure and function, and hijack host cell processes at many levels: they can act as enzymes 
or transcription factors, modulate small GTPase activity and interfere with ubiquitination, 
cytoskeletal organization and even the function of other effectors. Each L. pneumophila strain 
encodes a unique complement of over 300 effectors. Consequently, the total number of 
Legionella effectors to be studied far exceeds this number. The most investigated strains are 
Philadelphia and Paris, each secreting ~330 effectors. Redundancy in the function of effector 
proteins often precludes their analysis by knockout studies, rendering structural biology an 
attractive avenue for investigating the role of effectors as infective agents. 
Our lab relies on X-ray crystallography to obtain structural data on effectors. These data 
may point to a function for the protein of interest, which can be supported using biochemical 
assays. In this way, a functional understanding of effectors can be derived, in part, from 
structural knowledge. To this end, I have structurally characterized three effectors encoded by 
L. pneumophila (sp. Philadelphia): LpnE, MavE and MavL. 
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2. Review of the Literature 
 
2.1. Legionella pneumophila background 
 
2.1.1. Uptake into Host Cells 
Transmissive L. pneumophila is taken into the host cell by macropinocytosis, a process in 
which membrane projections fuse to generate a vesicle called the macropinosome. These 
projections or “ruffles” arise from the rearrangement of cortical actin filaments. It has been 
found that phosphatidylinositol(3,4,5)triphosphate (PI(3,4,5)P3) and PI(3,4)P2 play critical 
roles in micropinocytosis (de Carvalho et al., 2015). As such, enzymes involved in the 
generation of these phospholipids, such as phosphatidylinositol-3-kinase (PI3K) contribute to 
macropinosome formation. Indeed, PI3K converts PI(4,5)P2 to PI(3,4,5)P3 at macropinocytic 
entry sites. The role of PI(3,4,5)P3 and PI(3,4)P2 in micropinocytosis has been linked to actin 
polymerization. For example, PI(3,4,5)P3 recruits GEFs and GAPs harbouring PI(3,4,5)P3 PH 
domains, which direct actin polymerization by RhoGTPase activity. After internalization of 
the macropinosome, PI(4,5)P2 is regenerated on the cell surface (Steiner et al., 2017). 
The internalization process of L. pneumophila is thought to be initiated by the deposition 
of a secreted effector into the host cell cytosol (Watarai et al., 2001). Although the exact 
mechanism of host cell invasion remains to be elucidated, structural genes rtxA and enhC have 
been found to play a role in attachment. The rtxA gene product, RtxA, contains eight RTX 
motifs, which facilitate Ca2+ binding and host cell attachment. Meanwhile, enhC encodes a 
Sel1-like repeat (SLR) protein that mediates protein-protein interactions (Cirillo et al., 2000). 
LpnE is another SLR protein encoded by L. pneumophila that compensates for defects in entry 
arising from enhC deletion (Bandyopadhyay et al., 2012). Although the role of SLR proteins 
in host cell entry remains unclear, protein-protein interactions typically occur at the concave 
surface of the SLR super-helix (Cliff et al., 2006; Das et al., 1998; Scheufler et al., 2000). Thus, 
determining eukaryotic binding partners of LpnE/EnhC may provide mechanistic insights into 
how these proteins facilitate entry. 
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2.1.2. Biphasic Life Cycle of Legionella pneumophila 
The life cycle of L. pneumophila can be called biphasic, as this bacterium exists in either a 
replicative or transmissive form. During its growth within host cells the replicative form is 
adopted, and bacteria are non-motile, slender rods, which lack cytotoxicity. When nutrient 
levels become limiting, L. pneumophila differentiate into a morphologically distinct, 
flagellated and virulent transmissive form. It is this transmissive form that escapes from the 
spent host cell and reinitiates the process of infection. These distinct lifeforms allow L. 
pneumophila to conserve energy by expressing the genes for virulence and transmission only 
when conditions for growth and replication are no longer being met (Oliva et al., 2018).  
 
2.1.3. The Legionella pneumophila Type IV Secretion System 
The Type IV Secretion System (T4SS) is a functionally diverse nanomachine that shares 
evolutionary roots with the bacterial conjugation apparatus. These envelope-spanning 
multiprotein complexes translocate a wide variety of substrates out of the cell, including DNA, 
toxins and biofilm components. In the case of L. pneumophila, the T4SS is a dedicated effector-
translocating machine (Grohmann et al., 2017). There are two phylogenetic families of T4SS 
in Gram-negative bacteria, designated IVA and IVB. The IVA system is often represented by 
the Agrobacterium tumefaciens VirB/VirD4 T4SS, which is comprised of 11 VirB proteins 
and one VirD4 subunit (Li and Christie, 2018). These proteins have been functionally classified 
as cytoplasmic ATPases, inner membrane platform components, outer membrane core 
complex and pilus assembly components. The Dot/Icm secretion system encoded by L. 
pneumophila is the IVB paradigm and contains 27 subunits, many of which lack homologues 
in the IVA system (Grohmann et al., 2017). These subunits combine to form the wheel, collar, 
cylinder and cytoplasmic complexes that make up the T4BSS (Figure 2.1). 
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Figure 2. 1 Schematic of type IV secretion systems (T4SS). (A) Diagram of A. tumefaciens T4ASS 
showing 11 VirB subunits and the VirD4 chaperone. (B) Three-dimensional surface rendering of 
the L. pneumophila T4BSS revealed by cryo-electron tomography and subtomogram averaging. 
Components of the system are designated in white. PG = peptidoglycan, OM = outer membrane, 
IM = inner membrane. Figure adapted from (Chetrit et al., 2018; Li and Christie, 2018). 
 
A structure of the L. pneumophila IVB system has been obtained in situ by electron 
cryotomography. This model shows striking similarity to the IVA systems reported previously, 
suggesting a shared mechanism of translocation despite little similarity in the sequence and 
subunits of these complexes (Ghosal et al., 2017). Indeed, only the hat domain of the outer 
membrane core complex (OMCC) is structurally equivalent in both IVA and IVB systems. The 
proteins comprising these hat domains are DotG and VirD10 in L. pneumophila and A. 
tumefaciens, respectively. 
 
2.1.4. Phosphoinositide conversion on the Legionella-containing vacuole (LCV) 
PI(3,4,5)P3 and PI(3,4)P2 direct actin polymerization at the site of micropinocytosis. 
Consequently, the engulfed macropinosome is initially rich in PI(3,4,5)P3 and PI(3,4)P2. Upon 
internalization, these phospholipids are traded for PI3P in an Icm/Dot-independent manner. 
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Rab5 regulates the appearance and disappearance of PI3P in eukaryotic cells by recruiting PI3-
kinases or PI4- and PI5-phosphatases, respectively (Shin et al., 2005). Since the disappearance 
of PI(3,4,5)P3 and PI(3,4)P2 is correlated with the formation of PI3P, Rab5-recruited 
phosphatases may be involved in this process. In vesicles harboring Legionella (LCV) 
containing an intact Icm/Dot system, PI3P is exchanged for PI4P in an Icm/Dot-dependent 
manner (Steiner et al., 2017).  
The conversion of PI3P to PI4P in non-infected cells depends on host kinases. For example, 
the phosphatidylinositol is phosphorylated at position 4 by phosphatidylinositol-4-kinase 
(PI4K) enzymes, which are divided into subtypes based on the subcellular compartment they 
are associated with. In cells infected with Legionella, the small GTPase Arf1 localizes to the 
LCV and recruits PI4K IIIβ, an enzyme that typically binds to Golgi and the nucleus. It is 
therefore possible that PI4K IIIβ plays a role in generating PI4P on the LCV, although direct 
evidence for the association of PI4K IIIβ with the LCV has yet to be obtained (Steiner et al., 
2017).  
 
Figure 2. 2 Schematic of phosphoinositide conversion on the Legionella-containing vacuole 
(LCV). Rab5 (pink) and Arf1 (blue) recruit PI4/5-phosphatases and PI4K IIIβ to the LCV, where 
they generate PI3P and, ultimately, PI4P from PI(3,4,5) initially present on the macropinosome. 
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The Icm/Dot-dependent disappearance of PI3P from the LCV is also caused by effectors 
with PI metabolizing activity, such as SidF, LepB and SidP. LepB is a PI-4-kinase that acts on 
PI3P to generate PI(3,4)P2 which, in turn, is converted to PI4P by the 3-phosphatase SidF 
(Dong et al., 2016). Another substrate of SidF is PI(3,4,5)P3, a dominant lipid on the early 
macropinosome. This lipid is changed to PI(4,5)P2 by the 3-phosphatase activity of SidF (Hsu 
et al., 2012). The eukaryotic inositol polyphosphate 5-phosphatase, OCRL, then acts on 
PI(4,5)P2 to generate PI4P, thereby completing the conversion of PI(3,4,5)P3 to PI4P on the 
LCV (Zhang et al., 1995). SidP also promotes the loss of PI3P from the LCV, although it does 
not lead directly to the formation of PI4P. Instead, SidP uses its 3-phosphatase activity to 
generate PIP and PI5P from PI3P and PI(3,5)P2, respectively (Toulabi et al., 2013). Thus, 
Legionella has systems in place to convert PI3P, PI(3,4,5)P3 and PI(3,5)P2 to PI4P and PI5P 
on the LCV, while promoting PI4P production through the phosphorylation of PIP by PI4K 
IIIβ (Figure 2.2). 
 
2.1.5. Effectors that alter the host phosphoproteome 
L. pneumophila causes significant changes in the host cell phosphoproteome by secreting 
effectors that act as kinases and phosphatases. Several L. pneumophila kinases share sequence 
similarity with eukaryotic kinases, suggesting potential acquisition by horizontal gene transfer 
(Garcia-Vallve et al., 2003). Effectors acting as phosphatases have also been found to mimic 
eukaryotes by adopting haloacid dehalogenase-like (HAD-like) (Quaile et al., 2018) or 
phosphotyrosine phosphatase domains (Beyrakhova et al., 2018; Jia et al., 2018). Since 
phosphorylation plays a critical role in various host signaling processes, an understanding of 
how this post-translational modification is controlled by L. pneumophila is essential. The 
following is an overview of recent research into Legionella kinases and phosphatases. 
The ‘eukaryotic-like’ kinases of L. pneumophila include LegK1, LegK2, LegK3, LegK4 
and LegK7. These effectors phosphorylate serine or threonine residues on target proteins. 
Specifically, LegK1 phosphorylates IκB and upregulates the NF-κB pathway. The targets of 
LegK3 and LegK4 are unknown (Grishin et al., 2015), although recent structural data have 
provided insight into LegK4 functionality (see section 2.2.2.5). 
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In addition to acquiring kinases from eukaryotic genomes, bacteria have evolved their own 
set of kinases with structural similarity to nonregulatory kinases (Fookes et al., 2011; 
Hemrajani et al., 2010; Kim et al., 2005). Features that distinguish bacterial kinases from 
nonregulatory kinases are their small kinase domain and the absence of an activation loop. 
Indeed, the classification of LegK2 as ‘eukaryotic-like’ has been argued on the basis that an 
activation loop is absent in this molecule (Hervet et al., 2011). 
LegK2 promotes the virulence of L. pneumophila by phosphorylating ARPC1B and ARP3 
subunits of the ARP2/3 complex, leading to a local interference of actin remodeling around 
the LCV. Thus, the activity of LegK2 allows the LCV to evade endocytic trafficking (Michard 
et al., 2015). Another Legionella kinase, LegK7, was found to mimic the host Hippo kinase 
and phosphorylate MOB1. In so doing, transcriptional regulators TAZ and ZAP1 are degraded, 
leading to altered expression of genes associated with the PPARγ transcription factor (Lee and 
Machner, 2018).  
Several phosphatases have been identified in the L. pneumophila genome. The effector 
Lem4 is a phosphotyrosine phosphatase with possible activity toward CSF1R based on its 
preference for the consensus motif of this receptor (Beyrakhova et al., 2018). CSF1R resides 
on the LCV during infection (Hoffmann et al., 2014) and activates the mitogen-activated 
protein kinase / extracellular signal-regulated kinase kinase and phosphatidylinositol-3-kinase 
pathways. These signaling pathways depend on dimerization and autophosphorylation of 
CSF1R at Tyr708 and Tyr809. Dephosphorylation of CSF1R by Lem4 would therefore prevent 
downstream signaling events, although the presence of such activity during infection has yet 
to be reported. A crystal structure of the N-terminal Lem4 haloacid dehalogenase-like (HAD-
like) domain showed structural homology with mouse magnesium-dependent phosphatase 
(MDP1). Consistent with this finding, Lem4 has specificity toward phenyl-phosphate 
containing substrates, such as pNPP and pTyr (Beyrakhova et al., 2018). 
WipA and WipB are two other bacterial phosphatases secreted by L. pneumophila. Both 
proteins harbor a serine/threonine phosphatase domain resembling that seen in the eukaryotic 
phosphoprotein phosphatase (PPP) family (Jia et al., 2018; Prevost et al., 2017). WipB 
localizes to LAMP1-positive lysosomal compartments and binds the v-ATPase and associated 
LAMTOR1 phosphoprotein (Prevost et al., 2017). Another L. pneumophila effector, SidK, has 
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also been found to inhibit the v-ATPase and prevent acidification of the LCV (Zhao et al., 
2017). Since neither wipB nor sidK mutants caused a defect in the intracellular replication of 
L. pneumophila, these effectors may act redundantly to prevent LCV acidification by the v-
ATPase (Prevost et al., 2017). WipA is an unconventional protein tyrosine phosphatase (PTP) 
with structural resemblance to cold-active protein tyrosine phosphatase (CAPTPase). The 
substrates of WipA have yet to be determined (Jia et al., 2018). 
 
2.1.6. Modulation of the small GTPase Rab1 by Legionella effectors 
Rabs belong to the Ras-like small GTPase superfamily. These proteins are involved in 
vesicle fusion, budding, tethering and transport. To influence the trafficking of intracellular 
compartments, Rabs engage in a process of membrane binding and dissociation. Briefly, Rabs 
are prenylated by an enzyme called geranylgeranyltransferase, which promotes membrane 
localization. This is followed by Rab activation with a guanine nucleotide exchange factor 
(GEF), that displaces bound GDP with GTP. Nucleotide exchange causes two small areas of 
the Rab protein, called switch I and switch II regions, to transition from disordered to ordered 
states (Luitz et al., 2016). Structural organization of these switch regions propels activated Rab 
to adopt a conformation that interacts with specific effector proteins, such as tethering factors 
or motor proteins involved in transport. Eventually, the biological role of the Rab is complete 
and a GTPase activating protein (GAP) hydrolyzes bound GTP to GDP, deactivating the Rab. 
At this point, a GDP-dissociation inhibitor (GDI) binds GDP-Rab and extracts it from the 
membrane (Figure 2.3). GDI-GDP-Rab exists as a soluble complex until another cycle of 
membrane targeting begins (Goody et al., 2017). 
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Figure 2. 3 Regulation of Rab protein activity by Rab-escort protein (REP), prenylation, guanine 
nucleotide exchange factor (GEF), GTPase activating protein (GAP) and GDP-dissociation 
inhibitor. The GTP-bound Rab resists extraction until it is deactivated by GTP hydrolysis. Figure 
adapted from (Goody et al., 2017). 
 
Importantly, GEFs target Rabs to membranes. Since GDIs have lower affinity for activated 
than deactivated Rabs, the activation of a membrane bound Rab by GEF allows it to resist 
extraction from that membrane by GDI. Conversely, GAPs effectively remove Rabs from their 
resident membranes (Goody et al., 2017). These properties are exploited by Legionella 
effectors in the modulation of Rab activity. For example, by producing effectors that covalently 
modify Rabs such that the active conformation persists despite GTP hydrolysis, a Rab can 
remain membrane-associated for long periods of time. Moreover, host GAPs are often unable 
to deactivate this modified Rab (Spanò and Galán, 2018). What follows is a discussion of the 
methods used by L. pneumophila to modulate the activity of Rab1, a main regulator of the 
secretory pathway that is targeted by six different L. pneumophila effectors (Qiu and Luo, 
2017a; Steiner et al., 2017). 
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Figure 2. 4 Schematic of Rab1 regulation by Legionella pneumophila effectors. SidM (pink) 
promotes activation of Rab1 (light blue) while preventing canonical deactivation by host GAPs. 
SidD (dark green) initiates the process of deactivation by deAMPylating Rab1, rendering it a 
substrate of LepB (orange) or host GAPs. Alternatively, Rab1 can be retained in an inactive state 
by AnkX (grey), which PCylates the protein. This process is reversed by Lem3 (blue).  
 
When localized to the LCV, Rab1 drives the recruitment of ER-derived vesicles to the 
pathogen vacuole. This process is a vital part of LCV maturation and in the establishment of a 
replicative niche. It is important to note that not all six effectors targeting Rab1 promote its 
activation. In fact, some exist to reverse the activating effect of another. Effector pairs with 
inverse roles exemplify the regulatory complexity employed by L. pneumophila. 
SidM is one of the first L. pneumophila effectors to target Rab1 and is recruited to the LCV 
within 0 – 4 hours of infection (Müller et al., 2012). This protein binds PI4P on the LCV and 
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acts as a GEF toward Rab1, thereby targeting it to the pathogen vacuole. Once Rab1 has been 
activated on the LCV surface, SidM attaches an AMP moiety to Rab1 in a process called 
AMPylation (Hardiman and Roy, 2014) (Figure 2.4). It has been known for some time that 
AMPylated Rabs resist the activity of GTPase activating proteins (GAPs) and are thereby 
maintained in an activated state. Until recently, however, it was not known whether AMPylated 
Rab1 is maintained in an active conformation that can interact with GTP-state specific proteins. 
A recent study using molecular dynamics and umbrella sampling has shown that the AMP 
moiety promotes an active-like conformation of Rab1 regardless of the identity of bound 
nucleotide. This occurs by a stacking interaction between the adenine base of AMP and Phe45 
on Rab1, which rigidifies the switch II region of Rab1 (Figure 2.5). Thus, SidM drives the 
localization of Rab1 to the LCV and maintains it in an active conformation (Luitz et al., 2016). 
 
 
Figure 2. 5 AMPylated Rab1 is retained in an active conformation by a stacking interaction 
between the adenine base of AMP and the sidechain of Phe45. Figure adapted from (Luitz et al., 
2016).  
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Activated Rab1 promotes tethering of ER-derived vesicles to the LCV, which then fuse in 
a process involving the noncanonical pairing of Sec22b with Stx3 syntaxin proteins (Arasaki 
et al., 2012). Tethering of ER-derived vesicles to the LCV depends on the exocyst, a protein 
complex that drives fusion of exocytic vesicles with the plasma membrane. Specifically, Sec5, 
Sec6 and Sec15 form a complex with Rab1-SidM-Stx3 and recruit Sec22b-positive vesicles to 
the LCV. The fact that only a subset of exocyst subunits are implicated in this fusion process 
may point to a special role for these proteins in membrane tethering. Since Sec5, Sec6 and 
Sec15 all bind SidM, these proteins may function independently in the recruitment of ER-
derived vesicles to the LCV (Arasaki et al., 2018). 
Since Rab1 AMPylation induces an active conformation regardless of the bound 
nucleotide, one may question the importance of GEF activity in directing Rab1 to the LCV. 
Indeed, studies separating GEF- from AMPylating activity in SidM have shown AMPylation 
to be critical for Rab1 localization to the LCV (Hardiman and Roy, 2014). This suggests that 
AMPylation of Rab1 can occur without activation, and that this modification reduces the 
affinity of GAP for Rab1 to impede membrane extraction by GDI. 
Despite hydrolyzing bound GTP to GDP, cellular GAPs acting on AMPylated Rab1 are 
unable to reverse the effect of SidM (Luitz et al., 2016). Consequently, removal of AMP 
becomes a new prerequisite to deactivation of Rab1 in infected cells. It is intriguing to note 
that L. pneumophila also encodes an effector responsible for AMP removal. This effector is 
called SidD and is secreted into the host cell at a later stage than SidM (Figure 2.4). SidD is a 
de-AMPylase with a catalytic domain like that of metal-dependent protein phosphatases 
(PPMs). Bacterial PPMs have three metal binding sites, designated M1 – 3, with a conserved 
aspartate that coordinates M1 and M3. This residue was found to be absent in the crystal 
structure of SidD, shifting the M1 site and abolishing metal binding at M3 entirely (Figure 2.6) 
(Chen et al., 2013). Thus, SidD has been called a modified PPM that has adapted the ability to 
recognize Rab1. 
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Figure 2. 6 Structural overlay of the catalytic sites in several metal-dependent protein phosphatases 
(PPMs) with coordinating residues depicted as sticks. SidD (cyan) is structurally homologous to 
the tPhpA(D193A) mutant. Neither model has a residue to coordinate M1 and M3, leading to a 
similar shift in the M1 ion and the absence of an M3 ion for both. The remaining structures (yellow, 
green, magenta and red) contain the M1 and M3 coordinating aspartate residue. Figure adapted 
from (Chen et al., 2013). 
 
L. pneumophila also encodes an effector called LepB that antagonizes the GEF activity of 
SidM on Rab1 by acting as a GAP (Figure 2.4). The catalytic mechanism of LepB depends in 
part on its Arg444 sidechain, which coordinates the α- and β-phosphates of GTP. Meanwhile, 
Glu449 of LepB orients Gln70 of Rab1 which, in turn, orients a water molecule for attack on 
the GTP γ-phosphate. Surprisingly, Gln70 sits within a DXXGQ motif that is typically used 
by host GAPs for binding Rabs. Thus, a feature that distinguishes LepB from host GAPs is its 
use of Gln70 in catalysis rather than binding (Figure 2.7) (Mishra et al., 2013). The presence 
of effector proteins that reverse both the AMPylating and GEF activity of Rab1 highlights the 
significance of Rab1 regulation during infection. 
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Figure 2. 7 Structural comparison of (A) the LepB-Rab1 and (B) VirA Rab1 active sites. Note that 
Gln70 of Rab1 and Gln280 of VirA coordinate an ordered water molecule in a similar fashion. 
Canonical and non-canonical interactions are shown in magenta and green, respectively. Figure 
adapted from (Mishra et al., 2013).  
 
Another L. pneumophila effector that covalently modifies Rab1 is AnkX. This protein 
retains Rab1 in an inactivated state by phosphorylcholination (PCylation) of a serine (Ser79) 
residue adjacent to the tyrosine (Tyr80) residue to be AMPylated by SidM. Modification of 
these residues appears to be mutually exclusive (Neunuebel et al., 2012). That is, PCylated 
Rab1 cannot be AMPylated and vice versa. The proximity of these residues likely prevents 
such modifications from taking place simultaneously due to steric hindrance (Neunuebel et al., 
2012). AnkX has a slight preference for GDP-loaded Rab1 over its active counterpart and, 
importantly, prevents the interaction of Rab1 with GDI (Goody et al., 2017; Mukherjee et al., 
2011). Therefore, PCylation prevents inactive Rab1 from membrane extraction. This 
modification has also been found to prevent the interaction of LepB with Rab1 (Hardiman and 
Roy, 2014). Considering the preference of AnkX for GDP-Rab1 and the role of LepB in 
hydrolyzing bound GTP to GDP, it is interesting that GTP hydrolysis would be inhibited by a 
modification occurring predominantly on GDP-Rab1. Apparently, AnkX retains inactivated 
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Rab1 on the LCV and prevents its removal by LepB. Although the purpose of deactivating and 
immobilizing Rab1 is unclear, it would render this GTPase inaccessible to the host.  
PCylation of Rab1 by AnkX is reversed by the L. pneumophila effector, Lem3, which acts 
as a dephosphorylcholinase (dePCylase). The lem3 gene is separated from ankX by a 7bp 
intergenic region and these genes are transcribed convergently (Tan et al., 2011). Neither 
AnkX nor Lem3 are required for the intracellular replication of L. pneumophila in D. 
discoideum or bone-marrow derived macrophages (Tan et al., 2011). 
LidA is an L. pneumophila effector that localizes to the LCV early during infection by an 
interaction with PI3P or PI4P. LidA recruits GDI-free Rab1 to the LCV, bringing Rab1 and 
SidM into proximity which, in turn, leads to the activation and AMPylation of LCV-associated 
Rab1. The crystal structure of LidA reveals the presence of two twisted β-hairpin repeats 
(TBR), one of which is involved in binding Rab1. This interaction orients the central domain 
of LidA to position Rab1 for membrane anchoring (Meng et al., 2013). Thus, although SidM 
retains Rab1 on the LCV, it is LidA that drives its recruitment there. 
Another small GTPase implicated in the secretory pathway is Arf1. The L. pneumophila 
effector RalF retains Arf1 on the LCV using GEF activity, in much the same way that SidM 
recruits Rab1 (Nagai et al., 2002). Activated Arf1 facilitates secretion of vesicles from the 
LCV to the ER. Thus, Rab1 and Arf1 act in concert to promote a dynamic interplay of ER-
LCV traffic and expand the pathogen vacuole (Kagan and Roy, 2002; Mizuno-Yamasaki et al., 
2012). A recent study on small molecule inhibitors of ArfGEFs showed the GEF domain of 
RalF to resist inhibition by Brefeldin A. This result contrasted with other ArfGEFs, for which 
membrane binding had little impact on the efficacy of small molecule inhibitors. Full-length 
RalF harbors a capping domain with aromatic residues that mimic the Arf1 binding interface. 
Inhibition of RalF by Brefeldin A appears to depend on this capping regulatory domain 
(Benabdi et al., 2017).   
 
2.1.7. Hijacking the host ubiquitination machinery 
Ubiquitination is one of the best studied post-translational modifications of proteins. In 
eukaryotes, ubiquitin moieties are attached to target proteins in a complex process involving 
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E1-activating, E2-conjugating and E3-ubiquitin ligase enzymes. Since ubiquitination is 
important in the regulation of nearly all eukaryotic pathways, bacterial pathogens have evolved 
strategies to disrupt this process and use it for their benefit. L. pneumophila predominantly 
uses effector proteins that act as E3-ligase mimics or deubiquitinase (DUB) enzymes to 
interfere with host ubiquitination. Although the role of L. pneumophila effectors in 
ubiquitination has recently been reviewed in detail (Qiu and Luo, 2017b), some new findings 
have emerged in the last year. 
L. pneumophila uses effectors of the cycle inhibiting factor (Cif) family, which deamidate 
a conserved glutamine residue on ubiquitin. This behaviour contrasts that of typical Cif family 
effectors, where NEDD8 harbors the glutamine to be modified (Valleau et al., 2018). Until this 
point, Cifs were found exclusively in pathogenic bacteria encoding a type III secretion system. 
Two L. pneumophila Cifs, MavC (lpg2147) and MvcA (lpg2148), have been structurally 
characterized by X-ray crystallography. These proteins show remarkable specificity for 
ubiquitin and exhibit no activity against NEDD8. To determine whether the ability to 
distinguish ubiquitin from NEDD8 could be traced to the binding mode, NMR spectroscopy 
was used in conjunction with prior knowledge of the Cif:ubiquitin complex. No major 
differences were observed for the MavC/MvcA:ubiquitin spectra relative to Cif:ubiquitin, 
attributing specificity to the local architecture of the active site rather than a different overall 
binding strategy (Valleau et al., 2018). This notion has since been challenged in a study using 
ITC to demonstrate that the C-terminal tail of ubiquitin allows MvcA to distinguish it from 
NEDD8 (Zhu et al., 2018). The noncanonical deamidation of ubiquitin by MavC was found to 
increase the rate of Ube2N ubiquitination and was therefore thought to increase the reactivity 
of Ube2N-conjugated ubiquitin, perhaps even in the absence of native target (Valleau et al., 
2018). Furthermore, MavC activity has been found to dampen NF-κB signaling and prevent 
the formation of K63-linked ubiquitin chains on proteins belonging to pathways derived from 
NF-κB signaling. Finally, a third gene adjacent to MavC and MvcA, lpg2149, encodes an 
effector that inhibits the deamidase activity of these L. pneumophila Cifs (Valleau et al., 2018).  
Legionella also produces dedicated deubiquitinases (DUBs) to remove ubiquitin from 
target proteins. One such effector, LotA, is comprised of two ovarian tumour (OTU)-like 
domains harboring catalytic cysteines (C13 and C303). Proteins belonging to the OTU 
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superfamily are cysteine proteases with DUB activity. The C-terminal catalytic cysteine of 
LotA, C303, acts in conjunction with a PI3P-binding segment to guarantee removal of 
ubiquitin from the LCV. In the N-terminal domain, C13 cleaves K6-linked ubiquitin chains. 
LotA appears to function synergistically with SidEs, because inactivation of both proteins in 
L. pneumophila causes a greater defect in bacterial replication than either protein individually 
(Kubori et al., 2018). Since LotA disassembles K-linked ubiquitin chains, this enzyme is 
unlikely to show activity against the S-linked ubiquitin generated by the SidE-family of 
effectors (see section 2.2.2.3). Thus, LotA is more likely to act during early stages of infection, 
before ubiquitination of substrates by SidEs has occurred. This distinction of LotA DUB 
activity from that of SidE-family effectors can be justified by noting that LotA must bind PI3P 
to remove ubiquitin from the LCV. Since PI3P is enriched on the early LCV, LotA likely 
carries out its DUB activity at early stages of bacterial vacuole formation (Kubori et al., 2018).  
Another DUB encoded by L. pneumophila, SidJ, is unique in its ability to cleave PR-Ub 
linkages and shares a preference with SidE DUBs for K63-linked polyubiquitin chains. 
Although the catalytic mechanism of SidJ remains unclear, this enzyme does not act as a thiol- 
or metalloprotease and may therefore utilize a novel mechanism for cleavage of 
isopeptide/phosphoribosyl ubiquitin linkages. The DUB activity of SidJ is critical for L. 
pneumophila infection and reverses the ubiquitin-linkages generated by SidE-family enzymes 
(the N-terminal DUB activity of SidEs does not act on PR-Ub linkages) (Ronau and 
Hochstrasser, 2017). A detailed understanding of the SidJ DUB activity will provide insight 
into how L. pneumophila regulates its own pattern of ubiquitination. 
 
2.1.8. Interference with endocytic and retrograde trafficking pathways 
L. pneumophila disrupts secretory (anterograde), endocytic and retrograde trafficking 
pathways in macrophages. The secretory pathway defines transport of newly synthesized 
proteins or lipids from the ER to their cellular destinations (Qiu and Luo, 2017a). Endosomal 
trafficking describes the process in which cargos brought into the cell are transported to their 
designated organelles or destroyed within lysosomes (Allgood and Neunuebel, 2018). Finally, 
retrograde trafficking is the transport of endosomal cargo back to the ER (Elwell and Engel, 
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2018). Rab1 promotes (secretory) ER to Golgi traffic by recruiting the tethering factor p115 
and v-SNAREs to ER-derived vesicles (Allan et al., 2000a). In the following section, an 
overview of the methods used by Legionella to hijack endocytic and retrograde trafficking is 
given. 
Endocytic trafficking can be divided into three branches. In one, early endosomes are 
converted to late endosomes by a Rab-switching mechanism (Rink et al., 2005). Late 
endosomes then fuse with lysosomes, which harbor lytic enzymes to degrade the engulfed 
cargo. Another branch of the endocytic pathway is retrograde trafficking or the transport of 
early endosomes through the trans-Golgi network to the ER. Finally, early endosomes can be 
rerouted to the plasma membrane in a process called recycling endocytosis. These vesicular 
trafficking pathways are regulated by host Rab GTPases, which act as molecular switches and 
interact with effectors involved in membrane tethering and vesicle movement.  
Recycling endocytosis occurs via fast and slow pathways. In the fast pathway, early 
endosomes are transported directly to the plasma membrane. The slow pathway moves early 
endosomes along membrane tubules to a perinuclear region called the endocytic recycling 
compartment (ERC) (Allgood and Neunuebel, 2018). L. pneumophila has been found to 
interfere with both the fast and slow pathways of recycling endocytosis, as evidenced by its 
effect on transferrin recycling. Transferrin is a substrate of recycling endocytosis and remains 
bound to its receptor on early endosomes until they fuse with the plasma membrane (Mellman, 
1996). L. pneumophila diminishes the export of transferrin using the AnkX effector, which 
PCylates Rab35 and renders it inactive. Another Rab implicated in recycling endocytosis, 
Rab11a, was also found in association with the LCV and ubiquitinated in a manner dependent 
on the effector AnkB. Intriguingly, recruitment of Rab35 to the LCV depends on the presence 
of AnkB, which implies a role for ubiquitination in this process (Allgood and Neunuebel, 
2018). 
The LCV does not bind Rab5 or Rab7 and therefore deviates from the canonical endosome 
maturation process. In non-infected cells, Rab5 is recruited to early endosomes by the Rab5 
GEF, Rabex-5, and promotes their fusion using an effector called Rabaptin-5 (Stenmark et al., 
1995). Another Rab5 effector is the early endosome antigen 1 (EEA1), which has been found 
to play a role in tethering early endosomes to one another prior to fusion (Christoforidis et al., 
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1999). Rab7 is later recruited to the maturing endosome by a Rab7 GEF called the Mon1-Ccz1 
complex. The targeting of Mon1-Ccz1 to endosomes depends on Rab5-GTP and PI3P 
(Poteryaev et al., 2010). Thus, avoidance of Rab5 recruitment and activation prevents Rab7 
accumulation on endosomes. L. pneumophila exploits this interdependency of endosomal Rabs 
using the VipD effector, which binds Rab5 and prevents its association with Rabaptin-5 and 
EEA1 (Ku et al., 2012). This may help the LCV avoid fusion with early endosomes while 
preventing steps characterizing the development of late endosomes or autophagosomes. 
Furthermore, Rab5-activated VipD uses phospholipase A activity to catalyse the removal of 
PI3P from endosomal membranes, thereby protecting the LCV from downstream fusion events 
(Lucas et al., 2014). Another effector, lpg0393, has also been found to infiltrate endocytic 
trafficking. Specifically, lpg0393 is structurally related to Rabex-5 and interacts with Rab5, 
Rab21 and Rab22. By exerting GEF activity on these Rabs, lpg0393 competes with Rabex-5 
for their activation (Sohn et al., 2015). 
Legionella also avoids autophagy using the secreted effector RavZ, which binds and 
liberates phosphatidylethanolamine (PE)-conjugated microtubule-associated protein 1A/1B 
light chain 3B (LC3) from the LCV. In non-infected cells, LC3 associates with the phagophore 
membrane using its PE tail. Lipidation of LC3 facilitates autophagosome biogenesis and the 
recruitment of autophagy cargo (Pankiv et al., 2007; Xie et al., 2008). Another autophagy-
regulating protein, ATG4B, removes PE from LC3 in such a way that re-conjugation is 
possible (Nair et al., 2012; Nakatogawa et al., 2012). Although the purpose of PE 
deconjugation by ATG4B remains unclear (Agrotis et al., 2019), it is likely a form of regulatory 
control over autophagic trafficking. Unlike ATG4B, RavZ cleaves LC3 before the C-terminal 
glycine. This prevents LC3 from reattaching to PE and thereby reduces the pool of this 
autophagic component available to the host (Kwon and Song, 2018). Two structure-based 
hypotheses have been given for the mechanism of LC3 cleavage by RavZ. In one, RavZ is 
tethered to the membrane by two N-terminal and one C-terminal LIR motifs prior to catalysis. 
The other model suggests that a hydrophobic α-helix within RavZ separates LC3-PE from the 
membrane and exposes the cleavage site (Kwon and Song, 2018). A structure of RavZ in 
complex with LC3 is likely to clarify our understanding of this process. 
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It has been well established that retrograde trafficking impedes the survival of L. 
pneumophila within the host (Bärlocher et al., 2017). The polyphosphate-5-phosphatase, 
Dd5P4 (D. discoideum), and its human homologue, OCRL, play essential roles in retrograde 
transport and are recruited to the LCV at early stages of infection (Welin et al., 2018). An 
interaction of the LCV with these 5-phosphatases has been shown to restrict intracellular 
replication (Weber et al., 2009). A recent study using quantitative imaging flow cytometry has 
shown that Dd5P4 inhibits the recruitment of calnexin and Rab1 to the LCV but has no effect 
on Rab7/Rab8 accumulation. Since ER membranes are recruited to the LCV during maturation, 
calnexin can be considered a marker for the typical development of this vesicle. An absence of 
calnexin on the LCV therefore suggests that ER-interactions have been hampered. Such a 
disruption to LCV maturation is likely to affect replication, as this vacuole must develop into 
a niche that accommodates bacterial growth and division. Still, the mechanism relating 
calnexin recruitment to the LCV and a replication defect in L. pneumophila remains to be 
elucidated. 
In addition to its role in preventing LCV maturation, Dd5P4 enhances localization of the 
sorting nexin, Vps5, to the LCV (Welin et al., 2018). This suggests that Dd5P4 acts prior to 
formation of the retrograde trafficking vesicle. Analysis of retromer components (Vps26, 
Vps29 and Vps35) present on the LCV in cells lacking Dd5P4 showed that Vps26 levels are 
increased while Vps35 is decreased. This differential regulation of retromer components by 
Dd5P4 may arise from distinct retrograde coat complexes, which harbor a unique complement 
of cargo recognition subunits (Welin et al., 2018). That is, LCV formation may depend on the 
recruitment of a specific retrograde coat complex. The actin nucleator, WASH, was also found 
to restrict intracellular replication of L. pneumophila (Welin et al., 2018). WASH drives the 
retrograde trafficking vesicle away from the endosomal network and its effect on replication 
indicates that even early stages of retrograde transport play a role in the survival of L. 
pneumophila.  
Another L. pneumophila effector implicated in retrograde trafficking is RidL, which 
competes with TBC1d5 for binding to Vps29. Because TBC1d5 is a regulator of endosomal 
transport, RidL can be expected to block this retromer-mediated process (Yao et al., 2018).  
 
 21 
 
2.2. X-ray crystallography in the study of host-pathogen interactions 
 
2.2.1. Host-pathogen interactions 
Intracellular bacterial pathogens engage the host machinery and disrupt autoimmune 
defenses. In many cases, the host-pathogen interaction occurs at the protein level. Bacterial 
proteins called effectors mimic, bind or modify various host proteins such as transcription 
factors, enzymes and regulatory elements. Functional analysis of effectors often requires 
identification of their host target(s). Once found, these target proteins implicate a pathway or 
process for further investigation. For example, an effector that interacts with a retromer 
component is likely to interfere with retrograde trafficking. Detailed structural data on the 
effector or effector-target complex can be used to determine how this interference occurs. An 
effector may adopt a fold known to carry out a specific function. Alternatively, an effector-
target complex may show the target protein to be locked in an inactive conformation. By 
uncovering the consequences of target-binding, we can begin to infer the role of bacterial 
effectors in infection. 
 
2.2.2. Applications of X-ray crystallography in the study of bacterial pathogenesis 
X-ray crystallography has long been used as a tool to obtain structural data on effectors 
and the host-pathogen interface. This method allows the interaction of macromolecules to be 
visualized at atomic level resolution, provided such a complex can be captured in a crystal 
structure. Alternatively, ligand binding sites can be uncovered in models of independent 
effectors. Comparing the fold of an effector protein to that of a previously characterized model 
may give insights into its function. For example, if the unknown protein shares the fold of an 
enzyme, crystallography may be coupled with site-directed mutagenesis to reveal the 
mechanism. These strategies drive research forward by offering new lines of investigation into 
the protein of interest. Indeed, our appreciation of L. pneumophila pathogenesis has been 
largely aided by crystal structures. Many L. pneumophila effectors directly bind a eukaryotic 
protein to carry out their function in the host cell. Thus, crystal structures of effectors in 
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complex with their target often provide valuable insights into function. Herein, we review 
recent studies in which X-ray crystallography has advanced our understanding of L. 
pneumophila pathogenesis, with a special emphasis on host-pathogen interactions. 
 
2.2.2.1. The secretory pathway 
A key protein regulating secretory trafficking is the small GTPase, Rab1. In a non-infected 
cell, activated Rab1 localizes to the endoplasmic reticulum (ER) and Golgi apparatus (Plutner 
et al., 1991; Saraste et al., 1995), where it binds tethering factors (p115/v-SNAREs) to initiate 
the fusion of ER-derived vesicles with the Golgi (Allan et al., 2000b). L. pneumophila encodes 
several effectors to interfere with Rab1. One such effector is SidM/DrrA, which activates Rab1 
by catalyzing the exchange of bound GDP for GTP while promoting the separation of Rab1 
from GDI. Thus, by extracting GDP-Rab1 from GDI and catalyzing nucleotide exchange, 
SidM carries out both steps in the process of Rab1 activation. Structural studies on the SidM-
Rab1 complex indicate that SidM displaces GDI from Rab1. A comparison of the SidM/Rab1 
structure with a previously determined model of GDI/Ypt1:GDP revealed that Rab1 uses the 
same residues to bind both SidM and GDI. Further analysis led the authors to suggest that 
SidM evolved the ability to displace GDI by increasing its affinity for GDP-Rab1 (Suh et al., 
2010).  
Despite having GDF activity on GDP-Rab1, SidM binds GTP-Rab1 with much higher 
affinity. Therefore, while crystal structures of SidM/GTP-Rab1 have been obtained using 
relatively straightforward approaches, new methods of protein engineering were required to 
solve SidM in complex with GDP-Rab1. Specifically, bromoalkyl-lysine residues were 
incorporated at critical interfacial positions to generate covalent crystal contacts. This strategy 
led to the first structure of SidM:GDP-Rab1, which revealed that Mg2+ is essential for retaining 
Rab1 in the GDP-bound state and is coordinated by Ser22 and Asp63. The authors discovered 
that successive increases in the distances between these coordinating residues occur in 
structures of GppNHp-Rab1, SidM:GDP-Rab1 and SidM:Rab1 (Figure 2.8). This implies that 
dissociation of Mg2+ occurs prior to GDP removal, a critical new insight into the mechanism 
of nucleotide exchange by SidM (Cigler et al., 2017). 
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Figure 2. 8 Successive increases in the distance between Mg2+ coordinating residues (D63 and 
S22) in crystal structures of Rab1with a non-hydrolysable analogue of GTP analogue, GDP and 
no ligand. These findings suggest that Mg2+ exits the active site prior to GDP. 
 
SidM not only activates but also modifies Rab1 by adding adenosine monophosphate 
(AMP) to a tyrosine sidechain located in the so-called “switch II” region, which undergoes 
significant conformational changes upon nucleotide exchange. AMPylation keeps Rab1 in an 
active conformation that does not depend on the identity of bound nucleotide. This 
modification also prevents activated Rab1 from interacting with the host protein, MICAL-3. 
Intriguingly, L. pneumophila encodes an effector called LidA that disrupts secretory trafficking 
by binding to active, inactive or even AMPylated Rab1. LidA has also been shown to bind 
Rab6 and Rab8, which are recruited to the LCV during infection (Schoebel et al., 2011). 
Eukaryotic Rab effectors typically use two α-helices to interact with a hydrophobic triad 
between the switch regions of the Rab protein. The crystal structure of LidA in complex with 
Rab8a shows an unusually large binding interface of four α-helices that extends beyond both 
switch regions and the hydrophobic triad of Rab8a (Figure 2.9). The presence of interacting 
residues outside the switch regions likely allows LidA to bind AMPylated Rab and leads to its 
picomolar affinity for GTP-Rab proteins. A consequence of this high binding affinity is limited 
dissociation of the complex, rendering Rab inaccessible to host GAPs (Schoebel et al., 2011). 
This may imply a role for LidA in recruiting Rabs to the LCV, although the exact function of 
LidA in L. pneumophila pathogenesis remains unclear. The crystallographic data obtained for 
the LidA/Rab8a complex reveals a unique binding mechanism that has garnered LidA the title 
of “Rab supereffector.”  
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Figure 2. 9 Crystal structure of the LidA-Rab8a complex with Rab8a shown in grey and LidA in 
rainbow. The four interacting helices in LidA are labelled (α1L, α7L, α4L, α5L). Figure adapted 
from (Schoebel et al., 2011). 
 
2.2.2.2. Effectors with protease activity 
Several crystal structures of L. pneumophila effectors with protease activity have recently 
been determined. One of these structures was obtained in a study that coined the term 
“metaeffector” to describe effectors that mitigate the role of another. To fully characterize one 
of these effector/metaeffector pairs, the authors solved the crystal structure of LegL1 in 
complex with RavJ (Urbanus et al., 2016). Initially, the RavJ N- and C-terminal domains were 
solved independently. Structural homology between the N-terminus of RavJ and papain-like 
cysteine proteases (PLCP) allowed the authors to identify putative catalytic triad residues for 
this protein. Indeed, mutating any of these residues abrogated the growth defect in yeast cells 
expressing RavJ. Meanwhile, LegL1 is a leucine-rich repeat (LRR) protein that adopts a curved 
overall fold. In the LegL1/RavJ co-crystal, LegL1 arches over the RavJ catalytic triad, 
impeding its activity in a non-proteolytic mechanism of steric inhibition (Figure 2.10) 
(Urbanus et al., 2016). 
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Figure 2. 10 Crystal structure of (A) RavJ and (B) the RavJ-LegL1 complex. Active site residues 
are shown as sticks. LegL1 arches over the active site of RavJ to prevent catalysis. Figure adapted 
from (Urbanus et al., 2016). 
 
Lpg2622 is a substrate of the Lsp type II secretion system (T2SS) that also belongs to the 
PLCP family. Although the role of cysteine proteases in L. pneumophila pathogenesis remains 
unclear, a similar protein in Streptococcus pyogenes (SpeB) has been shown to degrade 
immunoglobulins and cleave cytokine precursors. These abilities help S. pyogenes evade host 
immunity and promote septic shock. Crystal structures have been solved for Lpg2622 in the 
apo-form and in complex with the E64 inhibitor. Lpg2622 shares the architecture of C1 family 
peptidases but contains a novel propeptide comprising a hairpin-turn-helix (β1-β2-α3) fold. 
Importantly, the propeptide of Lpg2622 does not fully occupy the active site cleft, although it 
makes extensive interactions with its catalytic C-terminus. This contrasts with the propeptides 
of cathepsin-L-like or B-like enzymes, which extend deep into the catalytic pocket to inhibit 
enzyme activity. Furthermore, removing any secondary structure elements from the Lpg2622 
propeptide leads to the formation of inclusion bodies. These findings suggest the propeptide is 
essential for proper folding of Lpg2622 and is unlikely to be cleaved. The Lpg2622-E64 
complex structure corroborates this notion by being the first PLCP-inhibitor model with the 
propeptide intact. Importantly, the β2-strand of the Lpg2622 propeptide plays a regulatory role 
in catalysis, as abolishing its interaction with the catalytic domain increased enzymatic activity 
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of Lpg2622 (Gong et al., 2018). These findings show a unique modification on PLCP family 
enzymes where the propeptide acts as a non-cleavable regulatory element. 
Other substrates of the L. pneumophila T2SS are the predicted aminopeptidase and 
acyltransferase, LapA and PlaC, respectively. A recent study on these proteins showed that 
mutating LapA increases the levels of PlaC mRNA in L. pneumophila and vice versa, 
suggesting that these proteins compensate for one another during infection. Moreover, 
mutating both LapA and PlaC significantly limits the invasion of Acanthamoeba castellanii by 
L. pneumophila. LapA cleaves various aminopeptides including leucine, valine, isoleucine, 
aspartate, methionine and phenylalanine as a nutrient source for L. pneumophila but the role 
of this function in host cell invasion remains unclear. To establish the molecular basis for its 
broad substrate specificity, the authors solved the crystal structure of LapA and showed it to 
contain a deep hydrophobic cavity adjacent to the active site, which could accommodate 
aromatic and aliphatic side chains. Comparison of the LapA model with a previously solved 
structure of LapB shows a wider and more negatively charged pocket in the latter, consistent 
with its ability to cleave near lysine and arginine residues. This is a case where X-ray 
crystallography has been used to show how small structural differences between similar 
proteins can produce significant functional consequences. Although the mechanism of 
complementation between PlaC and LapA remains to be deduced, it is clear from this study 
that enzymes secreted by the T2SS play an important role in L. pneumophila invasion. 
 
2.2.2.3. The ubiquitin pathway 
Many L. pneumophila effectors have been found to subvert host ubiquitination. One of 
these is AnkB, an effector that promotes ubiquitination by interacting with the eukaryotic 
Skp1-Cullin-F box (SCF) ubiquitin ligase. AnkB facilitates the attachment of poly-
ubiquitinated proteins to the LCV. These proteins are ultimately degraded into free amino 
acids, which serve as an energy source for L. pneumophila. The role of AnkB in pathogenesis 
is essential for L. pneumophila replication in human macrophages, making this protein a 
particularly interesting candidate for investigation. 
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Until recently, our understanding of how AnkB usurps the function of SCF remained unclear. 
A crystal structure of AnkB in complex with Skp1 revealed that N-terminal residues 2 – 165 
of AnkB adopt an F-box fold that is nearly identical to that of Skp2. The interaction between 
AnkB and Skp1 relies on a hydrophobic patch present in helices 1 and 2 within the AnkB F-
box. This patch causes AnkB to form inclusion bodies when purified in the absence of Skp1. 
A high resolution (1 Å) crystal structure of the AnkB ankyrin domain (res 54 – 168) shows a 
C-terminal pentapeptide (QEEKI) from one molecule binding the curved surface of a 
neighboring chain. Although this interaction is unlikely to be of biological significance to 
AnkB, it does highlight the promiscuity of protein-protein interactions mediated by ankyrin 
domains. Furthermore, mutations destabilizing the ankyrin fold of AnkB were found to disrupt 
the intracellular replication of L. pneumophila. Although other effectors harboring F-box 
domains are encoded by L. pneumophila, only AnkB contains an attached ankyrin domain. 
These structural data show that AnkB docks to the SCF using an N-terminal F-box domain 
while recruiting host proteins for ubiquitination with its ankyrin domain. Thus, AnkB provides 
two examples of molecular mimicry by independent domains that perform a concerted function 
(Wong et al., 2017).   
 
Figure 2. 11 Crystal structure of AnkB in complex with Skp1. (A) The ankyrin repeat region of 
AnkB is shown in green and the F-box is in pink. Skp1 is depicted in cyan. (B) Overlay of the 
Skp2 (dark blue) and AnkB (pink) F-boxes. Figure adapted from (Wong et al., 2017). 
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Another Legionella effector, RavN, is also involved in ubiquitination. Despite acting as an 
E3-ubiquitin ligase, RavN shares no primary sequence homology with any known E3. The 
crystal structure of RavN shows a similar fold to that seen in U-box E3 ligases, with the best 
alignment occurring at the central β-sheet region. This remote similarity between RavN and 
known E3s inspired the authors to search for additional effectors using hidden Markov model-
based secondary structure analysis. Four new effectors involved in ubiquitination were 
discovered in this way (Lpg2370, Lpg2577, Lpg2498, and Lpg2452/SdcB). The number of 
effectors employed in this process highlights the significance of ubiquitination to the survival 
of L. pneumophila. Structural deviations from the classical fold may suggest that these 
effectors were obtained by horizontal gene transfer and structurally altered during their 
evolution. This work demonstrates how structural biology can be used to reveal the function 
of effectors showing only vague similarity to known E3s (Lin et al., 2018).  
SidC is an L. pneumophila effector with E3 ubiquitin ligase activity that recruits ER-
derived proteins to the LCV. A crystal structure of the SidC N-terminal ubiquitin ligase (SNL) 
domain exhibited no homology to known proteins. Multiple sequence alignment of SidC 
proteins from various L. pneumophila species revealed conserved catalytic residues of a 
cysteine protease. Structural analysis showed this putative catalytic triad (Cys46, His444, 
Asp446) to reside on a negatively charged surface at the center of the SNL domain. 
Surprisingly, SidC does not act as a protease but exhibits E3 ligase activity that depends on the 
catalytic cysteine (Cys46). The authors suggest that His444 and Asp446 increase the 
nucleophilicity of Cys46 and thereby facilitate the transfer of ubiquitin from E2 onto SidC 
(Hsu et al., 2014). This serves as an example of how structural biology can operate in concert 
with bioinformatics to reveal functionally important residues in a protein of interest. 
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Figure 2. 12 Surface electrostatic rendering of the SidJ crystal structure showing a negatively 
charged surface (purple) containing putative catalytic triad residues. This area is enlarged on the 
right to show the catalytic residues and their hydrogen bonding pattern. Figure adapted from (Hsu 
et al., 2014). 
 
Another interesting method of E3-ligase mimicry is demonstrated by the SidE family of 
effectors (SdeA, SdeB, SdeC and SidE), which ubiquitinate target proteins without the help of 
E1 or E2 enzymes. These effectors rely on mono-ADP-ribosyltransferase (mART) and 
phosphodiesterase (PDE) activities to carry out ubiquitination in an NAD+-dependent manner. 
Specifically, mART activity catalyzes the formation of ADP-ribosylated ubiquitin (ADPR-
Ub), which is cleaved into AMP and phosphoribosylated ubiquitin (PR-Ub) by the PDE. 
Finally, PR-Ub is attached to serine on a target protein (Akturk et al., 2018). The use of serine 
contrasts with the conventional approach, in which ubiquitin is linked to the target protein by 
a lysine residue. 
Extensive structural studies have been carried out to explain the all-in-one approach to 
ubiquitination employed by SidEs. The crystal structure of SdeA contains a mono-ADP-
ribosyltransferase (mART) domain that is divided into an α-helical lobe (AHL) and a mART 
core. The mART core is near the phosphodiesterase (PDE) domain of SdeA, while the AHL is 
distant from remaining regions of the protein (Figure 2.13) (Kalayil et al., 2018). Solution 
NMR structures showed the AHL to be adjacent to the mART core, however, suggesting that 
transient movements of this domain occur to facilitate NAD+ binding and catalysis. 
Importantly, both mART and PDE domains were found to act independently of one another. 
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That is, a SdeA construct of mART only ubiquitinated target proteins if a construct of PDE 
was also present and vice versa. This suggests that ADP-ribosyltransferase and 
phosphodiesterase activities do not depend on the interaction of these individual domains. 
 
Figure 2. 13 Crystal structure of SdeA showing the mART core (pink) in proximity to the PDE 
domain (green), with the AHL (blue) distant from both. Solution NMR studies of this protein 
suggest the AHL can move near the mART core to facilitate catalysis. Figure adapted from 
(Kalayil et al., 2018). 
 
A complex structure of SdeA-Ub-NADH provided new perspective on the ADP-
ribosylation of ubiquitin at the mART domain. Although it had been accepted that Arg42 of 
ubiquitin attacks the N-ribose in an SN1 reaction, these atoms are too far apart in the complex 
to justify such a mechanism. To address this issue, molecular dynamics simulations were 
carried out using the SdeA-Ub-NADH complex structure with NADH replaced by NAD+. 
These studies revealed a nearby arginine residue, Arg72, which recognizes the strained 
nicotinamide moiety of NADH. Separation of nicotinamide from NAD+ destabilizes the 
interaction of Arg72 and allows Arg42 to move in the direction of ADP-ribose, bringing it into 
proximity with the N-ribose and thereby facilitating SN1 mediated catalysis (Dong et al., 
2018).  
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Figure 2. 14 Conformational changes of ubiquitin residues prior to ADP-ribosylation by SdeA. 
Arg72 initially recognizes the nicotinamide moiety of NADH (left) and moves away from the 
ligand once cleavage has occurred (middle and right). Meanwhile, Arg42 orients itself toward N-
ribose after nicotinamide has been cleaved. Figure adapted from (Dong et al., 2018). 
 
The crystal structure of inactive SdeD in complex with ADP-ribosylated ubiquitin provides 
insight into the interaction of ADP-ribose with the PDE domain. ADP-ribose contacts one 
glutamate and two histidine residues in the active site. These residues were invariant between 
SidE-family proteins, and the corresponding residues in SdeA (His277, His407 and Glu340) 
abolished phosphodiesterase activity when mutated to alanine. These data allowed the authors 
to propose a catalytic mechanism for the PDE domain, wherein Glu340 positions His277 for 
nucleophilic attack on the β-phosphate of ADP-ribose. This leads to the formation of a transient 
phosphoramidate intermediate, which is cleaved by a serine residue on the target protein 
(Akturk et al., 2018). 
 
2.2.2.4. Endocytic, autophagic and retrograde trafficking pathways 
L. pneumophila also disrupts endocytic and retrograde trafficking pathways in 
macrophages. Endosomal trafficking describes the process in which cargos brought into the 
cell are transported to their designated organelles or destroyed within lysosomes (Allgood and 
Neunuebel, 2018). Autophagy is a branch of endocytic trafficking that is dedicated to the 
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digestion of engulfed material. Conversely, retrograde trafficking is the transport of endosomal 
cargo back to the ER (Elwell and Engel, 2018). Crystal structures have added extensive detail 
to our understanding of how L. pneumophila uses effector proteins to disrupt these processes. 
VipD is an L. pneumophila effector that binds Rab5 on endosomes and interferes with the 
Rab5-Rab7 conversion that characterizes endosomal maturation. Furthermore, Rab5-activated 
VipD uses phospholipase A (PLA1) activity to catalyse the removal of PI3P from endosomal 
membranes and thereby protect the LCV from downstream fusion events (Lucas et al., 2014). 
The PLA1 activity of VipD depends on its interaction with Rab5. A crystal structure showed 
VipD to harbor a surface loop, called the ‘lid,’ that occludes the active site. The lid is a common 
regulatory feature among phospholipases that undergoes conformational changes to expose the 
catalytic site in activated enzymes. It was suggested that the VipD lid changes its orientation 
upon Rab5-binding. A crystal structure of the Rab5/VipD complex was solved to determine 
the conformational effects of the Rab5 interaction. As expected, Rab5-binding repositions the 
VipD lid to expose its catalytic pocket. The interaction of Phe442 in VipD within a 
hydrophobic pocket on Rab5 leads to a cascade of conformational changes that ultimately 
displaces the β10-α14 (lid) loop, which would otherwise block the active site. These 
conformational changes were determined based on comparisons of the complex with a model 
of isolated VipD (Lucas et al., 2014). This study serves as an elegant example of how the 
information in different crystal structures can be combined to explain molecular 
rearrangements. 
RidL is an L. pneumophila effector known to impede retrograde trafficking by engaging 
retromer components. The mechanism of inhibition has been revealed by two crystal 
structures. One model shows the RidL/Vps29-Vps35 complex (Romano-Moreno et al., 2017) 
and the other contains only RidL/Vps29 (Yao et al., 2018). Both structures provide insight into 
the host-pathogen interface by showing that RidL competes with the TBC1d5 regulator for 
binding to Vps29. This is made apparent by the similar conformations of binding loops present 
in RidL and TBC1d5. Since the retromer requires TBC1d5 for endosomal transport, RidL 
likely blocks retromer-mediated traffic by preventing the association of this regulator with 
Vps29 (Yao et al., 2018). These studies provide yet another example of molecular mimicry in 
effector-host interactions as revealed by X-ray crystallography. 
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Figure 2. 15 Crystal structure of the RidL N-terminal domain (cyan) in complex with Vps29 (grey). 
The binding loop of TBC1d5 (magenta) is overlaid and shown in greater detail on the right. Figure 
adapted from (Yao et al., 2018). 
 
Acidification of late endosomes and lysosomes depends on a membrane protein complex 
called the vacuolar H+-ATPase (v-ATPase), which pumps protons into these compartments at 
the expense of ATP hydrolysis (Harrison and Muench, 2018). Lowering the pH of phagosomes 
is an essential part of autophagy, as lysosomal digestive enzymes have optimal activity under 
acidic conditions and production of reactive oxygen species (ROS) requires protons (Vieira et 
al., 2002). The v-ATPase is comprised of a membrane-embedded (V0) and cytosolic (V1) 
region consisting of three catalytic A/B heterodimers. These heterodimers each contain a 
nucleotide binding site that undergoes conformational changes to facilitate ATP hydrolysis by 
a rotary catalytic mechanism (Walker, 1998). L. pneumophila relies on the effector SidK to 
prevent acidification of the LCV. The mechanism by which SidK inhibits v-ATPase activity 
was revealed using single particle electron cryomicroscopy (cryo-EM) in conjunction with 
crystallography. A crystal structure of the SidK N-terminus reveals three α-helical bundles 
with two short helices in bundle I that deviate from the helical axis. The cryo-EM model of 
SidK/v-ATPase shows three SidK molecules bound to the catalytic A-subunits of the complex. 
This interaction is mediated by SidK residues in the short and long helices of bundle I. The C-
terminus of SidK was poorly resolved in the cryo-EM map, suggesting flexible tethering of 
this molecule to the v-ATPase. Surprisingly, the SidK/v-ATPase interaction did not show any 
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significant conformational changes to v-ATPase. The authors found that SidK limited the 
flexibility in A/B heterodimers to lower the affinity of ATP for this region of the protein. This 
led to a ~40% decrease in v-ATPase activity, impeding acidification of the LCV without killing 
the host cell (Zhao et al., 2017). 
 
 
Figure 2. 16 Cryo-EM structure of SidK in complex with the vATPase. (A) Electron micrographs 
showing three molecules of SidK bound to the catalytic V1 region of the v-ATPase. SidK is well 
resolved at the N-terminus, where it contacts v-ATPase (teal arrowheads) but poorly resolved at 
the C-terminus (teal dashed circles). (B) Molecular contacts between SidK (teal) and the A-subunit 
of v-ATPase (yellow). Critical interacting residues within bundle I are denoted. (C) Cryo-EM map 
density showing a lack of definition at the C-terminus. Figure adapted from (Zhao et al., 2017). 
 
RavZ in an L. pneumophila effector that irreversibly removes PE from the autophagy 
marker, LC3 (see section 2.1.8). To address whether RavZ depends on membranes for its 
activity, researchers generated liposome-free LC3-PE by a semisynthetic approach and 
exposed these compounds to RavZ. These studies showed that RavZ does not rely on 
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membranes to deconjugate PE from LC3-PE, leading the authors to suggest that RavZ extracts 
LC3-PE from membranes prior to initiating cleavage. The crystal structure of RavZ in complex 
with LC3-PE revealed an LC3-interacting region (LIR) motif and lipid-binding site (LBS) on 
RavZ, which appear to position the LC3 C-terminus for cleavage. The absence of a LBS in 
ATG4B may explain the different mechanism of these proteins. A hydrophobic α-helix within 
RavZ is thought to separate LC3-PE from the membrane and expose the cleavage site (Yang 
et al., 2017). 
 
Figure 2. 17 Crystal structure of RavZ in complex with LC3. (A) RavZa contacts the α2-β3 loop 
(orange) of LC3 using its LIR loop (purple). The catalytic and PI3P-binding domains of RavZa 
are shown in blue and teal, respectively. LC3 is shown in green. (B) A symmetry related RavZb 
(cyan) contacts the LIR loop of RavZa with its α3 and β6-β7 loops (yellow). The flexible α3 could 
move to expose the LBS of RavZ. Figure adapted from (Yang et al., 2017). 
 
2.2.2.5. Effector kinases and phosphatases 
LegK4 belongs to the ‘eukaryotic-like’ family of kinases encoded by L. pneumophila. It is 
comprised of an N-terminal domain, a eukaryotic-like kinase domain (consisting of N- and C-
lobes) and a C-terminal domain. A helical cap makes extensive contacts with and likely 
stabilizes the N-lobe of the kinase domain in LegK4. In contrast to conventional kinases, 
LegK4 does not depend on autophosphorylation of the activation loop to stabilize this segment 
of the protein. An extensive hydrogen bond network allows LegK4 to adopt an active 
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conformation in the absence of autophosphorylation. Furthermore, the LegK4 structure reveals 
a noncanonical dimeric interface that stabilizes the activation loop to facilitate catalysis (Figure 
2.18). These structural observations help to explain the constitutive activity of LegK4 and 
reveal how fascinatingly an effector can evolve to suit the pathogen (Flayhan et al., 2015). 
 
 
Figure 2. 18 Crystal structure of the LegK4 dimer with chain A shown as surface and chain B 
shown as ribbon (left). Interactions between αF helices (orange) at the dimer interface facilitate a 
hydrogen bond between Asn263 and Ser232 on the P+1 loop. This interaction is present in both 
apo- and substrate-bound forms, suggesting that dimerization has a stabilizing effect on the 
activation loop. Figure adapted from (Flayhan et al., 2015). 
 
Ceg4 is a haloacid dehalogenase (HAD)-like phosphotyrosine phosphatase with activity 
against eukaryotic MAP kinases. The crystal structure of Ceg4 reveals an N-terminal HAD-
like domain and a C-terminal domain with two transmembrane helices. Ceg4 appears to rely 
on its C-terminal domain for interacting with substrate, as deletion of this region abrogates 
binding to MAP kinases. Importantly, an α-helical cap domain that forms a lid over the active 
site was also observed in Ceg4. Although such caps have been observed in other HAD-like 
proteins, the Ceg4 cap takes on a novel fold that is compatible with broad substrate specificity. 
Indeed, a tyrosine residue from two different Ceg4 tags was found to make intimate contacts 
with the active site of a neighboring molecule in two different crystal lattices (Figure 2.19). 
This was taken to be an indication of substrate promiscuity allowed by the Ceg4 cap domain. 
 37 
 
Ceg4 likely exerts its effect at a late stage of infection, as evidenced by low transcription levels 
prior to exponential growth of L. pneumophila (Quaile et al., 2018). These studies support the 
role of Ceg4 as a HAD-like phosphotyrosine phosphatase and provide an example of substrate 
promiscuity afforded by a novel cap domain. 
 
Figure 2. 19 Crystal structure of Ceg4. (A) The expression tag (orange) of one chain extends past 
the cap domain (grey) and into the catalytic pocket of another. (B) A tyrosine residue in the tag 
hydrogen bonds with Asp11 and a chloride anion in the HAD-like domain of a neighboring chain. 
Figure adapted from (Quaile et al., 2018). 
 
Legionella also encodes SH2-domain containing effectors that bind pTyr with much higher 
affinity than eukaryotic SH2 proteins. Crystal structures have been solved for two of these 
pTyr super-binders in complex with tyrosine phosphorylated peptides: 1) L. longbeachae 
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LeSH and 2) L. pneumophila RavO. Compared to the Src SH2 domain, LeSH contains a 45-
residue insertion called the pancreatic polypeptide (PP) that undergoes conformational changes 
upon peptide binding. This unique clamping mechanism may help to explain the variability in 
phosphorylated peptides bound by Legionella SH2 domains, as eukaryotic SH2 domains 
respond differently to substrate binding. More importantly, however, was the finding that 
LeSH lacks a specificity pocket for sidechains near the phosphorylated tyrosine. Although 
RavO exhibited modest preference for hydrophobic residues in the P + 1 position, it too 
accommodated a wider variety of phosphorylated peptides than its eukaryotic counterparts. 
The presence of bacterial SH2-domain containing proteins lacking distinct specificity pockets 
may suggest that these proteins have evolved independently of tyrosine kinases, which also 
show preference for specific sequences (Kaneko et al., 2018).    
 
Figure 2. 20 The effector-recruiting surface of DotM. (A) Crystal structure of DotM shown as a 
surface electrostatic representation. Putative E-block binding residues are labelled and divided into 
regions (M1 – M5). (B) Essential residues for effector binding are shown as sticks. They belong 
to M1, M2 and M4 regions. Figure adapted from (Meir et al., 2018). 
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2.2.2.6. Structural components of the type IVB secretion system 
L. pneumophila injects many of its effectors into the host cell using an envelope-spanning 
multiprotein complex called the intracellular multiplication / defect in organelle transport 
(Icm/Dot) type IVB secretion system (T4BSS). This functionally diverse nanomachine shares 
evolutionary roots with the bacterial conjugation apparatus, which can translocate a wide 
variety of substrates out of the cell, including DNA, toxins and biofilm components. By 
contrast, the L. pneumophila T4BSS is a dedicated effector translocating machine that recruits 
substrates by two distinct mechanisms: E-block mediated and IcmSW-dependent translocation.  
A recent crystal structure of the L. pneumophila DotM protein provides insight into the E-
block mediated approach of effector uptake. DotL, DotM and DotN form the T4BSS coupling 
complex, which recruits effectors and funnels them into the secretion channel. While DotL is 
exclusively an inner membrane protein, both DotM and DotN have cytoplasmic components 
that may be involved in effector recognition (Meir et al., 2018). The DotM structure reveals 
several patches of basic residues (M1 – M5) that may bind the glutamate-rich motif (E-block) 
of secreted effectors (Figure 2.20). Mutagenesis of residues in the M1, M2 and M4 regions 
completely abolished the interaction of DotM with effectors, as evidenced by isothermal 
titration calorimetry. These studies pinpoint a set of crystal effector-binding residues within 
the DotM. Presumably, E-block-containing effectors dock to these basic residues on DotM 
prior to entering the secretion channel (Meir et al., 2018). 
IcmS and IcmW are a set of chaperones that maintain effectors in a conformation that is 
amenable to translocation. Until recently, it was unclear if the IcmSW heterodimer functioned 
independently or as a component of the T4BSS. X-ray crystallography has brought clarity to 
this issue by establishing that IcmSW is an integral part of the T4BSS coupling complex. 
Indeed, the crystal structure of a complex containing IcmSW and DotL(656-783) showed the 
latter to adopt an extended conformation spanning IcmSW. This IcmSW-DotL(656-783) 
structure contains a concave surface lined with hydrophobic residues, which was found in 
another crystal structure to be the binding site for an additional component of the core complex 
called LvgA. By docking crystal structures of DotL(590-569)-DotN and DotL(656-783)-
IcmSW-LvgA onto a small-angle X-ray scattering (SAX) envelope, individual components of 
the ring-like T4BSS coupling complex were determined (Figure 2.21). These components were 
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used to generate a hexameric assembly, which agrees with the likely oligomeric state of DotL 
(Kwak et al., 2017). These data did not point to a clear role for IcmSW in facilitating the 
translocation of effectors, however. Additional studies using photo-crosslinking assays showed 
IcmSW to interact with effectors via the DotL binding interface. In accordance with these 
findings, neither IcmSW-DotL, IcmSW-LvgA nor IcmSW-DotL-LvgA were able to bind 
effectors. These results point to a dual role for IcmSW in binding the T4BSS and effector 
proteins (Xu et al., 2017), although further studies are needed to reveal how these exclusive 
binding events are coordinated. 
  
 
Figure 2. 21 Model of the hexameric type 4 coupling protein (T4CP) complex showing two 
opposing monomers. DotL (pink) adopts an extended conformation that spans DotN (orange) and 
IcmSW (yellow and cyan). Figure adapted from (Kwak et al., 2017). 
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Another component of the T4BSS is an AAA+ ATPase called DotB, which is a major 
energy source for the system. This protein is thought to facilitate assembly of the T4BSS and 
promote secretion of substrates. ATPases are generally understood to cycle through three 
conformations during catalysis: apo, ATP-bound and ADP-bound. Surprisingly, a crystal 
structure of the DotB hexamer from L. pneumophila (DotBL) showed subunits to take on two 
unique conformations that do not depend on the state of nucleotide binding. Indeed, DotBL was 
crystallized in the presence of AMP-PNP and a phosphate was seen in the active site of both 
conformers. DotBL is comprised of an N-terminal PAS-like domain and a C-terminal domain 
containing Walker A and B motifs. By aligning the N-terminal domains of DotBL proteins 
comprising the hexamer, two distinct orientations of the C-terminal domain were observed.  
 
Figure 2. 22 Crystal structure of the DotB hexamer. (A) Top and side views of the DotB 
hexamer with α and β conformers shown in blue and purple, respectively. (B) Both DotB 
conformers aligned by their N-terminal domain (NTD) to show a hinge point giving rise to 
unique C-terminal domain (CTD) orientations. (C) Organization of conformers in DotB 
hexamer, as viewed from above. Figure adapted from (Prevost and Waksman, 2018). 
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These unique conformations of DotBL were called α and β, with the β conformer having 
its C-terminus rotated 46° toward the center of the hexamer (Figure 2.22). Since α and β 
conformers occurred alternately in the DotBL hexamer (αβαβαβ), the rotation of the C-terminus 
in β produced unique contact interfaces within and between subunits. In contrast to DotBL, the 
hexamer of Yersinia pseudotuberculosis (DotBY) adopts an ααβααβ organization. Although 
DotBY was crystallized in the absence of ATP, structural analysis showed the β conformer to 
have an active site that accommodates phosphate binding, while the α conformer does not. This 
was evidenced by an unwinding of the first helix in the Walker A motif in only the β conformer 
of DotBY. Taken together, these structural findings reveal a new level of conformational 
complexity for DotB proteins (Prevost and Waksman, 2018). Effectors involved in nucleotide 
metabolism 
An essential property of many eukaryotic proteins is their ability to bind nucleotides. For 
example, kinases rely on an ATP-binding site to facilitate the transfer of phosphate moieties 
onto a target protein. Another important class of nucleotide-binding molecules are G-proteins, 
which regulate vesicular trafficking and bind GDP or GTP to transition from inactive to active 
states, respectively. Furthermore, nucleotides such as cyclic-AMP (cAMP) and cGMP act as 
second messengers in a variety of signaling pathways. Since many L. pneumophila effectors 
have been acquired from eukaryotes by horizontal gene transfer, it is not altogether surprising 
that several contain nucleotide binding sites, considering the broad role of nucleotides in host 
cell processes. 
While many nucleotide binding effectors have a clearly defined function, as is the case for 
kinases, phosphatases, glycohydrolases and SidE-family proteins, others remain functionally 
uncharacterized. One such protein is the L. pneumophila effector, lpg1496, which comprises 
three domains with unique nucleotide-binding capabilities. A crystal structure of the lpg1496 
C-terminus reveals a domain homologous to the cAMP-specific phosphodiesterase (PDE) from 
Leishmania, called LmjPDEB1. Although malachite green assays against an array of 
nucleotides showed no PDE activity for the C-terminal domain of lpg1496, this construct co-
crystallized with ADP. The authors suggested ADP-ribosyltransferase activity for this domain, 
based on the unique orientation of ADP in the active site relative to other known PDEs. Limited 
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proteolysis on lpg1496 revealed two N-terminal domains with homology to histidine kinase-
like ATP binding regions and S-adenosylmethionine-dependent methyltransferase proteins 
(KLAMPs). Crystal structures were solved for both N-terminal KLAMP domains of lpg1496, 
revealing two antiparallel α-helices, flanked on either side by solvent exposed β-sheets. 
Intriguingly, these KLAMP domains have different nucleotide preferences. Specifically, the 
N-terminal KLAMP domain (KLAMP1) binds 3’-5’-cAMP, whereas the middle KLAMP 
domain (KLAMP2) binds ADP. These binding properties likely arise from conformational 
differences at the nucleotide binding β4-β5 loop, which harbors a cis-proline in KLAMP2 and 
a trans-proline in KLAMP1 (Figure 2.23) (Wong et al., 2015). The function of these domains 
and why they occur together in the same protein are questions that remain unanswered. This 
study reveals a novel and versatile nucleotide binding fold in bacterial effectors that may have 
unique functional properties. 
 
 
Figure 2. 23 Crystal structure of KLAMP domains in lpg1496. (A) Model of the KLAMP1 domain 
with secondary structure elements labeled. (B) Overlay of KLAMP1 (faint green) and KLAMP2 
(wheat) domains, showing similar overall architecture with differences in the loop regions. Note 
the conformational differences between β4-β5 loops, which account for the unique ligand binding 
properties of these domains. Figure adapted from (Wong et al., 2015). 
 
Another nucleotide binding protein found in L. pneumophila is the hypoxanthine-guanine 
phosphoribosyltransferase (LpHGPRT), derived from eukaryotic proteins with the same 
function. HGPRTs play a role in the nucleotide salvage pathway, which generates inosine or 
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guanosine monophosphate to be incorporated into DNA or RNA. Supplementing the L. 
pneumophila growth medium with guanine has been shown to increase the replication rate of 
this pathogen. LpHGPRT may therefore facilitate the nucleotide synthesis that accompanies 
bacterial growth under these conditions. Crystal structures of apo-LpHGPRT and GMP-
LpHGPRT reveal an overall α/β fold like that of 6-oxopurine PRTs. Four loops (I – IV) 
surround the ligand binding site and are organized by the dimerization of LpHGPRT. Unlike 
the human HGPRT enzymes, loop II of LpHGPRT is conformationally similar in apo- and 
ligand-bound structures. This similarity arises from an arginine residue on loop II that 
hydrogen bonds to the GMP phosphate while stabilizing loop II by interacting with a threonine 
residue on a nearby α-helix (Figure 2.24). In human HGPRT proteins, this position contains a 
serine residue that is unable to mediate these stabilizing interactions, explaining the 
conformational flexibility observed in loop II of human HGPRTs. The fact that loop II is 
clearly defined in the electron density of both apo- and GMP-bound LpHGPRT suggests that 
this loop is stably anchored into position to cover bound nucleotide (Zhang et al., 2016). By 
limiting the motions required to achieve an active conformation, this single mutation increases 
the efficiency of LpHGPRT. 
 
Figure 2. 24 Crystal structure of LpHGPRT. (A) Conformation of loop II in apo- (yellow) and 
ligand-bound (cyan) LpHGPRT. Note the stabilizing interactions contributed by Arg76 in both 
models. (B) Overlay of apo-human HGPRT (PDB id 1Z7G) (green), human-HGPRT-GMP (PDB 
id 1HMNP) (purple) and K68A HGPRTase HPP PRPP Mg complex (PDB id 1D6N) (grey). 
LpHGPRT is coloured as in (A). Figure adapted from (Zhang et al., 2016). 
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3. Rationale and Objectives 
Legionella pneumophila causes Legionnaire’s disease predominantly in elderly or 
immunocompromised individuals. This pathogen has an unusually large number of effector 
proteins. Indeed, the effector repertoire of L. pneumophila is nearly five times that of 
Escherichia coli O157:H7 and Salmonella enterica. It is well adapted to a large spectrum of 
protozoa (Ensminger, 2016) and has accumulated a wide range of mechanisms to overtake 
these varied hosts. Studying such infective tactics can expose how bacterial pathogens evade 
the eukaryotic immune response. L. pneumophila can also be studied in mouse models to 
observe the way higher eukaryotes react to infection. Another advantage of L. pneumophila is 
its intermediate virulence level toward humans. Since milder pathogens do not respond as 
quickly to the host immune system, researchers use these organisms to observe aspects of the 
host/pathogen interplay that would not otherwise be detectable.  
The virulence of intracellular pathogens is characterized by their effector protein repertoire, 
which allows them to establish a replicative niche inside host cells and evade xenophagy 
(Kwon and Song, 2018). Most effectors are substrates of the Icm/Dot type IV secretion system 
(T4SS) and are injected into the host cell during infection. Each Legionella species encodes a 
unique complement of effectors with only eight core T4SS substrates being present in all 
genomes. This variability in effectors suggests that Legionella species have acquired different 
virulence strategies during their evolution. The predicted number of effectors has recently been 
expanded to include additional proteins with eukaryotic-like motifs and their orthologs. 
Together, nearly 18000 unique effectors are encoded by the Legionella genus (Gomez-Valero 
et al., 2019). The study of Legionella virulence is therefore a formidable undertaking that will 
reveal many ways in which eukaryotic processes are coopted by the pathogen.  
Functional redundancy is an obstacle in characterizing effector proteins; deletion of a gene 
encoding a redundant effector is unlikely to produce a phenotype (Ensminger, 2016). Structural 
data on such a protein can provide an alternative avenue toward functional analysis. For 
example, protein structures can be used to predict putative catalytic residues, allosteric 
regulators and regions of functional significance on the protein of interest.  
The work in this dissertation began with a broad screen of uncharacterized L. pneumophila 
effectors for their suitability in structural studies. Several proteins were promising, due to their 
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level of expression, solubility and homogeneity. Of these, LpnE, MavL and MavE produced 
well-diffracting crystals. I was able to solve their structures and perform some functional 
characterization on each of these proteins. LpnE had been partially functionally characterized 
at the onset of the project. Conversely, there was little published data available for MavL and 
MavE. These proteins are actively being investigated by our collaborators and their three-
dimensional structure will be of help in directing their efforts toward full functional 
characterization. 
LpnE is an effector implicated in host cell entry that is exported independently of the T4- 
or T2SS (Newton et al., 2006, 2007a). Once in the macrophage cytosol, LpnE is anchored to 
the Legionella-containing vacuole (LCV) and binds the N-terminal 236 residues of 
oculocerebrorenal syndrome of Lowe (OCRL) protein. Recruitment of OCRL to the LCV has 
been found to restrict the intracellular replication of L. pneumophila by an unknown 
mechanism (Weber et al., 2009). The objective of this project is to obtain molecular insights 
on the interaction of LpnE with OCRL using structural biology and protein-protein interaction 
studies. In so doing, we hope to expand our understanding of Sel1-like repeat (SLR) proteins 
in pathogenicity. 
MavL is a substrate of the T2- and T4SS, with homologues in all L. pneumophila species 
but none in L. longbeachae (DebRoy et al., 2006; Gomez-Valero et al., 2011). There is 
presently little data on MavL in literature, although our collaborators Elizabeth Hartland et al. 
have found MavL to bind the E2 ubiquitin conjugating enzyme, Ube2q1/Nice5, by yeast two-
hybrid and co-immunoprecipitation (unpublished data). The potential role of MavL in host 
ubiquitination remains to be elucidated. The objective of this project is to obtain a crystal 
structure of MavL as a step toward understanding its role in L. pneumophila pathogenesis. 
MavE is another effector of unknown function translocated by the T4SS (Huang et al., 
2011). Our collaborator, Dr. Yousef Abu-Kwaik, has discovered that L. pneumophila lacking 
MavE form LCVs that are targeted to lysosomes for destruction (unpublished data). Thus, 
MavE appears to play a significant and non-redundant role in LCV trafficking and/or 
maturation. The objective of this project is to characterize MavE by X-ray crystallography. In 
so doing, we hope to gain molecular insights into its function in vacuolar trafficking. 
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4. Utilized Methods 
This chapter describes the general methods employed in all projects outlined in this 
dissertation. In sections 4.1 – 4.6, the protocols for protein cloning, expression, purification 
and analysis are given. Section 4.7 is a description of the methodology and theoretical 
background of X-ray crystallography. Finally, a list of primers and chemicals used is provided 
in section 4.8 
 
4.1. Cloning 
Protein constructs were designed using the ligation independent cloning (LIC). Briefly, this 
approach relies on the generation of complementary overhangs on the insert and vector, such 
that annealing occurs spontaneously and without a ligase enzyme. These overhangs are 
produced using the 3’ → 5’ exonuclease activity of T4 DNA polymerase in the presence of 
either dGTP (for the vector) or dCTP (for the insert). The T4 exonuclease is unable to 
hydrolyze deoxy-nucleotides and therefore halts when it encounters dGTP or dCTP in the 
vector or insert, respectively. This leads to the production of 15-base pair complementary 
overhangs, which can anneal in the absence of ligase (Eschenfeldt et al., 2009). By this 
approach, the DNA sequences were cloned into the pMCSG7 expression vector (Stols et al., 
2002) incorporating a TEV-cleavable, N-terminal His6-tag. 
 
4.2. Protein Expression 
The following is a general protocol used in the large-scale expression of recombinant 
proteins described in this dissertation. Plasmids were transformed into chemically competent 
BL21(DE3) cells and plated on LB agar containing ampicillin (100 µg/mL). A single 
transformant was inoculated into 20 mL of LB supplemented with ampicillin (100 µg/mL) and 
glucose (0.4%), and grown overnight at 37 °C. This overnight suspension was subcultured into 
1 L of terrific broth (TB) supplemented with ampicillin (100 µg/mL) and grown at 37 °C. Once 
the cell culture reached an optical density (A600) of ~1.0, the temperature was reduced to 18 
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°C, 1 mM of isopropyl β-D thiogalactopyranoside (IPTG) was added to the culture to induce 
protein expression and the cells were incubated for ~16 more hours. Cells were pelleted at 
6900 g for 15 min in a Beckman JLA 8.1000 rotor and stored at -80 °C until further processed. 
Approximately 10 g of pellet was obtained from 1 L of culture.  
 
4.3. Protein Purification 
Cells were resuspended in 30 mL of a lysis buffer (50 mM Tris, pH 8.0, 10% (v/v) glycerol, 
0.1% (v/v) Triton X-100) and lysed twice at 35 kPsi in a cell disruptor (Constant Cell 
Disruption Systems, Kennesaw, Georgia). The lysate was spun at 21 000 g for 30 min in a 
Beckman JA25.50 rotor. Supernatant was added to 5 mL of Qiagen Ni-NTA beads 
preequilibrated with three column volumes of a buffer containing 20 mM Tris, pH 8.0, and 50 
mM NaCl, and the beads were washed with 50 mL of this buffer. Protein was eluted with the 
same buffer supplemented with 100 mM imidazole. Purified protein was concentrated to 16 
mg/mL in a Millipore centrifugal filter spun at 4000 g. In the final step of purification, the 
protein was loaded onto a Biorad or GE gel filtration column to isolate the monomeric or 
oligomeric species of interest. 
 
4.4. Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a method for 
separating proteins based on their molecular weight (Shapiro et al., 1967). The speed at which 
a protein moves within an electric current depends on its charge-to-mass ratio. If the charge of 
all proteins examined is brought to a constant, however, the speed of protein migration can be 
related directly to its mass. This equalization of charge between proteins can be achieved using 
sodium dodecyl sulfate (SDS), a strong anionic detergent that binds and linearizes protein to 
form a denatured protein-detergent-complex (PDC). Importantly, the PDC contains 
approximately half the number of SDS molecules as there are amino acids in the protein 
(Smith, 1994). Since each molecule of SDS is negatively charged, the overall charge of the 
PDC is overwhelmingly negative. Thus, solubilizing a protein in SDS minimizes differences 
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in charge between proteins, rendering mass the only remaining parameter to distinguish them 
(Shapiro et al., 1967; Smith, 1994). The PDCs then migrate through a sieve-like 
polyacrylamide matrix under an electric field (Smith, 1994).  
SDS-PAGE separates proteins by the method of isotachophoresis. In this approach, 
stacking- and resolving-polyacrylamide gels of differing pH are used. The protein sample 
initially passes through the stacking gel, where it is concentrated between leading (chloride) 
and terminating (glycinate) ions present in the reservoir buffer. In the resolving gel, the 
mobility of glycinate overtakes that of PDCs due to a pH change. Proteins can then be separated 
from one another in the resolving gel based on size, because they are no longer concentrated 
between chloride and glycinate ions (Smith, 1994).  
 
4.5. Isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) is a method used to measure the heat taken up 
(endothermic) or expelled (exothermic) during a chemical reaction. These values reflect the 
extent of a reaction (in moles) and its change in enthalpy (ΔH). ITC can also be used to measure 
the rate of a reaction, which is proportional to the rate at which heat is exchanged with the 
surroundings. Thus, ITC is a valuable tool for determining the amount of a reaction taking 
place and the rate at which a reaction occurs (Freyer and Lewis, 2008). 
An isothermal titration calorimeter measures the enthalpy of a reaction by the method of 
power compensation. In this approach, the calorimeter measurement cell is maintained at 
constant temperature using a control heater which responds to changes in heat by varying its 
power output. A neighboring cell in the instrument (containing only reaction buffer or water) 
is supplied with constant power by the control heater to serve as a reference for temperature 
changes in the measurement cell. The raw output in the ITC experiment is the power (µJ/s) 
required to keep the measurement cell at constant temperature (Freyer and Lewis, 2008). 
ITC experiments are typically conducted as a series of injections, where analyte (ligand) is 
titrated into the measurement cell containing the protein of interest. Selection of appropriate 
concentrations for ligand and protein is a critical factor in the experiment. Excessive analyte 
could lead to a rapid saturation of binding sites on the protein, while too little analyte or protein 
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may produce undetectable heat changes. In practice, the ligand is often kept at a greater 
concentration than the protein to ensure that saturation of binding sites occurs during the 
experiment. This is because the volume of protein in the measurement cell (350 µL) far exceeds 
that used for individual titrations (5 µL). Therefore, high analyte concentrations are often 
needed to achieve the appropriate reaction stoichiometry. Saturation of ligand-binding sites is 
reflected by successive decreases in the measured heat changes. In such a case, the largest heat 
change in the experiment represents a case where all binding sites in the protein are occupied 
by ligand. If the protein/ligand interaction is reversible, we expect some unbound protein to be 
available for ligand binding in the next injection. This is evidenced by a smaller heat change 
because only a subset of analyte molecules interact with the ligand. Heat changes continue to 
diminish in subsequent injections until effectively no protein is available to bind analyte. 
ITC is an extremely sensitive method for measuring changes in heat. Even the titration of 
water into water gives a measurable signal. As such, a background exists for all injections 
measuring the interaction of a ligand with protein. To account for this, an additional experiment 
should be carried out where buffer is titrated into the same solution of protein as that used in 
the protein/ligand experiment. Importantly, the injected buffer should be the same as that used 
to prepare the ligand This is because even slight differences in buffer composition can affect 
the measured signal. 
In summary, ITC quantifies the heat given off or absorbed during a chemical reaction. This 
method is particularly useful for measuring interactions between a protein and ligand. By 
monitoring the change in heat during successive injections of analyte into protein, information 
on binding stoichiometry and even a binding constant can be obtained. However, a profile of 
buffer into protein should be obtained and subtracted from the raw protein/ligand data to 
correct for background heat changes that do not reflect the biological phenomenon under study. 
 
4.6. Dynamic light scattering 
Dynamic light scattering (DLS) is a method for estimating the size distribution 
(polydispersity) of molecules in solution. In protein biochemistry, DLS is used to determine 
the homogeneity and relative size of a molecule. Aggregated or precipitated protein is also 
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readily detected by this method. Taken together, these properties make DLS an excellent 
quality assessment tool for purified protein prior to performing crystallization trials or 
biological assays (Maguire et al., 2018). 
The physical principle underlying DLS is that the hydrodynamic diameter of a molecule in 
solution can be related to its diffusion coefficient. Since molecules in solution undergo 
Brownian motion, the intensity of scattered light will fluctuate over time. The decay in 
scattered light intensity is used to generate an autocorrelation curve, which is proportional to 
the diffusion coefficient of the molecule under study (provided the sample is free of 
contaminants). Once obtained, the sphere-equivalent hydrodynamic diameter of the molecule 
can be calculated using equation 4.6:  
 
𝐷𝑡 = 𝑇𝑘𝐵/3𝜋𝜂𝑑 4.6 
 
where Dt is the diffusion coefficient, T is the temperature in Kelvin, kB is Boltzmann’s constant, 
η is the solution viscosity and d is the hydrodynamic diameter of the molecule. It is important 
to note that all molecular weights calculated from this value of d assume a spherical molecule 
in solution. Thus, size estimates obtained from DLS are only approximations of the true 
molecular weight (Maguire et al., 2018).    
 
4.7. X-ray crystallography in macromolecular structure determination 
 
4.7.1. A brief overview of crystallography 
In 1895, Röntgen found that the permeability of an object to X-rays could be related to its 
density (Röntgen, 1896). Laue expanded on this finding by suggesting that radiation diffracts 
when passed through a crystal, provided the wavelength of this radiation is similar in 
magnitude to the distance between lattice planes. This hypothesis was verified by Friedrich 
and Knipping, who showed that a diffraction pattern is indeed produced when copper sulfate 
crystals are irradiated with X-rays (Friedrich and Knipping, 1913). Bragg then described the 
diffraction process as reflection of partial rays from a surface (Bragg, 1912). A critical property 
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of this surface is periodicity, since even slight irregularities would abolish the reflected wave 
magnitude. Crystals are characterized by symmetry and consistent, repeating units. Thus, when 
a crystal is irradiated with X-rays, constructively interfering waves are amplified such that 
diffraction maxima are visible on a detector (Rupp, 2010). 
The description of diffraction as reflection of waves from a surface allowed Bragg to 
develop an important mathematical relationship describing the condition for constructive 
interference called Bragg’s law (equation 4.1), which states that the path difference between 
two waves must equal an integer number of wavelengths if constructive interference is to occur 
(Bragg, 1913). 
 
 
Relating interplanar spacing to incident wave angle allowed a deeper connection between 
the diffraction pattern and crystal content to be made. First, the sum of all constructively 
interfering waves reflected from a common set of planes was termed a structure factor. As 
such, each diffraction maxima could be assigned a structure factor corresponding to a specific 
set of planes (hkl) in the crystal (equation 4.2). Importantly, the structure factor is a Fourier 
integral of electron density within the crystal. Since the Fourier transform is invertible, another 
Fourier integral also exists wherein electron density is described as a summation of structure 
factors representing the diffraction pattern (equation 4.3) (Rupp, 2010). Thus, a mathematical 
description of electron density within the crystal can be uncovered by performing an inverse 
Fourier transform on the complex structure factors. This description of electron density is often 
rendered as a contour map, which serves as a guide for initial model building. 
 
 
𝐹ℎ𝑘𝑙 = ∑ 𝑓𝑗
𝑛
𝑗=1
𝑒2𝜋𝑖(ℎ𝑥𝑗+𝑘𝑦𝑗+𝑙𝑧𝑗) = |𝐹ℎ𝑘𝑙|𝑒
𝑖𝜙 
4.2 
                2𝑑𝑠𝑖𝑛𝜃 = 𝑛𝜆 4. 1 
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𝜌(𝑥, 𝑦, 𝑧) =  
1
𝑉
∑ 𝐹ℎ𝑘𝑙𝑒
−2𝜋𝑖(ℎ𝑥𝑗+𝑘𝑦𝑗+𝑙𝑧𝑗) 
ℎ𝑘𝑙
 
 
4.3 
 
We measure the intensity I of the scattered radiation, which is proportional to |Fhkl|
2 but 
do not directly measure the phase angle ϕ (eq. 4.2). Therefore, the phase of the structure factor 
is not recorded during data collection for each measured reflection. The lack of phase 
information, which is an essential component of a structure factor, is called the “phase 
problem.” Several experimental and computational methods have been developed to determine 
the missing phases. These approaches are described briefly in subsequent sections. 
In summary, crystals are periodic structures that allow the visualization of diffraction 
maxima, which occur only where Bragg’s law for constructive interference is met. 
Constructively interfering waves (and their experimentally determined phases) are combined 
into a Fourier integral called a structure factor, which represents diffraction from a set of planes 
within the crystal. The inverse Fourier transform of all structure factors gives a mathematical 
description of electron density distribution that can be viewed as a contour map outlining the 
unknown molecule (Rupp, 2010). 
 
4.7.2. Growing protein crystals 
Crystallizing a protein requires that a super-saturated state is achieved without 
precipitating, denaturing or otherwise altering the molecule of interest (Moreno, 2017). This is 
done by adding mild precipitating agents and changing other parameters such as temperature 
or pH. In addition, ligands or ions that affect the protein conformation may be required to 
ensure homogeneity for crystallization. Under ideal conditions, these mild precipitating agents 
will concentrate the protein in such a way that crystallization occurs, while other forms of 
coalescence such as precipitation or phase separation are avoided (Chernov and Komatsu, 
1995; Malkin et al., 1996).  
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The process of crystallization is divided into nucleation and growth. In nucleation, 
molecules randomly distributed in solution assemble into an ordered array. This initial stage 
of order is followed by the growth phase, wherein additional molecules of the same kind 
organize themselves onto the nuclei scaffold. Excessive nucleation can arise when 
supersaturation levels of the protein are too high. Such conditions may lead to showers of 
microcrystals or precipitation (Chernov and Komatsu, 1995; Malkin et al., 1996). 
Alternatively, no nucleation events will occur if the protein concentration is too low. Arriving 
at the optimal level of supersaturation for nucleation is therefore critical for ensuring proper 
crystal formation and growth conditions.  
Supersaturation is a state where protein remains in solution despite being present at a 
concentration beyond the solubility limit. To reestablish equilibrium, excess protein may form 
aggregates, precipitates or crystals. A phase diagram can be used to describe the critical points 
of saturation with respect to protein and salt concentration (Figure 4.1). On this diagram, a 
clear boundary distinguishes the stable and metastable states. This is because the solubility 
limit for a protein under specific conditions can be readily defined. The metastable state 
represents the low end of supersaturation, wherein crystal growth can occur, but nucleation is 
unlikely. Conversely, both nucleation and growth can occur in the labile state (Moreno, 2017). 
Ideally, we would hope to have our protein enter the labile level of supersaturation initially, 
followed by a lengthy period in the metastable zone. This is possible, as the formation of nuclei 
from existing protein in solution may indeed reduce the saturation level from labile to 
metastable. Still, the range of conditions under which such an event can occur are limited. 
Comprehensive screening of crystallization conditions and optimization is therefore needed to 
find the right condition (Garman, 2014). 
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Figure 4. 1 Phase Diagram for Protein Crystallization. Under conditions of low salt and protein 
concentration, the solution remains undersaturated. The solubility of protein in solution can be 
gradually decreased by raising the salt concentration. In the metastable state of supersaturation, 
protein crystals may grow but are unable to nucleate. Both nucleation and crystal growth may 
occur in the labile state of supersaturation. At very high salt and protein concentrations, the protein 
is likely to crash out of solution in a precipitated form. This Figure is adapted from (Moreno, 
2017).  
 
The nature of the protein itself is also a critical factor in the crystallization process. For 
example, disordered or flexible regions on a protein may obstruct potential crystal contacts. 
Recombinant DNA technology has afforded researchers the luxury of stripping those unwanted 
regions to produce a new protein construct that is amenable to crystallization. Co-
crystallization with antigen-binding fragments (Fabs) may also facilitate crystal growth by 
generating intermolecular contacts that would not otherwise be present (Bailey et al., 2018). 
This strategy is particularly beneficial in the case of membrane proteins, which are often 
solubilized in a detergent micelle that increases the distance between regions of contact.  
Other methods of altering the protein to increase the likelihood of crystallization include 
methylation, surface-entropy reduction and limited proteolysis. Methylation of surface lysine 
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residues reduces protein solubility and makes it easier to achieve a supersaturated state. Surface 
entropy reduction depends on computer-assisted prediction of surface residues that may 
interfere with crystal formation (Sledz et al., 2010; Walter et al., 2006). Residues that increase 
surface entropy are often those with long and flexible sidechains, such as lysine or arginine. 
Identification of the putative interfering residues is followed by site-directed mutagenesis, 
expression, purification and crystallization trials (Derewenda and Godzik, 2017). Finally, 
limited proteolysis can be an efficient way to arrive at an appropriate construct for 
crystallization. For example, any stable product arising from digestion of a protein is relatively 
inaccessible to proteolysis. Since proteases initiate peptide hydrolysis on linear sequences, the 
stable core is stripped of any such sequences vulnerable to attack. By extension, this core 
fragment is less likely to harbor flexible regions and may therefore be a better candidate for 
crystallization. One caveat to this approach is the possibility that regions cleaved by a protease 
are of functional significance to the protein of interest.  
 
4.7.3. Cryo-crystallography and data collection 
Cryo-crystallography is a branch of science that applies crystallographic methods at low 
temperature (Macchi, 2012). This method was first adapted to the crystals of macromolecules 
by Häkon Hope (Hope, 1988). The study of crystals at low temperature is often carried out 
using X-ray diffraction, although other approaches may also be used. Moreover, this science 
is not limited to structure determination. For example, the study of phase transitions can 
enhance our understanding of the phase diagram for a crystalline material (Macchi, 2012). This 
information may be useful for chemists or physicists studying molecular trends under wide 
temperature ranges. For many interested in protein structure, however, cryo-crystallography 
has been reduced to a technique used for preserving crystals prior to data collection. This 
technique has nontrivial advantages for the diffraction experiment, such as decreasing radiation 
damage, improving resolution and reducing thermal motion (Larsen, 1995). 
In macromolecular crystallography, the cryo-technique involves flash freezing a crystal in 
liquid nitrogen and maintaining it at ~100K for data collection. To ensure that a crystal survives 
the cooling process, it must first be submerged in a cryoprotectant solution. Common 
cryoprotectants include glycerol, 2-methyl-2,4-pentanediol and ethylene glycol. These 
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molecules interact with water and prevent the formation of ice crystals at low temperature. 
Although water does enter a solid state under these conditions, it is said to be vitrified rather 
than frozen (Rajan and Matsumura, 2018). 
For data collection, the crystal is rotated within the X-ray beam and intensities are recorded 
on the detector. These intensities are integrated over a small rotation angle to produce images 
(frames) containing the diffraction data. Critical parameters to monitor during data collection 
are completeness and redundancy. Completeness gives the ratio of observed to expected 
reflections, while redundancy tells us how many times a reflection was measured. The number 
of expected reflections is known for each type of crystal symmetry (Laue group) which, in 
turn, can be determined using only a few diffraction frames (Wlodawer et al., 2013). 
Knowledge of crystal symmetry arms us with the ability to measure completeness and 
redundancy during data collection. Moreover, it allows us to determine the minimum overall 
rotation needed to collect a full dataset. This can be a critical step in the process, as crystal 
decay is a common problem during data collection and the lifespan of a crystal is never known 
a priori (Krojer et al., 2013). 
 
4.7.4. Data processing 
Processing of X-ray data collected by the rotation method is divided into indexing, 
integration and scaling. Typically, one of four software packages is used to carry out these 
processes: Mosflm, HKL2000, the XDS suite and DIALS (Powell, 2017). The automation of 
data processing was facilitated, in part, by standardizing experimental parameters for both the 
crystal and instrument.  
Indexing begins with the assignment of hkl indices to each measured reflection. This is 
done by projecting the two-dimensional coordinates of each reflection onto scattering vectors 
of the three-dimensional Ewald sphere. These scattering vectors can be represented as points 
in the reciprocal lattice (Ewald, 1969). Each reflection is therefore related to a reciprocal lattice 
point which, in turn, is defined by a set of planes within the crystal (hkl). Scattering vectors are 
then used to search for a unit cell described by the diffraction pattern. Symmetry of the unit 
cell is defined using 1 of 14 Bravais lattices. Correct assignment of Bravais lattice symmetry 
allows the location of reflections to be predicted. If there is poor agreement between predicted 
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and experimental reflections, it is unlikely that the Bravais lattice was assigned correctly 
(Powell, 2017). 
Integration is the process of measuring diffracted intensities by adding together all values 
for pixels forming a spot. The difficulty in this task is defining a boundary for each reflection. 
This is a crucial step in processing, as it allows the signal to noise ratio for each reflection to 
be maximized. Since intensity profiles for each spot are smooth curves, the assignment of spot 
boundaries is somewhat arbitrary. Several automated methods have been developed to 
overcome this problem. For example, background pixels can be assigned by systematically 
removing intense spots until the statistical distribution of remaining spots agrees with that 
expected for a random sample. Another method used in the Mosflm package is called ‘profile 
tolerance’ and relies on the assignment of spot intensities (rather than background). These 
methods allow summed intensities for each reflection to be obtained (Powell, 2017). As will 
be seen in the following section, reflection intensities are proportional to structure factor 
amplitudes, which are ultimately used in the calculation of electron density maps. 
Summed intensities obtained in the integration step must be brought to a common scale 
that accounts for changes occurring during data collection. Radiation intensity, the crystal and 
even the detector response are some examples of variables in the experiment. Scaling can be 
thought of as an effort to correct for such variation and produce a set of intensities that are 
consistent between frames (Powell, 2017). Finally, redundant or symmetry-related reflections 
are merged to produce the final dataset. 
Once processed, a dataset must be assessed for quality. The parameters used for this 
purpose are redundancy, Rmerge, completeness, CC1/2 and the signal to noise ratio of each 
reflection. Redundancy refers to the number of times a reflection is measured (see section 
4.1.3). Greater redundancy leads to more accurate reflection intensities which, in turn, provide 
improved structure factors.  Rmerge describes the agreement between intensities of symmetry-
related reflections. Since these values are expected to be the same, a good dataset should show 
only limited deviation between them (i.e. a low Rmerge) (Wlodawer et al., 2008). 
Completeness is the percentage of expected reflections that were measured for each resolution 
shell. For a protein crystal, completeness of over 75% in the highest resolution shell is 
considered acceptable, provided the overall value (for all shells) exceeds 95%. CC1/2 is a form 
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of the Pearson correlation coefficient that evaluates the reproducibility of measurements used 
to estimate reflection intensity (Wang et al., 2017). It is useful for detecting weak signals in 
high resolution shells, because it is insensitive to scale factors distinguishing the two frames 
being compared. Convention dictates that a CC1/2 of over 60% in the highest resolution shell 
is a good indication of where to cut the data (Karplus and Diederichs, 2012). The signal to 
noise ratio (denoted I/σI) gives the intensity over background for each reflection. Values of 1-
2 are typically observed in the highest resolution shell (Evans and Murshudov, 2013).  
 
4.7.5. Phasing methods 
Each spot on the detector arises from constructively interfering waves reflected by 
electrons within the crystal. Thus, every reflection has a corresponding resultant wave that 
produces it. Crystallographers describe this resultant wave using structure factors. Importantly, 
structure factors have both amplitude and phase. The amplitude of each structure factor is 
proportional to the square root of the measured intensity for the associated reflection (Rupp, 
2010). Structure factor amplitudes are therefore determined during data collection, whereas 
phases remain unknown and must be determined indirectly. The process of determining phases 
for each measured reflection is called the ‘phase problem.’ Obtaining phases is essential for 
structure determination, because the electron density map can only be calculated once complete 
structure factors (having both amplitude and phase) are obtained (Thorn, 2017). This is because 
electron density is the inverse Fourier transform of structure factors summed over all values of 
hkl. Hence, structure factors and electron density are reciprocally related. Since electron 
density represents the molecule, the function describing it is said to exist in ‘real space’ while 
structure factors exist in ‘reciprocal space’ (Rupp, 2010).  
 
4.7.5.1. Molecular replacement 
Molecular replacement is a method for obtaining initial phase estimates from a homologous 
model (McCoy, 2017). This requires orienting the homologous structure in the unit cell of the 
unknown such that phases from the homologue correlate with the experimentally measured 
intensities. In so doing, estimates of complete structure factors are obtained and used in the 
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calculation of an electron density map. The orientation process is the greatest computational 
challenge of molecular replacement and is divided into rotational and translational searches. 
Various positions of the homologue in the unit cell are evaluated for their agreement with 
experimental data using Patterson maps calculated for each (Evans and McCoy, 2008; McCoy, 
2017). A Patterson map gives interatomic distances and can be calculated without phases 
(Patterson, 1934). These interatomic distances can be thought of as a barcode for the 
orientation of each structure in the unit cell. The experimental and model Patterson map are 
scored for their level of overlap to arrive at the correct placement of the model into the new 
unit cell (Evans and McCoy, 2008). Finally, complete structure factors are created using 
amplitudes from experimental data and the phases of our correctly positioned homologue. A 
molecular replacement solution is characterized by an interpretable electron density map fitted 
to the homologous model. This model is refined to agree with the experimental data and 
gradually improve the phase estimates.  
 
4.7.5.2. Single anomalous dispersion 
Single anomalous dispersion (SAD) is an experimental approach for determining phases. 
It relies on the additional scattering that occurs when an atom is irradiated at a characteristic 
frequency called the absorption edge. This scattering is considered anomalous and leads to 
differences in the intensities of symmetry-related reflections (Friedel pairs). These differences 
are used to calculate the positions of anomalous scatterers through the analysis of a difference 
Patterson map, from which the complete structure factors (FA) for those atoms giving rise to 
anomalous scattering can be calculated. This set of anomalously scattering atoms is called a 
substructure. The scattering amplitudes of the protein and the protein with anomalous scatterers 
are related by the equation below (equation 4.4). 
 
𝐹𝑃𝐴 = 𝐹𝐴 + 𝐹𝑃 ∴ 𝐹𝑃 = 𝐹𝑃𝐴 − 𝐹𝐴 4.4 
 
The scattering amplitudes for the substructure (FA) can be calculated and the magnitudes 
of scattering amplitudes for the protein alone (FP) and protein with anomalous scatterers (FPA) 
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are known from the diffraction experiment. With this information, two possible solutions for 
the phase of FP are arrived at using a mathematical operation that is often represented by a 
Harker diagram (Figure 4.2). This diagram depicts structure factors as vectors on a coordinate 
system comprising real (x) and imaginary (y) axes. The phase of each structure factor is the 
angle its vector makes with the positive real axis, while amplitudes are given by the vector 
length (Rupp, 2010). This notation gives a convenient illustration of equation 4.4 and its 
application to the phase problem.  
In the context of SAD phasing, Harker diagrams are used to depict the difference between 
symmetry related reflections, or Friedel pairs, during anomalous scattering. To do this, we start 
with a vector representing a structure factor without anomalous contribution (FP+), having 
phase +φ and magnitude proportional to the vector length. The Friedel mate of this structure 
factor (FP-) is the reflection of FP+ in the real axis, since Friedel pairs have the same amplitude 
but opposite phase (-φ). Anomalous scattering has two components, designated f’ and f”, 
respectively. Importantly, only f” contributes to the difference between Friedel pairs (Figure 
4.2) and the X-ray wavelength is therefore selected to maximize the anomalous contribution 
by f”. Differences between the structure factor with anomalous contribution (FPA+) and its 
symmetry mate (FPA-) can be easily visualized by reflecting FPA- in the real axis (Figure 4.2). 
By drawing a circle of radius FPA+ centred at the head of the f”+ vector and another of radius 
FPA- centred at the head of the f”- vector (after reflection in the real axis), we can see two 
points of intersection corresponding to potential solutions to the phase problem. This problem, 
called phase ambiguity, forces us to choose an average value between these possible solutions 
for each structure factor (blue vector, Figure 4.2). Initial phase estimates to be improved upon 
by density modification are therefore quite inaccurate. Density modification gradually 
improves these phases using a set of computational approaches to distinguish molecular 
envelope from solvent. When density modification is applied to the substructure with correct 
chirality, we can begin to see a sensible electron density map. By improving our averaged 
phase estimates for each structure factor, density modification simultaneously solves the 
problem of handedness for our substructure and phase ambiguity. Ultimately, this allows 
complete structure factors to be obtained for all reflections representing the protein 
(Hendrickson, 2014).  
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Importantly, the SAD method of phasing relies on minor differences in scattering between 
Friedel pairs. Since SAD phasing uses a single dataset, small changes between symmetry 
related reflections can be measured accurately. By contrast, heavy atom phasing utilizes two 
or more datasets. This approach depends on significant differences in scattering that are caused 
by a heavy atom soaked into the crystal. Thus, although SAD phasing is an adaptation of heavy 
atom methods, it is made possible by minimizing the error in measured reflections.  
Unlike protein models, the substructure given by the set of structure factors, FH, provides 
no indication of the correct chirality. Common structural features in proteins, such as right-
handed α-helices, are evidence that our model has arisen from the proper substructure. Since 
the substructure is comprised of a small number of atoms, no such features are present within 
it. That is, we have no way of knowing whether the right- or left-handed substructure is correct 
a priori. This information is reflected by an interpretable electron density map which, in turn, 
depends on the correct assignment of phases to each structure factor. Phase ambiguity forces 
us to choose an average value between the possible solutions to the phase problem for each 
structure factor. Initial phase estimates to be improved upon by density modification are 
therefore quite inaccurate. Density modification gradually improves these phases using a set 
of computational approaches to distinguish molecular envelope from solvent. When density 
modification is applied to the substructure with correct chirality, we can begin to see a sensible 
electron density map. By improving our averaged phase estimates for each structure factor, 
density modification simultaneously solves the problem of handedness for our substructure 
and phase ambiguity. Ultimately, this allows complete structure factors to be obtained for all 
reflections representing the protein (Hendrickson, 2014). 
Light atoms such as nitrogen, oxygen, carbon and hydrogen have absorption edges outside 
the range of wavelengths used in crystallography. These atoms are common in biological 
macromolecules but contribute negligibly to anomalous scattering. By contrast, heavy atoms 
produce a significant anomalous signal. While some proteins contain metals suitable for 
anomalous phasing (eg. Fe or Zn), others need heavy atoms (eg. Hg or Pt) to be artificially 
incorporated in a trial-and-error method called soaking (Pike et al., 2016). In this approach, 
native crystals are transferred to a solution containing the heavy atom, which binds the 
crystallized protein without disrupting its conformation. Once this occurs, the soaked crystal 
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can be used to obtain a new dataset with intensity differences caused by the heavy atom. 
However, any structural changes in the heavy atom derivative protein will also be reflected in 
the corresponding dataset, provided they do not break the crystal. It is impossible to distinguish 
these differences from those caused by the heavy atom alone (Rupp, 2010). Thus, several 
attempts may be required before an isomorphous dataset can be obtained. 
The use of selenium circumvents the issues inherent to soaking, as it is incorporated 
directly into the protein in the form of a nonstandard amino acid called seleno-methionine. 
Replacing the sulfur atom for selenium has little structural impact on methionine. Thus, seleno-
methionine derivatives are typically isomorphous to their native protein counterparts 
(Hendrickson et al., 1990). A caveat to this method is that the recombinant protein should have 
enough methionine residues to produce a significant anomalous signal when replaced by 
seleno-methionine (Hendrickson, 2014). Incorporation of selenium into the recombinant 
protein can be done using auxotrophic bacterial strains and introducing seleno-methionine into 
the growth media during protein expression. Isomorphism between native and seleno-
methionine derivative proteins may also be important in highlighting the biological 
significance of our structure. That is, we need not worry about structural changes affecting our 
interpretation of the model. 
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Figure 4. 2 Argand (left) and Harker (right) diagrams depicting phase ambiguity arising from the 
single anomalous dispersion (SAD) method. The structure factor FP+ and its Friedel mate, FP- are 
shown in green. The anomalous contributions are shown in red (f’) and magenta (f”). By inverting 
FPA- in the real axis, we see two points of intersection for structure factors of magnitude FPA- 
(larger circle) and FPA+ (smaller circle). These circles are centred at the head of each unique f” 
contribution. The phase angle selected for SAD is the average of these potential solutions (blue 
arrow).     
 
4.7.6. Model building and refinement 
Electron density maps are visualized using molecular graphics software such as COOT. 
With high resolution data and knowledge of the protein sequence, initial models can often be 
built automatically. These models require limited visual inspection and correction by the user. 
At lower resolution, user experience is critical to model building, as molecular features are 
difficult to discern. In either case, model building is followed by computational refinement of 
molecular parameters (stereochemistry, bond lengths, etc.). This process of manual building 
and refinement is repeated until further improvements to the structure can no longer be made 
(Salunke and Nair, 2017).  
The refinement software scores model quality using an R-factor (Rwork), which quantifies 
the agreement between experimental structure factors and those calculated from the model 
(equation 4.5). 
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𝑅𝑤𝑜𝑟𝑘 =  ∑[|𝐹𝑜𝑏𝑠(ℎ𝑘𝑙)|
ℎ𝑘𝑙
− |𝐹𝑐𝑎𝑙𝑐(ℎ𝑘𝑙)|] / ∑ 𝐹𝑜𝑏𝑠(ℎ𝑘𝑙)
ℎ𝑘𝑙
 
4.5 
 
Since both the model and experimental data are used in the calculation of electron density, 
refinement can be biased in favor of the model. Another R-factor (Rfree) was introduced to 
overcome the problem of model bias. Rfree indicates how well the structure factors calculated 
from a model can predict the 5 – 10% of reflections that have been excluded from the 
refinement process (Salunke and Nair, 2017).  
Two maps are often used to guide model building: 2Fo – Fc and Fo – Fc, where Fo are the 
structure factors obtained experimentally (observed) and Fc are the corresponding structure 
factors calculated from the model. The 2Fo – Fc map provides an outline of molecular features, 
while Fo – Fc shows areas of excessive or insufficient electron density (Salunke and Nair, 2017; 
Wlodawer et al., 2008). 
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4.8. List of Materials 
 
4.8.1. List of primers used in thesis projects 
 
4.8.1.1. LpnE/OCRL 
 
4.8.1.2. MavE 
 
 
 
Forward LIC sequence 5’-TACTTCCAATCCAATGCC-3’ 
Reverse LIC sequence 5’-TTATCCACTTCCAATGTTA-3’ 
LpnE-22 forward 5’-GCTACGACTCAGGAAGGTGAGGAG-3’ 
LpnE-73 forward 5’-GAAAAAACAGAGCAATTATTACTTGCCTC-3’ 
LpnE-158 forward 5’-AACTCTAATGCGGCTTTGGCTATTGG-3’ 
LpnE-176 forward 5’-AAAAAGGATAAGACTCAAGCTCTCAACT-3’ 
LpnE-375 reverse 5’-TTTTTTGGCCTTGTAATTATCCGTATATTG-3’ 
OCRL-140 reverse 5’- GTCCTTAGTGTCTAATTTCTGGTACCA-3’ 
OCRL-176 reverse 5’- TTCCCGATGAATCCCAGTAGGCTGATT-3’ 
OCRL-183 reverse 5’-TGAAAAGGGTGGAGGTGGGGGTTCCCGATG-3’ 
OCRL-208 reverse 5’- CTTCCGCATGGTGTTGGTCACTTTGGG-3’ 
OCRL-10 forward 5’-CCGCTTGCCACTGTCGAGGGTATGGAGATG-3’ 
MavE-39 forward 5’-ACTAGATTTGAAAGAAATTTCCTGATTAATA-3’ 
MavE-172 reverse 5’-TTCGTCTTTGAGTTTGGCAATTAATTCTT-3’ 
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4.8.1.3. MavL 
MavL-42 forward 5’-AATGGCCTATCAATTGTTGCTCAGTAAAG-3’ 
MavL-388 reverse 5’- ATTAAATACAATGCCATTTTCTCTGACATAATC-3’ 
MavL-435 reverse 5’-ACTATGAGAAAAAAGACTGAA-3’ 
Ube2q1-1 forward 5’-CAGCAGCCGCAGCCGCAGGGGCAGCAGCAG-3’ 
Ube2q1-422 reverse 5’-GCCGTCTTCTTTTGGGGGTGTGTACCAGCC-3’ 
4.8.2. List of chemicals 
 
100 mM dCTP and 100 mM dGTP    NEB, N0446S 
100×BSA       NEB 
30% Acrylamide/Bisarcylamide(29:1)   Bioshop, ACR009.500 
Adenosine diphosphate ribose   Sigma Aldrich, AO752-25MG 
Ammonium persulfate (APS)    BioShop, AMP001.25 
Coomassie Brilliant Blue R-250    AMRESCO, (0427-25G) 
Dithiothreitol (DTT)      Thermo Fisher Scientific, BP17225 
DNA loading buffer      Norgen, 28129 
DpnI        NEB, R0176L 
Enrich SEC650      Bio-Rad, 780-1650 
Enrich SEC70      Bio-Rad, 780-1070 
Gelgreen nucleic acid gel stain    Biotium, 41005 
Glycerol       Thermo Fisher Scientific, G31-4 
Glycine       Thermo Fisher Scientific, BP381-5 
HEPES (4-(2-hydroxyethyl)-1-   BioShop, HEP001.1 
piperazineethanesulfonic acid) 
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HiTrap chelating column     GE Healthcare Life Science, 17-0409-03 
Imidazole       BioShop, IMD508.1 
Isopropyl β-D-1-thiogalactopyranoside (IPTG)  Thermo Fisher Scientific, BP1755100 
KOD hot start DNA polymerase kit    Novagen, 71086 
MPD (Methyl-pentane-diol)     Hampton Research, Aliso Viejo, CA 
Ni2+ (II) sulfate hexahydrate     Sigma-Aldrich, 227676-500G 
Ni-NTA agarose      Qiagen, 142338540 
Poly-ethylene glycol (PEG) Molecular 8000  Hampton Research, Aliso Viejo, CA 
Potassium phosphate dibasic (K2HPO4)   BioShop, PPD303.1 
Potassium phosphate monobasic (KH2PO4)   Thermo Fisher Scientific, P285-500 
Protein marker      Bio-Rad, 161-0377 
QIAprep Spin Miniprep Kit (250)    Qiagen, 27106 
QIAquick Gel Extraction Kit (250)    Qiagen, 28706 
Sodium chloride (NaCl)     BioShop, SOD002.10 
Sodium dodecyl sulfate (SDS)    BioShop, SDS001.1 
Superdex 200 10/300      GE Healthcare Life Science, 28990944 
Tris-HCl      BioShop, TRS002.1 
T4 DNA ligase and corresponding buffer   NEB, M0202S 
T4 DNA polymerase and corresponding buffer  NEB, M0203L 
TEMED (N,N,N′,N′-Tetramethylethane)   BioShop , TEM001.25 
Tryptone       Thermo Fisher Scientific, BP1421-2 
Yeast Extract       BioShop, YEX401.205 
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5. Structure of the Legionella Effector LpnE and its interaction with OCRL 
 
5.1. Literature Review on LpnE and OCRL 
 
5.1.1. LpnE is an effector protein that plays a role in host cell invasion 
LpnE (Legionella pneumophila Entry) was identified by Newton and colleagues in a study 
seeking to explain the difference in virulence between L. pneumophila and L. micdadei 
(Newton et al., 2006). Specifically, the authors intended to understand the increased virulence 
of L. pneumophila relative to other Legionella species. L. pneumophila accounts for ~90% of 
Legionnaire’s disease in North America (Benson and Fields, 1998; Yu et al., 2002) and ~50% 
in Australia (Yu et al., 2002), whereas L. micdadei and L. longbeachae were found responsible 
for only 5% of cases worldwide (Benin et al., 2002; Muder and Yu, 2002). They used genomic 
subtractive hybridization to reveal genetic differences between L. pneumophila and L. 
micdadei. Genes found only in L. pneumophila were investigated for their ability to confer 
virulence. One among these was lpg2222, which encodes an effector with eight predicted 
tetratricopeptide (TRP) repeats. This protein was suspected to play a role in host cell invasion 
because of its similarity to another L. pneumophila TRP effector called EnhC, which shares 
this function. Further studies showed L. pneumophila lacking lpg2222 to be less efficient at 
invading THP-1 and A549 cell lines than wild-type bacteria. Importantly, neither intracellular 
replication nor host cell attachment were affected in lpg2222-deficient L. pneumophila. Based 
on these findings, the TRP protein encoded by lpg2222 was named LpnE (Legionella 
pneumophila Entry) for its role in promoting host cell entry (Newton et al., 2006). 
 
5.1.2. Structure and Function of tetratricopeptide (TRP) repeat proteins 
Tetratricopeptide (TRP) repeats are 34-residue structural motifs comprised of a pair of 
antiparallel α-helices. These repeats occur in tandem arrays, which fold into a right-handed 
super-helix with a concave amphipathic surface implicated in protein-protein interactions 
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(Figure 5.1). Inter- and intra-repeat stabilization is achieved by hydrophobic interactions 
between consensus residues (Cerveny et al., 2013; Urosev et al., 2013) and, in rarer cases, with 
disulfide bonds (Lüthy et al., 2002, 2004). Indeed, individual repeats are composed of small 
and large hydrophobic residues that form the scaffold upon which ligand binding residues are 
grafted (Cerveny et al., 2013). TRP repeat-containing proteins participate in various cellular 
processes including transcription, kinase inhibition, protein folding and immunity (Mittl and 
Schneider-Brachert, 2007). This variability in function arises from binding promiscuity at the 
concave surface of the TRP super-helix. Although the source of promiscuity remains unclear, 
it is likely a consequence of non-covalent interactions mediated by uncharged polar side chains 
(Cerveny et al., 2013). A prospective binding partner could hydrogen bond to these residues 
along the inner surface of the super-helix. This would allow the TRP protein to clasp around 
its partner without employing a specific binding cleft (Figure 5.1). 
 
Figure 5. 1 Crystal structure of the tetratricopeptide (TRP) repeat protein IpaC (green) in 
complex with the IpaB(51-72) peptide (yellow). (Left) View of the complex from above, 
depicting the outer convex and inner concave surfaces of the TRP super-helix. (Right) Side 
view of the complex, showing the IpaB(51-72) peptide to adopt an extended conformation in 
the concavity. Figure adapted from (PDB id 3GZ1). 
 
The order in which TRP repeats fold is governed by the relative stability of each repeat. 
That is, the most stable repeats fold first, followed by neighboring repeats in a cooperative 
process. Similarly, when a single TRP repeat unfolds, adjacent repeats do so as well. On this 
basis, terminal repeats are more likely to unfold than others because they have only one 
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neighboring repeat (Perez-Riba et al., 2018). There are exceptions to this, since intrinsic repeat 
stabilities must also be considered in the folding and unfolding processes. In fact, cooperativity 
of folding depends on the mismatch between intrinsic and interfacial repeat stabilities. Thus, a 
central TRP repeat may be sufficiently unstable to initiate unfolding, despite being steadied by 
two neighboring repeats (Perez-Riba et al., 2018). 
The cooperative folding of repeat proteins may be linked to their function. Indeed, two 
‘banana-shaped’ repeat proteins acting as allosteric modulators have been described: the 
HEAT repeat protein PR65 and the LRR (leucine-rich repeat) protein Skp2 (Figure 5.2). These 
proteins both promote enzymatic activity of their substrates by binding a recognition subunit 
at one end and a catalytic subunit at the other. Importantly, this pattern of allosteric behaviour 
was found to depend on the overall shape of the repeat protein and not the repeat identity 
(Perez-Riba et al., 2018). This may implicate the cooperative folding pattern of these proteins 
in their allosteric properties. For example, protein-protein interactions occurring at the N-
terminus of a repeat protein could lead to conformational changes that are transmitted to the 
C-terminus in a cooperative fashion. These studies show TRP repeat proteins to be dynamic 
structures that bridge molecular events by transmitting a conformational signal across the 
repeats. 
The best studied TRP proteins in bacterial pathogens are class II chaperones, which belong 
to the type III secretion system and deliver two hydrophobic translocators into the eukaryotic 
membrane. Together with a third hydrophilic stabilizing protein, the two translocators form a 
pore in the eukaryotic membrane called a translocon (Cerveny et al., 2013). A crystal structure 
of the Pseudomonas aeruginosa class II chaperone PcrH (TRP) in complex with a peptide 
belonging to the minor translocator PopD showed these proteins to interact along the concave 
surface of the super-helix (Job et al., 2010). The binding interface is also employed by the 
major translocator (PopB) when interacting with PcrH (Discola et al., 2014). Thus, major 
(PopB) and minor (PopD) translocators are each bound independently to the concave surface 
of PcrH. This finding demonstrates how binding promiscuity of the TRP super-helix is utilized 
in the delivery of translocon subunits to the eukaryotic membrane.  
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Figure 5. 2 Conformational dynamics of tetratricopeptide repeat (TRP) proteins may transmit 
molecular signals from one end of the super-helix to the other. (A) HEAT-repeat protein PR65 
(green) binding a catalytic subunit (C) at the C-terminus and a regulatory subunit (B55) at the N-
terminus. (B) Leucine-rich repeat (LRR) protein Skp2 forms a hinge-like interaction with Skp1. 
Cks1 binding causes tightening of this hinge, leading to reduced mobility of Skp2. These 
conformational changes may be transmitted through the Cullin subunit (Cul1) to the E2 ubiquitin-
conjugating enzyme. 
 
The role of TRP proteins in translocon formation may point to a similar role for LpnE/EnhC 
as chaperones in host cell entry. For example, by binding proteins that locally disrupt 
eukaryotic membrane integrity, LpnE may facilitate the entry of an entire bacterium into the 
host cell. This suggestion is consistent with the observed role of TRP proteins as adaptors in 
the formation of macromolecular complexes (Cerveny et al., 2013; Mittl and Schneider-
Brachert, 2007). Further studies are required to identify binding partners of LpnE relevant to 
its role in entry. Another factor that warrants consideration is the dynamic properties of TRP 
proteins. This adds an additional layer of complexity to deciphering the function of TRP 
proteins; binding promiscuity and cooperative conformational changes transmitted through the 
repeats may lead to multiple functions for a single TRP protein. 
Sel1-like repeat (SLRs) are a subclass of the TRP family, distinguished by their longer 
length and greater variability in the consensus sequence. Instead of 34-residue motifs, SLRs 
contain 36 – 44 residues. This difference in length arises from a 4-12 residue insertion in one 
loop and a 2-residue deletion in the other. Superposition shows the SLR super-helix to be wider 
than that of TRPs due to these loop-length variations (Figure 5.3) (Mittl and Schneider-
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Brachert, 2007). Both LpnE and EnhC belong to the SLR class of proteins and harbor 9- and 
21-repeats, respectively. The fact that LpnE promotes host cell entry (Newton et al., 2006) may 
suggest that EnhC does not require its full SLR complement to do the same. Alternatively, 
these proteins may facilitate host cell entry by different methods employing unique adaptor or 
pore-forming proteins.  
 
Figure 5. 3 Superposition of the SLR protein HcpC onto the TRP domain of O-linked GlcNac 
transferase. Helices 1 and 2 of HcpC are shown in magenta and blue, respectively, while the 
GlcNac transferase is shown in grey. Note the tighter turns in the TRP repeat, relative to the SLRs. 
Figure adapted from (Mittl and Schneider-Brachert, 2007).  
 
5.1.3. Additional roles of LpnE in Legionella pneumophila pathogenesis 
LpnE promotes the infection and intracellular replication of L. pneumophila in 
Acanthamoeba castellanii and A/J mice using a full complement of SLRs, as deletion of only 
two C-terminal repeats rendered an invasion defect in L. pneumophila. Once inside the cell, L. 
pneumophila uses LpnE to modulate LCV trafficking. This was evidenced in a study where L. 
pneumophila lacking lpg2222 produced LCVs with an impaired ability to avoid vesicles 
positive for lysosome-associated membrane protein-1 (LAMP1) (Newton et al., 2007b). Thus, 
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LpnE appears to direct the LCV away from canonical endocytic trafficking routes leading to 
lysosomal degradation. Finally, LpnE is exported from bacterial cells in the absence of both 
the Icm/Dot type IV secretion system and Lsp type II secretion system (Newton et al., 2007b). 
The mechanism by which LpnE is exported from L. pneumophila without these secretion 
systems remains unclear. 
 
5.1.4. Oculocerebrorenal syndrome of Lowe (OCRL) protein 
Oculocerebrorenal syndrome of Lowe (OCRL) is an inositol polyphosphate 5-phosphatase 
that regulates endocytosis, autophagy and retrograde trafficking in eukaryotic cells. The 
regulatory effect of OCRL arises from its phosphatase activity, which alters vesicular lipid 
composition (De Matteis et al., 2017) by dephosphorylating PI(4,5)P2, Ins(1,4,5)P3 and 
PI(3,4,5)P3. The reduction of PI(4,5)P2 by OCRL on early endosomes facilitates their 
progression along the endocytic pathway. Dephosphorylation of PI(4,5)P2 to PI4P causes the 
dissociation of clathrin from early endosomes, because PI(4,5)P2 anchors clathrin to 
membranes. OCRL also regulates endo-lysosomal fusion under conditions of sustained 
autophagic flux, where PI 5-kinase enzymes increase the presence of PI(4,5)P2 on the 
lysosome. Uncontrolled accumulation of PI(4,5)P2 limits the fusion of autophagosomes with 
lysosomes by inhibiting the TRPML1 calcium channel. Thus, OCRL maintains PI(4,5)P2 at 
appropriate levels on the lysosome under these conditions (Dong et al., 2010; Zhang et al., 
2012). Finally, overexpression of OCRL in HeLa cells impedes retrograde trafficking of cation 
independent mannose 6-phosphate receptor (CI-MPR) and clathrin. This likely arises from the 
association of OCRL with the trans-Golgi network (TGN) through Rab1 or Rab6, since CI-
MPR and clathrin are redistributed from the TGN to late endosomes (Dressman et al., 2000; 
Olivos-Glander et al., 1995). These findings consistently show that OCRL requires its 
phosphatase activity for regulating vesicular trafficking events. 
Mutations in the oculocerebrorenal syndrome of Lowe (OCRL) protein give rise to a 
disease of the same name (Lowe syndrome) characterized by dysfunction of proximal renal 
tubules (Zaniew et al., 2018). These tubules are lined with epithelial cells that take up proteins 
by clathrin-mediated endocytosis, which almost eliminates plasma proteins from human urine 
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under physiological conditions. A brief overview of this process is given below to provide 
context for the role of OCRL in Lowe syndrome. 
Clathrin-mediated endocytosis starts with the interaction of two multiligand receptors, 
megalin and cubulin, which are anchored to the membrane by another protein called 
amnionless (AMN). Once ligand binds to cubulin, the megalin/cubulin/AMN complex 
interacts with the clathrin coat using adaptor proteins such as disabled homologue 2. Thus, 
ligand binding induces uptake of the megalin/cubulin/AMN complex into clathrin-coated pits 
that separate from the membrane to form early endosomes (Coudroy et al., 2005). Sustained 
acidification of these endosomes by the vacuolar H+-ATPase leads to ligand dissociation and 
subsequent uncoating of clathrin (Herak-Kramberger et al., 1998). These uncoated vesicles are 
termed late endosomes, which fuse with lysosomes for the degradation of unbound ligand by 
lytic enzymes contained therein. 
Insights into how higher eukaryotes combat L. pneumophila infection were obtained in a 
study showing LpnE to bind the eukaryotic protein, Oculocerebrorenal syndrome of Lowe 
(OCRL). As described in section 2.1.8, OCRL plays a role in retrograde trafficking. When 
recruited to the LCV by its interaction with LpnE, OCRL restricts intracellular replication of 
L. pneumophila by an unknown mechanism (Weber et al., 2009). This contrasts with the 
beneficial role of OCRL in enriching PI4P on the LCV outer surface. Also, L. pneumophila 
effectively diminishes the proportion of OCRL available to mediate canonical endocytic 
trafficking. As such, the recruitment of OCRL to the LCV may initially benefit L. pneumophila 
but, ultimately, this interaction impedes replication. 
Importantly, the phosphatase domain of OCRL is not contained within the construct found 
to interact with LpnE. In fact, only the N-terminal 236 residues of OCRL are recruited to the 
LCV by LpnE (Weber et al., 2009). This OCRL construct comprises a pleckstrin homology 
(PH) domain followed by an unstructured linker. The phosphatase domain lies C-terminal to 
this linker. Therefore, LpnE brings the phosphatase domain of OCRL in proximity to the LCV 
without directly binding it. In this way, the phosphatase domain can exert its enzymatic activity 
on the LCV without being affected by protein-protein interactions. It remains unclear if the 
LpnE/OCRL interaction allows the LCV to avoid endocytic trafficking, but it would facilitate 
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the production of PI4P on the LCV at early stages of infection. Further studies are needed to 
clarify the role of OCRL in LCV trafficking. 
 
5.2. Experimental Procedures for the LpnE and OCRL project 
 
5.2.1. Cloning of recombinant LpnE 
The entire lpnE (lpg2222) gene was amplified from Legionella pneumophila (Philadelphia) 
genomic DNA by PCR. Since residues 1–22 of LpnE were predicted to encode a signal peptide 
(SignalP, http://www.cbs.dtu.dk/services/SignalP/), the DNA sequence encoding residues 22–
375 was also amplified. These constructs were designed using the ligation-independent cloning 
(LIC) method. Digesting LpnE(22-375) with trypsin led to the production of a stable fragment, 
which was identified by mass spectrometry to be LpnE(73-375). This construct was also cloned 
into pMCSG7 by the LIC method. Finally, two truncated LpnE constructs were also designed: 
LpnE(158-375), LpnE(176-375) by this approach. 
 
5.2.2. Cloning of recombinant OCRL 
A plasmid containing the human OCRL gene was purchased from Addgene (pcDNA3-HA-
human OCRL, plasmid #22207). The following constructs of OCRL were designed: OCRL(1-
236), OCRL(10-236), OCRL(1-140), OCRL(10-140), OCRL(10-176), OCRL(10-208). 
Amplicons were placed in pMCSG7 and a pGEX derivative with a TEV cleavage site 
(pRL652) via ligation-independent cloning (LIC), as described above for LpnE. 
 
5.2.3. Protein expression and purification 
Initially, LpnE(1-375) and LpnE(22-375) were expressed in BL21(DE3) and purified as 
described below. LpnE(1-375) did not express from pMCSG7 in our hands and exhibited poor 
solubility as a GST fusion protein. His-LpnE(22-375) expressed well and was eluted from Ni-
NTA in 100 mM imidazole and then loaded onto size-exclusion column (SEC650, 
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Biorad/S200, GE Life Sciences, Mississauga, Canada) for separation of oligomeric states. 
Analysis of the eluted fractions by dynamic light scattering (DLS) showed LpnE(22-375) to 
have a high degree of polydispersity. 
Since LpnE(22-375) formed various aggregates/oligomers in solution, we investigated if 
the presence of OCRL(10-208) would improve the behavior of this protein. Cell pellets 
containing His-LpnE(22-375) and His-OCRL(10-208) were mixed, co-lysed, and purified on 
Ni-NTA followed by size-exclusion chromatography. This protocol resulted in a single narrow 
peak containing both proteins. An additional strategy to identify a fragment of LpnE(22-375) 
with good solubility was limited proteolysis. Digestion with trypsin produced a stable and 
soluble fragment, which was identified by mass spectrometry to consist of residues 73–375. 
This trypsin digestion product gave a symmetrical peak on gel filtration and led to the initial 
crystal hits. Subsequently, LpnE(73-375) was cloned to replicate the trypsin digestion product 
and used in all further structural experiments. 
LpnE(73-375), LpnE(22-375), LpnE(158-375), LpnE(176-375), OCRL(10-140), 
OCRL(10-176), OCRL(10-208), and OCRL(10-236) plasmids were transformed into the 
pMCSG7 vector, expressed and purified as described in sections 4.1 – 4.6. Size exclusion 
chromatography was carried out using a Biorad SEC650 or GE Superdex200 column. The 
His6-tags were cleaved after affinity chromatography, overnight at 20 °C using TEV protease 
at a 1:50 (enzyme:target) ratio.  
 
5.2.4. Crystallization of LpnE(73-375) 
Analysis of the LpnE sequence indicates the presence of a signal peptide encompassing 
residues 1–21. We have cloned and expressed the expected mature form of LpnE containing 
residues 22–375 in E. coli. Although we were able to crystallize LpnE(22-375), these crystals 
diffracted poorly. We applied limited proteolysis to identify a better candidate for 
crystallization. A limited digest of LpnE(22-375) showed the presence of a stable 36 kDa 
fragment. This fragment was identified by mass spectrometry to comprise residues 73–375 and 
contain most of the predicted SLRs. Subsequently, this fragment was cloned with an N-
terminal His6-tag, overexpressed in E. coli BL21(DE3)pLysS cells and used for structural and 
binding studies. 
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Monomeric and dimeric fractions of LpnE(73-375) were screened for crystallization by the 
sitting drop method in 96-well plates using in-house and commercial screens. Only monomeric 
fractions of LpnE(73-375) showed low polydispersity by dynamic light scattering (DynaPro 
Plate Reader II, Wyatt Technology, Santa Barbara, CA, USA). The proteins were concentrated 
to ~60 mg/mL in buffer containing 15 mM Tris-HCl, pH 8.0, and 50 mM NaCl, and 
preparations with and without the His-tag were screened. Untagged LpnE(73-375) gave 
extremely fine-needle clusters under a few conditions and optimization failed to improve the 
crystal size. Conversely, His-tagged LpnE produced single crystals in many different 
conditions. After optimization by the hanging drop vapor diffusion method, the best crystals 
were obtained at 20 °C in drops containing 1 µL protein mixed with 1 µL of reservoir solution 
[20% PEG 8000, 0.2 M ammonium sulfate, 0.1 M 2-(N-morpholino)ethanesulfonicacid 
(MES), pH 6.5] and suspended over 500 µL reservoir solution. The LpnE(22-375)-OCRL(10-
208) complex displayed low polydispersity and was screened with the His-tag and with the tag 
removed by TEV protease. Only His-tagged preparations gave crystals after 5–7 days of 
growth at 20 °C under various conditions within the ProComplex Suite. Examination of the 
crystal content by SDS/PAGE revealed that His-LpnE(22-375) was the sole constituent. These 
crystals diffracted poorly and were recalcitrant to optimization. 
 
5.2.5. Data collection and structure determination 
The His-LpnE(73-375) protein crystals were cryoprotected by transferring to 1 µL mother 
liquor containing 20% (v/v) glycerol, 0.2 M ammonium sulfate, 20% PEG8000, 0.1 M 2-(N-
morpholino)ethanesulfonic acid (MES) pH 6.5. Diffraction data were collected to 1.75 Å 
resolution at the Canadian Macromolecular Crystallography Facility (CMCF) 08ID beamline, 
Canadian Light Source, using a Rayonix MX300_CCD Detector (Grochulski et al., 2011). 
Integration and scaling were carried out using the XDS software package (Kabsch, 2010) 
(Table 1). The structure was solved by molecular replacement using the MOLREP program 
(Vagin and Teplyakov, 2010). Residues 28–285 of H. pylori cysteine-rich protein C (HcpC, 
PDB code 1OUV, (Lüthy et al., 2004)) were used as a search model, and two molecules were 
expected in the asymmetric unit based on Matthew’s coefficient. This molecular replacement 
solution showed good fit to the electron density only for the N-terminal half of the protein, 
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indicating a slightly different relative orientation of the N- and C-terminal segments between 
LpnE and the model structure. Therefore, the model protein was divided into two parts and 
used independently for molecular replacement with Phaser (McCoy, 2017). The final solution 
showed a small reorientation of the two fragments. This model was rebuilt with 
phenix.autobuild script and refined using phenix.refine (Adams et al., 2011) with intermittent 
manual rebuilding with Coot (Emsley et al., 2010). The coordinates and structure factors have 
been deposited with the Protein Data Bank with ID code 6DEH. 
 
5.2.6. Interaction studies using size exclusion chromatography 
The interaction of LpnE(73-375), LpnE(158-375), and LpnE(176-375) with OCRL(10-
140), OCRL(10-176), OCRL(10-183), and OCRL(10-208) was evaluated by size-exclusion 
chromatography. Recombinant proteins were purified as described previously and their hexa-
histidine tags were cleaved using TEV protease. Complete digestion of the tag was monitored 
by SDS/PAGE. Purified and cleaved proteins were either injected onto a Biorad SEC70 
column for analysis or mixed with a putative-binding partner at an approximate 1:1 molar ratio. 
Putative complexes were allowed a minimum of 30 minutes at 4 °C to form before being 
injected onto the SEC70 column. 
 
5.2.7. Size exclusion chromatography with multi-angle light scattering 
The binding of LpnE(73-375) and LpnE(22-375) to OCRL(10-208) and OCRL(10-236) 
was evaluated using size-exclusion chromatography (SEC) with multi-angle light scattering 
(SEC-MALS) at room temperature. A 500 µL sample of size-exclusion purified (Biorad 
SEC650) LpnE and OCRL was injected at 2 mg/mL on an analytical size exclusion column, 
S200 Increase (Wyatt Technologies, Santa Barbara, CA), using AKTA Explorer FPLC system 
(GE Healthcare). Elution from the column was passed on to the MALS system comprising 
MiniDawn TREOS (Wyatt Technology, Santa Barbara, CA). The column was equilibrated at 
room temperature with buffer comprised of 15 mM TrisHCl, pH 8.0, and 50 mM NaCl. 
Detector normalization was achieved using 2 mg/mL BSA (Pierce, Burlington, Canada). 
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5.2.8. Isothermal titration calorimetry of LpnE(73-375) with OCRL(10-208) 
Titrations were carried out using the Nano ITC instrument (TA Instruments, New Castle, 
DE). 200 µM OCRL(10-208) in a buffer containing 15 mM Tris-HCl, pH 8.0, and 50 mM 
NaCl was titrated into the calorimeter cell containing 50 µM LpnE(73-375) in the same buffer. 
Experiments were performed at 20 °C on untagged proteins. Data analysis was done with 
NANOANALYZE software (TA Instruments, New Castle, DE, USA) using an independent 
binding model (see section 4.5.2 for detailed explanation of ITC). 
 
5.2.9. Cloning LpnE for localization in human cells 
To obtain the GFP fusion expression vector, LpnE(1-375) and LpnE(73-375) were PCR-
amplified from the genomic DNA of L. pneumophila (strain Philadelphia). Fragments were 
digested with XhoI and BamHI and ligated to the same restriction sites of pEGFP-N1 
(Clontech Laboratories, Mountain View, CA, USA) expression vector. Restriction enzymes 
and T4 DNA ligase were purchased from New England Biolabs (NEB, Ipswich, MA, USA). 
To obtain LpnE(22-375)-GFP, the signal peptide was looped out of pEGFP-N1 harboring 
LpnE(1-375). Successful cloning of each plasmid was confirmed by DNA sequencing. 
 
5.2.10. Transient transfection of HEK293 cells 
Human Embryonic Kidney cell line 293 (HEK293) was cultured in Dulbecco’s Modified 
Eagle Medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% Fetal Bovine 
Serum (FBS) (Sigma-Aldrich) at 37°C with 5% CO2. DNA constructs were transfected into 
HEK293 cells using the X-treme GENETM HP DNA Transfection Reagent (Roche, Cat. 
06366236001, Mississauga, Canada) according to the manufacturer’s instructions. 
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5.2.11. Immunofluorescence 
GFP-tagged LpnE(1-375), LpnE(22-375), or LpnE(73-375) expressing cells were grown 
on 12 mm diameter glass cover-slips. Cells were fixed with 4% paraformaldehyde solution 
prepared in phosphate buffered saline (PBS) for 30 min at 20°C, washed in PBS, permeabilized 
with 0.5% Triton X-100 in PBST, and blocked in 5% normal horse serum for 20 min. Cells 
were then incubated with primary anti-GM130 antibody (BD Transduction Laborato-ries, 
Mississauga, Canada) for 60 min at room temperature at a dilution of 1:200 in the blocking 
solution. Cells were washed with PBST, and a secondary Alexa Fluor 546 goat anti-mouse IgG 
(Invitro-gen, Carlsbad, CA, USA) was overlaid on coverslips for 20 min at 20°C at a dilution 
of 1:2000 in blocking solution. Slides were mounted and visualized on a Laser Scanner 
Confocal Microscope (Zeiss LSM700, Thornwood, NY, USA). 
 
5.3. Results 
 
5.3.1. LpnE/OCRL Binding Studies 
LpnE has been shown by immunoprecipitation to interact with the N-terminal region of 
OCRL comprising residues 1–236 (Weber et al., 2009). This region encompasses a pleckstrin 
homology (PH) domain (aa 1–119) (Mao et al., 2009) and a long flexible linker connecting the 
PH domain to the inositol polyphosphate 5-phophatase catalytic module (Trésaugues et al., 
2014). Although PH domains have been implicated in protein–protein interactions, we 
suspected that the unstructured linker of OCRL may harbor binding elements essential for its 
interaction with LpnE.  
His-LpnE(73-375) eluted from the SEC column in two peaks corresponding to monomeric 
and dimeric species. The monomer was homogeneous, and we first explored if this fragment 
binds OCRL(1-236). We have shown using size-exclusion chromatography (SEC) that 
LpnE(73-375) does indeed interact with GST-OCRL(1-236), as evidenced by a distinct peak 
shift for the His-LpnE(73-375)–GST-OCRL(1-236) complex relative to His-LpnE(73-375) 
and GSTOCRL(1-236) alone (Figure 5.4A). Secondary structure predictions (PsiPred, [21]) of 
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OCRL show that the region 135–200 neighboring the PH domain is devoid of secondary 
structure and is followed by a short helix (aa 201-206). A polyproline motif (PPPPP) is present 
within this unstructured region (aa 177-181) and may also promote the binding of OCRL to 
LpnE [22]. Moreover, the first nine N-terminal residues of OCRL are a string of hydrophobic 
residues. To define which part of OCRL(1-236) is crucial for interacting with LpnE, we 
designed the following constructs of OCRL based on the above information: OCRL(1-140) 
and OCRL(10-140) that correspond to the PH domain, OCRL(10-176), OCRL(10-183), 
OCRL(10-208), and OCRL(10-236). These constructs were cloned with a cleavable His6-tag. 
All recombinant proteins were purified by affinity chromatography using Co2+ Talon resin and 
eluted with a buffer containing 100 mM imidazole. The His6-tag was cleaved with TEV 
protease overnight at room temperature. All OCRL constructs, except the shortest OCRL(10-
140), were found to have a degradation product corresponding to ~15 kDa after TEV cleavage. 
We found the longest construct, OCRL(10-236), to be poorly expressed and vulnerable to 
proteolytic degradation, making data interpretation difficult for this protein. We therefore 
concentrated our efforts on the other constructs. One of these, OCRL(1-140), includes the first 
nine residues to observe their role in binding LpnE. Our C-terminal truncations of OCRL 
systemically probe into the region without predicted secondary structure and should provide 
insight into the residues required to promote an interaction with LpnE.  
The interaction of untagged LpnE and OCRL constructs was investigated by size-exclusion 
chromatography using a BioRad SEC70 column. The proteins were mixed in an approximate 
1 : 1 molar ratio and incubated for 30 minutes on ice. When LpnE(73-375) was combined with 
OCRL(10-208), a clear shift in the elution profile was observed, with the main peak migrating 
to a shorter elution time and containing both proteins. This indicated that the two proteins form 
a complex (Figure 5.4B). To quantify their binding, we measured the binding constant for 
LpnE(73-375) with OCRL(10-208) by isothermal titration calorimetry and obtained a value of 
16 µM (Figure 5.4C) confirming a modest binding strength. Next, we tested if the shorter 
OCRL(10-183) interacts with LpnE(73-375). A shift in the profile is also visible for this 
complex, with fractions containing both proteins appearing at lower elution volumes (Figure 
5.4D). Additional deletion of the polyproline segment from OCRL (OCRL(10-176)) leads to 
a substantial weakening of the interaction with LpnE. This is evidenced by a small shift to 
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lower volumes and limited overlap of fractions containing the proteins (Figure 5.4E). We 
interpret the small shift of the peaks as indicating a dynamic formation and dissociation of the 
complex, which increases somewhat the apparent molecular weight of each protein. Finally, 
the shortest OCRL constructs, OCRL(1/10-140), do not interact with LpnE(73-375); they show 
no shift in the elution profile and no overlap of the fractions containing each protein is observed 
(Figure 5.4F). We conclude that the polyproline region in OCRL significantly contributes to 
the binding with LpnE.  
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Figure 5. 4 Interaction of LpnE with OCRL fragments.(A) SEC profile of His‐LpnE(73‐375)–
GST‐OCRL(1‐236) complex and His‐LpnE(73‐375) alone from BioRad SEC650 column with the 
SDS/PAGE gel across the protein fraction of the complex. His‐LpnE(73‐375) elutes in two peaks, 
monomer (mon) and dimer (dim); (B) Combined SEC profiles and SDS/PAGE corresponding to 
each profile for LpnE(73‐375) in blue, OCRL(10‐208) in green and their mixture in red. The 
proteins were injected on Biorad SEC70 column. The same column was used in all the runs 
presented this figure and the proteins are marked using the same color scheme; (C) the ITC profile 
for binding of OCRL(10‐208) to LpnE(73‐375). Binding constant of 16.2 μM was calculated from 
the measured data; (D) combined SEC profiles and SDS/PAGE corresponding to each profile for 
LpnE(73‐375), OCRL(10‐183), and their mixture; (E) combined SEC profiles and SDS/PAGE 
corresponding to each profile for LpnE(73‐375), OCRL(10‐176) and their mixture; (F) combined 
SEC profiles and SDS/PAGE corresponding to each profile for LpnE(73‐375), OCRL(10‐140), 
and their mixture; (G) combined SEC profiles and SDS/PAGE corresponding to each profile for 
LpnE(158‐375), OCRL(10‐208), and their mixture; (H) combined SEC profiles and SDS/PAGE 
corresponding to each profile for LpnE(183‐375), OCRL(10‐208), and their mixture. 
 
We then explored how far LpnE can be truncated on the N-terminal side before OCRL 
binding is abolished. To this end, we expressed His6-tagged LpnE with five- [LpnE(158-375)] 
or six- [LpnE(176-375)] helices removed from the LpnE(73-375) constructs. These proteins 
were purified, and their tags were cleaved with TEV protease. We investigated whether 
OCRL(10-208) retains an ability to bind these truncated LpnE(73-375) constructs. The SEC 
profile of LpnE(158-375) and OCRL(10-208) shows a shift of the main peak to lower volumes 
and the presence of both proteins in the peak fractions, indicating retention of binding (Figure 
5.4G). This LpnE (158-375) fragment still interacted with OCRL(10-183) (Figure 5.5A) but 
not with OCRL(10-176) (Figure 5.5B) or OCRL(10-140) (Figure 5.5C). The shorter LpnE 
construct, LpnE(176-375), mixed with OCRL(10-208) showed almost no shift in peak position 
(Figure 5.4H), suggesting a much weaker interaction between these two protein fragments. We 
conclude that the LpnE segment aa 158-177 containing an a-helix plays a key role in OCRL 
binding. 
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Figure 5. 5 LpnE(158-375)-OCRL interaction profiles. SEC elution profiles of individual 
constructs and their 1 : 1 mixture and corresponding SDS-PAGE gels of peak fractions are shown. 
LpnE is in blue, OCRL in green, and the mixture in red. The proteins were injected on the Biorad 
SEC70 column. (A) LpnE(158‐375), OCRL(10‐183), and their mixture; (B) LpnE(158‐375), 
OCRL(10‐176), and their mixture; (C) LpnE(158‐375), OCRL(10‐140). 
 
Further analysis of the putative LpnE-OCRL complexes was carried out on untagged 
proteins using size exclusion chromatography combined with multi-angle light scattering 
(SEC-MALS). LpnE(22-375) eluted in a peak corresponding to a molecular weight of 41.8 
kDa, which indicates that this protein is monomeric (39.4 kDa theoretical) (Figure 5.6A).  
Similar to its behavior on the SEC650 column, His-LpnE(73-375) eluted in two distinct 
peaks representing monomeric (35.7 kDa) and dimeric (71.5 kDa) states of the protein. 
Cleavage of the hexa-histidine tag abolished LpnE(73-375) dimerization, suggesting a role for 
the tag in promoting dimer formation (Figure 5.6B). Indeed, untagged LpnE(73-375) gave a 
molecular weight estimate of 34.5 kDa on SEC-MALS (33.7 kDa theoretical monomer). 
OCRL(10-208) also proved to be monomeric and eluted in a 23.3 kDa peak on SECMALS 
(22.9 kDa theoretical monomer) (Figure 5.6C). In agreement with the SEC data, the SEC-
MALS interaction of LpnE(73-375) with OCRL(10-208) produced a peak with an 
accompanying molecular weight estimate of 69.6 kDa, which corresponds loosely to the 
expected molecular weight for a 1 : 1 complex of these proteins (56.6 kDa theoretical) (Figure 
5.6D).  
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Figure 5. 6 Interaction of LpnE(73‐375) or LpnE(22‐375) with OCRL(10‐208) monitored by SEC‐
MALS and SDS/PAGE. (A) LpnE(22‐375) elutes as a single peak with MW of 41.8 kDa. 
SDS/PAGE shows the fractions from the column; (B) LpnE(73‐375) elutes as a single peak with 
Mw of 34.5 kDa. The middle part of the SDS/PAGE gel (shown in panel A) has been spliced out 
to move molecular weight markers close to the relevant lanes of the gel; (C) OCRL(10‐208) elutes 
as a single peak with MW of 23.3 kDa. Degradation products of OCRL elute in the second peak; 
(D) LpnE(22‐375) with OCRL(10‐208). The complex elutes within fractions 40–43; (E) LpnE(22‐
375) with OCRL(10‐208). The complex elutes as a broad peak within fractions 36–42. Excess of 
OCRL(10‐208) elutes in the second peak and degradation products as the third peak.  
 
A ~10 kDa deviation from the expected value may suggest that the LpnE(73-375)-
OCRL(10-208) complex is not spherical in solution, as MALS molar mass estimates are 
predicated on this assumption. The LpnE(22-375)- OCRL(10-208) mixture eluted together in 
a peak with a corresponding molecular weight of 147.7 kDa (Figure 5.6E). This could represent 
an LpnE(22-375)2- OCRL(10-208)2 heterotetramer according to theoretical estimates (130.2 
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kDa). As for the LpnE(73- 375)-OCRL(10-208) complex, the deviation of LpnE (22-375)2-
OCRL(10-208)2 from its expected molecular weight may imply the complex is nonglobular. 
Intriguingly, conformational homogeneity of full-length LpnE(22-375) was promoted by 
the presence of OCRL(10-208). When purified alone, LpnE(22-375) produced an extremely 
broad peak on size exclusion (Figure 5.7, magenta trace) and gave consistently high 
polydispersity (> 20 %Pd) as measured by dynamic light scattering (DLS). By including an 
ion exchange step in the purification protocol and increasing the salt concentration in the size 
exclusion buffer to 600 mM, greater purity of LpnE(22-375) could be achieved, although this 
came at the cost of significant yield reduction. No crystals could be obtained with the protein 
prepared by this protocol despite broad screening. When copurified in the presence of 
OCRL(10-208), however, a simple purification protocol consisting of affinity chromatography 
followed by ion exchange allowed us to obtain large quantities of the complex at low 
polydispersity. Unlike LpnE(22-375) alone, the size exclusion peak for the complex was sharp 
and distinct (Figure 5.7, green trace), suggesting that homogeneity is increased for the 
complex. 
Crystallization trials on the LpnE(22-375)-OCRL(10-208) complex gave hits under several 
conditions. In particular, the ProComplex Suite (Qiagen) produced crystals in B1, C5, C8, D3, 
D10, D11, D12, E8, E9, F1, F4 and G5 wells. These crystals would only grow if tags remained 
intact for both LpnE(22-375) and OCRL(10-208). However, analysis of these crystals by SDS-
PAGE showed only LpnE(22-375) to be present within them. The absence of OCRL(10-208) 
likely reflects a tendency for this protein to degrade, as OCRL(10-208) also disappeared from 
the stock and drop solutions. Efforts to solve the structure of LpnE(22-375) by crystallography 
were hampered by the low-resolution data (>5 Å) obtained from these crystals. Consequently, 
it remains unclear what role OCRL(10-208) plays in facilitating the crystallization of LpnE(22-
375).  
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Figure 5. 7 Overlay of size exclusion chromatograms obtained for His-LpnE(22-375) alone 
(magenta) and the His-LpnE(22-375)-His-OCRL(10-208) complex (green) on a GE Superdex200 
column. 
 
Table 5. 1 List of ProComplex Suite Conditions giving rise to crystals of HisLpnE(22-375) 
ProComplex Well Condition 
B1 0.2 M Lithium sulfate, 0.1 M Tris pH 7.5, 5 % PEG4000  
C5 0.1 M Tris pH 8.0, 20% PEG4000 
D10 0.1 M Potassium chloride, 0.1 M HEPES pH 7.5, 15 % PEG6000 
D11 0.1 M Tris pH 7.5, 15 % PEG6000 
D12 0.1 M Tris pH 8.5, 20 % PEG6000 
E8 0.1 M Magnesium acetate, 0.1 M MOPS pH 7.5, 12 % PEG8000 
E9 0.2 M Sodium chloride, 0.1  M HEPES pH 7.5, 12 % PEG8000 
F1 0.1 M HEPES pH 7.0, 20 % PEG8000 
F4 0.1 M HEPES pH 7.0, 18 % PEG12000 
G5 0.1 M Potassium chloride, 0.1 M HEPES pH 7.0, 1 M Ammonium 
sulfate 
 
5.3.2. Structure determination of LpnE(73-375) 
Of the various constructs, only LpnE(73-375) led to well-diffracting crystals. Its crystal 
structure was solved by molecular replacement and refined to a resolution of 1.75 Å. There are 
two molecules in the asymmetric unit. Each molecule consists of 17 antiparallel α-helices 
(Figure 5.8A). The helices are twisted into a right-handed super-helix. While short segments 
of the two molecules superimpose with root-mean-square deviation (rmsd) of 0.2–0.3 Å, the 
superposition of molecule A and B gives rmsd of 1.2 Å and indicates a small difference in 
super-helical twist of the helices (Figure 5.9). The loops connecting neighboring helices are 
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short on one edge of the super-helix and long on the other edge (Figure 5.8A). The helices are 
organized into helix-loop-helix pairs that are classified as Sel1-like repeats (SLRs). Two 
conventions have been used to describe multiple Sel1- like repeats. In a description by Lüthy 
et al. (Lüthy et al., 2004), the two helices of the Sel1-like repeat are joined by a short loop 
while the long loop connects two repeats. In the other description introduced by Mittl and 
Schneider-Brachert (Mittl and Schneider-Brachert, 2007), the two helices of the Sel1-like 
repeat are connected by a long loop. Here, we follow the first definition as it better fits the 
LpnE structure. The 17 α-helices of LpnE(73-375) form eight SLRs (α1–α16), with the C-
terminal helix α17 capping the repeats (Figure 5.8D). The first helix of each SLR is designated 
as helix αA and the second as helix αB and are marked as n-αA, n-αB, where n = 1–8 and numbers 
the SLR in LpnE. The structural superposition of the eight repeats is shown in Figure 5.8B 
together with their aligned sequences (Figure 5.8C). The intra-SLR loops in LpnE are three 
residues long while the inter-SLR loops are longer, ~7 residues. SLRs in LpnE are 36 amino 
acids in length except for SLR1 which has 33 amino acids (Figure 5.8C). 
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Figure 5. 8 Crystal structure of His‐LpnE(73‐375) comprising eight SLRs and a C‐terminal 
capping helix. (A) Overall structure of His‐LpnE(73‐375). The SLR repeats are individually 
colored, with the N‐terminal SLR1 blue and C‐terminal SLR8 magenta. The capping helix is red. 
The N‐terminal tag residues are colored gray; (B) structural superposition of SLR1 to SLR8 repeats 
of LpnE(73‐375); (C) sequence alignment‐based structural superposition of SLRs and the 
consensus sequence. The sequences of the predicted four helices in the 22–72 region are added to 
the alignment. The SLR0 sequence fits the consensus sequence quite well, but the sequence of 
putative SLR‐1 diverges from the consensus; (D) the position of the capping helix differs from the 
expected position of the αA helix of the next SLR; (E) the packing of the two neighboring 
molecules involving the largest contact area. They interact through their N‐ (blue) and C‐terminal 
(red) helices. The residues belonging to the affinity tag were omitted from this view. 
 
The first helices (αA) of Sel1-like repeats (SLRs) are located on the convex, exterior side 
of the super-helix, while the second helices (αB) are on the concave, interior side. While both 
surfaces of the super-helix have hydrophilic character, they differ in that the convex side 
contains many charged side chains while the concave side is lined with uncharged polar side 
chains. Helix 1-αA of the N-terminal repeat deviates the most from the SLR consensus 
sequence (Figure 5.8C). Hydrophilic residues Glu73, Lys74, Thr75, Glu76, Gln77, Ser82, and 
Asn84 are evenly dispersed throughout this helix. This arrangement comes in contrast with the 
amphipathic αA helices found in the rest of the molecule, which display distinct hydrophobic 
and hydrophilic sides. The final C-terminal capping helix α17 does not follow the Sel1-like 
arrangement pattern. While the loop between 7- αB and 8- αA is seven residues long, the loop 
connecting 8-αB to α17 is only three residues long. Thus, α17, instead of adjoining helix 8-αB 
on the opposite side to 8-αA as occurs between neighboring SLRs, folds toward helix 8-αA 
and provides the side chain of Tyr367 for stacking with Trp329 that would otherwise be 
exposed to the solvent and caps the SLR repeats (Figure 5.8D). 
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Figure 5. 9 Superposition of the two independent LpnE molecules based only on SLR‐1 and SLR‐
2.The difference in twist along the super-helix axis becomes clearly visible. 
 
5.3.3. Crystal contacts 
LpnE molecules in the asymmetric unit are related by non-crystallographic twofold 
symmetry and pack in a head-to-head/tail-to-tail fashion to form a twisted, doughnut-shaped 
dimer. Concave surfaces of each super-helix line the solvent-filled interior of the twisted 
doughnut (Figure 5.8E). The bulk of interactions between monomers are mediated by the N-
terminal tag and connecting residues, which extend along the concave surface of the opposite 
chain. Indeed, these residues each contribute ~915 Å2 of contact area to the ~2500 Å2 interface 
between LpnE monomers. Elimination of the tag residues reduces the overall contact interface 
to ~655 Å2, confirming the significance of this region to the interaction. Further inspection of 
contacts between untagged proteins reveals that ~364 Å2 and ~279 Å2 are contributed at the 
N- and C-terminus, respectively. Interactions between molecules in neighboring asymmetric 
units are even smaller than this, suggesting that untagged LpnE is monomeric. Consistent with 
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this notion, cleaved LpnE(73-375) runs only as a monomer on gel filtration, whereas tagged 
LpnE(73-375) shows both monomer and dimer species. The fact that non-protein residues give 
rise to dimerization suggests this oligomeric state is not of biological significance to LpnE.  
 
 
 
Figure 5. 10 Packing of LpnE(73‐375) in the crystal. (A) The loose dimers form cylindrical stacks 
extending along the crystallographic a‐axis with water channels in the middle; (B) the stacks are 
arranged in a hexagonal lattice in the b,c‐plane viewed down the a‐axis. This view is rotated 90° 
along the horizontal axis relative to the view in A. 
 
The concave surface of Sel1-like repeat (SLR) superhelices conventionally mediates 
protein-protein interactions or substrate binding. As such, it is not altogether surprising that 
tag residues of a nearby chain nestle into this groove on LpnE. Residues that bind the hexa-
histidine tag are located on helices 5-αB, 6-αA and 6-αB. Three aspartate residues (Asp242, 
Asp275 and Asp281) stabilize the interaction by forming hydrogen bonds with sidechains of 
His50 and His54 at the N-terminus of the neighboring protein. Several tyrosine residues 
cushion the hexa-histidine tag by engaging in hydrophobic or hydrogen bond interactions. The 
remaining residues of the tag extend along a predominantly polar and uncharged surface 
formed by helices 2-αB, 3-αB, 4-αA, 4-αB and 5-αB. Importantly, most connecting residues of 
the tag are poorly resolved in the electron density map. This conformational flexibility may 
arise from nonspecific interactions between polar tag residues and the concave surface of 
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LpnE. Surprisingly, Thr63, Glu64 and Asn 65 are better resolved than other residues of the 
extended chain. Closer inspection of this region shows that Glu64 is stabilized by hydrogen 
bonds to His230, Lys232 and Ser196, which anchor it to the concave surface of LpnE and 
rigidify flanking residues. Taken together, this interaction demonstrates the versatility of 
protein-protein interactions mediated by polar residues present on the concave surface of the 
LpnE super-helix. 
LpnE dimers are stacked such that their interiors combine to form a solvent channel. The 
packing of these cylindrical stacks is pseudohexagonal, with seven molecules arranged into an 
approximate hexagon when viewed along the a-axis (Figure 5.10B). Histidine tags from 
separate stacks coordinate Ni2+ ions to stabilize the pseudohexagonal arrangement (Figure 
5.11A/B). One of these Ni2+ ions is coordinated in a square planar fashion by ND1His52 and 
backbone amides of Met49, His50 and His51, with an average Ni-N distance of 1.95 Å (Figure 
5.11C). The second Ni2+ ion connects NE2His52 and NE2His53 from neighboring chains, with 
water molecules above and below it to establish octahedral coordination (Figure 5.11D). These 
His-tag interactions provide a rationale for their role in crystal formation.  
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Figure 5. 11 The ‘handshake’ formed by the His‐tags from two molecules. (A) The His‐tags join 
two dimers shown in Figure B. The molecules contributing to the handshake are shown in wheat 
and cyan; their dimeric partners are semitransparent; (B) The close‐up of the His‐tags joined 
through tetrahedral coordination of a common Ni2+ ion. A second Ni2+ in each His‐tag rigidifies 
the peptide through a square planar coordination with the His side chain and backbone atoms; (C) 
square planar coordination of Ni2+ ion within one His‐tag; (D) tetrahedral coordination of the Ni2+ 
ion bridging two His‐tags. 
 
5.3.4. Cellular localization of LpnE 
Previous intracellular studies of LpnE have focused on its role in vacuolar trafficking 
(Newton et al., 2007b) or host cell translocation (Bandyopadhyay et al., 2012), but not 
subcellular localization. To investigate this, we tagged LpnE(1-375) and LpnE(73-375) with a 
C-terminal GFP tag and overexpressed them in HEK293 cells. A subset of cells transfected 
with a vector encoding only GFP served as a control. The subcellular localizations of GFP and 
LpnE(1‐375)‐GFP in HEK293 cells were examined by fluorescence microscopy. The GFP 
control was distributed throughout the cells (Figure 5.12A, upper panels), whereas LpnE(1‐
375)‐GFP predominantly showed a punctate pattern (Figure 5.12A, lower panels). The 
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subcellular localization of ectopically expressed LpnE(1‐375) suggested that this protein may 
possess a hydrophobic membrane localization domain and bind‐specific host organelles. To 
identify the nature of the punctate species, we analyzed the possible colocalization of 
ectopically expressed LpnE(1‐375)‐GFP with ER and Golgi markers in HEK293 cells. These 
experiments showed that LpnE(1‐375)‐GFP colocalizes with the cis‐Golgi marker GM130 
(Figure 5.12A, middle), but not the ER marker calnexin (Figure 5.12A, right) or 4′,6‐
diamidino‐2‐phenylindole (DAPI) identifying the nucleus (Figure 5.12A, left). To quantify the 
degree of colocalization of LpnE and intracellular marker, we calculated the Pearson 
correlation coefficient for each marker. A Pearson coefficient of 0.72 and 0.18 was obtained 
for GM130 and calnexin, respectively, supporting the colocalization of LpnE with Golgi. 
Conversely, overlap coefficients of 0.29 and 0.24 were obtained for GFP with GM130 and 
calnexin. 
To identify the segment of LpnE that encodes for Golgi localization, we first investigated 
localization of the LpnE(73‐375) fragment, which behaved well and was successfully 
crystallized. In contrast to the punctate pattern observed for LpnE(1‐375), LpnE(73‐375) was 
distributed throughout the cell (Figure 5.12C), indicating that the first 72 residues are guiding 
Golgi localization. Next, we investigated the localization of a predicted mature protein: 
LpnE(22‐375). Surprisingly, this construct was also distributed throughout the cytosol of the 
HEK293 cells (Figure 5.12D). Thus, neither of the ectopically expressed LpnE(73‐375) or 
LpnE(22‐375) colocalized with the cis‐Golgi marker. In order to test whether the first 22 
residues of LpnE serve as a localization peptide, we fused this LpnE peptide to the N-terminus 
of two other effector proteins LegA15 and LpiR1, which we previously showed to have 
cytosolic localization. We expressed these proteins in HEK293 cells and observed their 
localization. Wild‐type LegA15 and LpiR1 were distributed throughout the cytoplasm. When 
these proteins were fused to the LpnE peptide, however, they displayed a punctate pattern that 
colocalized with the Golgi marker (Figure 5.12E). The Pearson correlation coefficients for 
wild‐type LegA15 and Lpir1 with cis‐Golgi marker GM130 were 0.34 and 0.29, respectively, 
while for the tagged proteins, it was 0.71 and 0.53, respectively (Figure 5.12F). These results 
suggest that the putative signal peptide of LpnE is responsible for its cis‐Golgi localization. 
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Figure 5. 12 Localization of various LpnE fragments in HEK293 cells. (A) The plasmid containing 
either GFP or LpnE(1‐375)‐GFP was transfected to HEK293 cells. Left grid—nucleus visualized 
with DAPI. Middle grid—the cis‐Golgi visualized with anti‐GM130 antibody, right grid—the ER 
visualized with anti‐calnexin antibody. Top panels—GFP alone, lower panels—LpnE(1‐375)‐
GFP. The scale bar indicates the length of 5 μm; (B) quantitation of colocalization by Pearson 
coefficient. The Pearson correlation coefficient was determined with coloc 2 plugin of 
the imagej software 35 and was calculated with at least 30 cells (mean and standard deviation, SD, 
of the mean from each experiment, ***P < 0.001); (C) LpnE(73‐375)‐GFP localization in 
HEK293 cells compared with DAPI staining of the nucleus (top panel) and the cis‐Golgi staining 
with anti‐GM130 antibody (lower panel); (D) LpnE(22‐375)‐GFP localization in HEK293 cells 
compared with GM130 marker; (E) fusion with LpnE signal peptide led Legionella 
pneumophila effector LegA15 and Lpir1 to Golgi apparatus. (F) quantitation of colocalization by 
Pearson coefficient of Figure 5.12D with at least 30 cells was calculated (mean and standard 
deviation, SD, of the mean from each experiment, ***P < 0.001). 
 
5.4. Discussion 
LpnE is one of several Legionella effectors containing predicted SLR‐like repeats and 
shares ~30% sequence identity with EnhC, LidL, Lpg1062, and Lpg1356. The effector plays 
a role in bacterial entry into the host cell, in phagosome acidification and helps the LCV evade 
fusion with the lysosome. Two host proteins, OCRL and OBSL1, were confirmed to be LpnE‐
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interacting partners and the LpnE‐binding regions on these two proteins have been roughly 
identified (Newton et al., 2007b; Weber et al., 2009). We determined which segment of LpnE 
is directing its cellular localization, determined the 3‐D structure of the SLR repeat containing 
domain, and refined the OCRL segment required for interaction with LpnE. 
 
5.4.1. LpnE localization 
Our localization studies showed that full‐length LpnE is localized to the cis‐Golgi in 
HEK293 cells. We then investigated if the SLR‐containing fragment, LpnE(73‐375), retains 
this localization pattern. Intriguingly, this construct was found predominantly in the cytosol. 
Since the first 22 residues were predicted as a signal peptide, we rationalized that the 
localization is associated with the segment 22–72. This is not the case, however, as LpnE(22‐
375) was also found in the cytosol. We, therefore, concluded that the first 21 amino acids direct 
LpnE to the cis‐Golgi. LpnE is not delivered to the host cell through the Dot/Icm secretion 
system and the mechanism of its translocation is presently unknown (Newton et al., 2007b). 
The N-terminus does indeed contain a signal peptide, but it is not known if this peptide is 
recognized inside Legionella or in the host cell and if or when it is cleaved off. While the 
mechanism of LpnE retention at the cis‐Golgi remains unknown, it is possible that specific 
amino acid residues act as a sorting signal. Specific recruitment of LpnE to the cis‐Golgi may 
depend on a preference for characteristic glycerophospholipid/sphingolipid ratios, as these 
lipids distinguish cis‐Golgi from trans‐Golgi (Banfield, 2011). 
The biological significance of LpnE(1‐375) retention at the cis‐Golgi remains unclear. It is 
important to note that a punctate localization pattern was observed only in ~20% of HEK293 
cells, while a cytosolic localization was observed in the remaining cells. This suggests cleavage 
of the signal peptide in some instances. LpnE is known to bind phosphatidylinositol‐3‐
phosphate (PI3P) and localize to the Legionella‐containing vacuole (LCV) (Weber et al., 
2009). The retention of LpnE at the LCV may be mediated by the signal peptide and/or the aa 
23–72 segment. Cleavage of the signal peptide would liberate LpnE from the LCV, allowing 
it to interact with various eukaryotic proteins via the concave surface of its super-helix. 
Recruitment of OCRL to the LCV and its association with LpnE may render the latter 
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inaccessible to host signal peptidases and thereby impede the infective role of LpnE. This 
notion is in keeping with previous studies showing that the first 51 residues (including the 
signal peptide) are not necessary for LpnE export and invasion (Newton et al., 2007b). In short, 
LpnE may interfere with host cell processes outside of its known role in uptake, with the signal 
peptide allowing its brief retention on the LCV. 
 
5.4.2. LpnE/OCRL interaction studies 
Our SEC‐MALS data suggest that both LpnE(73‐375) and LpnE(22‐375) interact with 
OCRL(10‐208), albeit with different stoichiometry. The 69.6 kDa peak containing both 
LpnE(73‐375) and OCRL(10‐208) agrees reasonably well with the theoretical molecular 
weight estimate of 56.6 kDa for a 1 : 1 complex of these proteins. Meanwhile, the 147.7 kDa 
peak observed for LpnE(22‐375)‐OCRL(10‐208) cannot be rationalized in the same way, as a 
1 : 1 stoichiometry would correspond to a theoretical molecular weight of 62.3 kDa. Thus, the 
observed peak at 147.7 kDa may represent an LpnE(22‐375)2‐OCRL(10‐208)2 heterotetramer. 
It is tempting to speculate from these data that the N‐terminal 22–72 residues of LpnE 
promote its own dimerization and thereby render a dimer‐of‐dimers in the presence of 
OCRL(10‐208). This hypothesis, however, would also suggest that LpnE(22‐375) readily 
dimerizes in the absence of OCRL(10‐208). Our studies of LpnE(22‐375) have shown this not 
to be the case, as LpnE(22‐375) appears to be monomeric by SEC‐MALS (39.4 kDa calculated 
vs. 41.8 kDa measured). An alternative explanation is that the binding of OCRL(10‐208) to 
LpnE(22‐375) induces a conformational change in either LpnE or OCRL, exposing a protein–
protein interaction interface that gives rise to dimerization. The fact that no dimer‐of‐dimers is 
observed for LpnE(73‐375)‐OCRL(10‐208) may point to a special role for the N‐terminal 22–
72 residues of LpnE in promoting this process. 
LpnE(22-375) produces a broad peak when eluting from Biorad SEC650 or GE 
Superdex200 columns. This indicates that LpnE(22-375) is conformationally heterogeneous at 
the concentrations used for this assay. Indeed, a 100 µL injection of LpnE(22-375) at only 2 
mg/ml was used for the SEC-MALS analytical column, whereas 500 µL injections at 
concentrations above 15 mg/ml were the norm during routine purifications. Since LpnE(73-
375) retains distinct monomer and dimer peaks at high concentrations, the conformational 
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heterogeneity of LpnE(22-375) must be attributed to its N-terminal 22-72 residues. We expect 
some level of flexibility for this fragment of LpnE, as it was accessible to trypsin. Still, 
flexibility alone does not explain the concentration-dependent change in gel filtration profiles 
for LpnE(22-375). It is possible that the N-terminal 22-72 residues interact transiently with the 
concave surface of the SLR super-helix in a nearby molecule. Such an interaction would lead 
to the formation of higher order oligomers that rapidly assemble and disassemble when the 
protein concentration is high enough. This explanation is consistent with previous findings that 
show TRP repeat proteins to be promiscuous in their binding properties. 
Copurifying LpnE(22-375) with OCRL(10-208) produces a sharp peak on gel filtration 
with purified fractions showing low polydispersity on DLS. This suggests that OCRL(10-208) 
limits the conformational diversity of LpnE(22-375). A potential explanation for this 
phenomenon is that OCRL(10-208) occupies the protein-binding interface of LpnE(22-375) 
and prevents the formation of LpnE oligomers at high concentration. OCRL(10-208) may also 
stabilize the LpnE N-terminus by interacting with residues in this region. These effects could 
rationalize the crystallization of LpnE(22-375) when purified in the presence of OCRL(10-
208). That is, OCRL(10-208) may retain LpnE(22-375) in a single conformation that is 
amenable to crystallization. It is worth noting, however, that OCRL was absent from crystals 
obtained using preparations of LpnE(22-375)-OCRL(10-208). The gradual disappearance of 
OCRL(10-208) from these preparations may facilitate the crystallization of LpnE(22-375) by 
increasing the concentration of properly folded LpnE monomers in solution. Alternatively, a 
small fragment of OCRL(10-208) may remain bound to LpnE(22-375) to stabilize it for 
crystallization. Since no structure was solved for LpnE(22-375), it remains unclear what role 
OCRL(10-208) played in the process of crystallization. Still, the fact that LpnE(22-375) 
crystals were obtained only when this protein was copurified with OCRL(10-208) supports the 
notion that OCRL stabilizes LpnE by a direct interaction. 
His-LpnE(22-375) crystallized in a variety of wells from the ProComplex Suite (Qiagen) 
(Table 1), which has conditions derived from those used in the protein data bank (PDB) for 
protein-protein complexes. The screen is biased in favor of low to medium molecular weight 
PEGs, 0.1 – 0.2 M salt concentration and pH ranges from 5.0 – 8.0 (with a few exceptions). 
Inspection of Table 1 shows that His-LpnE(22-375) prefers a pH range of 7.0 – 8.5 and medium 
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molecular weight PEGs (4, 6, 8 and 12K) at 15 – 20 %. Conditions C5, D11, D12, F1 and F4 
contain no salt, indicating that this component is dispensable for the crystallization of His-
LpnE(22-375). It is intriguing that crystals of His-LpnE(73-375) can be grown only in 
conditions previously used to obtain protein-protein complexes, because LpnE(22-375) was 
purified in the presence of OCRL(10-208). That is, we were hoping to obtain a complex of 
LpnE(22-375) and OCRL(10-208) when crystals of His-LpnE(22-375) were grown. Protein-
protein complexes are sensitive to the destabilizing effect of extreme pH. Furthermore, 
complexes are often less soluble than their individual constituents and therefore require lower 
molecular weight PEGs and PEG concentrations (Radaev et al., 2006). His-LpnE(22-375) 
crystallizes at moderate pH values and with lower % PEG than His-LpnE(73-375) [0.1 M MES 
pH 6.5, 0.2 M ammonium sulfate, 30 % PEG 8000]. These observations, when coupled to the 
fact that His-LpnE(22-375) could not be crystallized in the absence of OCRL(10-208), can be 
used to further justify our suspicion that some component of OCRL interacts with and 
stabilizes LpnE to promote crystallization. It is difficult to speculate what role the His-tags 
play in the crystallization of LpnE(22-375), although they may promote the interaction of 
nearby molecules in a similar fashion to that observed in our model of LpnE(73-375). Future 
efforts to crystallize LpnE(22-375) should continue to explore the stabilizing effect of 
OCRL(10-208) on this protein.   
To investigate which parts of LpnE and OCRL are essential for their interactions, we 
expressed a series of LpnE constructs with N‐terminal deletions and OCRL constructs with C‐
terminal deletions. We showed that while OCRL(10‐208) and OCRL(10‐183) bind LpnE, the 
slightly shorter construct lacking the polyproline sequence, OCRL(10‐176) binds LpnE very 
weakly or not at all. This suggests that the polyproline segment of OCRL is critical for LpnE 
binding. The polyproline motif within OCRL likely adopts a left‐handed PPII helix, as this is 
energetically favorable to PPI, and these helices are implicated in protein–protein interactions 
(Moradi et al., 2009). This extended structure could fit alongside the Sel1 helical motifs 
forming a concave surface on LpnE. To determine the region of LpnE critical for binding 
OCRL, we investigated binding of OCRL(10‐208) to the shortened LpnE constructs. 
LpnE(158‐375) is missing five helices from the crystallized LpnE construct and still binds 
OCRL. Moreover, like LpnE(73‐375), this construct also binds OCRL(10‐183) but not the 
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shorter OCRL constructs. However, deleting one more helix from LpnE [LpnE(176‐375)] 
abrogates binding, indicating that the 159–175 helix (3‐αB) is critical for the interaction. This 
helix is at the center of the curved surface in the structure of LpnE. Taken together, our data 
suggest that the interaction is between the polyproline segment of OCRL and the 3‐αB helix of 
LpnE. Our studies make clear that the N‐terminal PH domain of OCRL is unlikely to be 
involved in binding LpnE and the primary interactions are predominantly with the unstructured 
linker between the PH and 5‐phosphatase domains of OCRL. 
The polyproline motif in OCRL comprises residues 177 – 183 and consists of PPPPPFS. 
Since no crystal structure was obtained for LpnE in complex with OCRL, it remains unclear 
how the polyproline motif interacts with the 3-αB helix of LpnE. Our structure of LpnE(73-
375) provides an example of how an extended peptide can bind the concave surface of the 
super-helix. Inspection of the LpnE(73-375) crystal structure reveals that tag residues of one 
chain are in proximity to the 3-αB helix of a neighboring chain. The PISA server shows that 
interacting residues in this helix consist of Asn160, Leu163, Ala164, Tyr167, Asp170 and 
Thr171. These residues have sidechains oriented toward the center of the doughnut shaped 
dimer and characterize the concave surface at this region. Polyproline motifs engage in protein-
protein interactions because they lack intramolecular hydrogen bonds and rely on external 
sources to satisfy them. Considering that several of the interacting residues in 3-αB have polar 
sidechains that can act as hydrogen bond donors, it is easy to envision how this helix might 
stabilize a polyproline II helix. It should also be noted that the polyproline motif is highly 
hydrophobic. Thus, the presence of hydrogen bond donors may need to be counterbalanced 
with nonpolar residues that contribute to hydrophobic packing of the proline sidechains against 
the super-helix. Leu163, Ala164 and the aromatic ring of Tyr167 could serve this purpose, 
although these residues occupy only a small central segment of the 3-αB helix and are unlikely 
to interact with five consecutive proline residues in an extended conformation. It should not be 
assumed, however, that the polyproline motif binds exclusively to residues within the 3-αB 
helix. Indeed, Ala182, Tyr186, Ala189 and Ala190 along the concave face of the neighboring 
helix, 4-αA, might form a hydrophobic cleft with the 3-αB helix. If residues from both these 
helices work in concert to facilitate the binding of OCRL, we should expect that removal of 3-
αB would abolish the interaction. This is consistent with our observation that binding of 
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LpnE(176-375) to OCRL(10-208) does not occur. A complex structure of LpnE with the 
OCRL polyproline peptide will still be needed to truly appreciate the mode of interaction 
between these proteins.  
 
5.4.3. Structural comparison with other Sel1-like repeat proteins 
SLR proteins are prevalent in nature and many structures of proteins containing these 
domains are known. Comparison of LpnE(73‐375) with other such proteins using the DALI 
server (Holm and Rosenström, 2010) identified EsiB (PDB id 4BWR (Urosev et al., 2013)) 
from extra‐intestinal pathogenic E. coli (ExPEC), HcpB (PDB id 1KLX (Lüthy et al., 2002)), 
HcpC (PDB id 1OUV (Lüthy et al., 2004)) of the Helicobacter pylori cysteine‐rich (Hcp) 
family and mouse SEL1L (PDB id 5B26 (Jeong et al., 2016)) of the ER‐associated protein 
degradation (ERAD) machinery as the closest structural homologs. EsiB, HcpB, and HcpC are 
all SLR proteins from bacterial pathogens and their roles in virulence remain uncertain. 
Although LpnE has greater sequence identity with EsiB and SEL1L (36%) than with HcpB 
(29%) or HcpC (31%), structural superposition shows that repeats align best with HcpC 
(RMSD 2.3 Å). This difference is attributable to the long inter-repeat loops, which lean in the 
direction of the convex outer face of the super-helix. These longer loops play an important role 
in defining the super-helical geometry of the structure and are noticeably better aligned 
between LpnE and HcpC. It is likely that this structural similarity made HcpC a good candidate 
model to obtain initial phases for LpnE by molecular replacement. 
Like EsiB, LpnE lacks the intra-repeat disulfide bonds seen in HcpC or its shorter homolog, 
HcpB to help stabilizing the repeats. Instead, the super-helical packing of LpnE is stabilized 
predominantly by its continuous hydrophobic core. This stabilization strategy is also observed 
in EsiB, which exhibits a strikingly similar pattern of SLR residues to that seen in LpnE. 
Despite sharing the same sequence identity with LpnE as EsiB, SEL1L forms a super-helix 
with a tighter twist and associates into dimers through C‐terminal helical extension following 
the last SLR repeat. 
In EsiB, the hydrophobic core is centered at Leu7 on helix A. Leu7 makes contacts with 
Trp28 and hydrophobic residues found at positions 26, 29, 30 and 33 of helix B. In the same 
way, Leu7 of LpnE is nearly always in close contact with Trp27, and hydrophobic residues 
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found at positions 25, 28, 29 and 32. The presence of Trp27 in LpnE as an analogue to Trp28 
of EsiB is nontrivial; this residue has been implicated in substituting for the effect of disulfide 
bonds in Hcp family SLR proteins. Additional similarities between the hydrophobic cores of 
LpnE and EsiB include contacts between Leu7 and Tyr11, and hydrophobic interactions 
between positions 10 and 25 in LpnE (10 and 26 in EsiB).  
A notable difference between LpnE and EsiB can be seen at position 29. In LpnE, this 
position is dominated by the residues glutamine and glutamate, whereas the corresponding 
position 30 in EsiB is predominantly arginine. The hydrogen bond between guanidinium and 
hydroxyl groups of Arg30 and Tyr11 in EsiB is not mimicked by Gln/Glu29 of LpnE. Thus, 
the kink observed in helix B of EsiB is not present in LpnE.  
Intra-repeat interactions are stabilized by hydrogen-bonded glutamine residues at positions 
4 and 34 (35 in EsiB) in both LpnE and EsiB. The stacking interaction between Tyr11 and 
Gln24 of EsiB is seen in only two of the eight repeats of LpnE. Position 23 of LpnE is 
dominated by lysine, rather than glutamine. The intra-repeat loops are comprised mostly of 
seven residues, with SLR2 having one residue less, and SLR5 lacking two residues. As with 
EsiB, a critical valine (Val17 in LpnE) mediates interactions with the hydrophobic core 
residues Tyr11 and 26. Interestingly, this valine is present in only four of seven intra-repeat 
loops observed in our LpnE structure. The inter-repeat loop is comprised of three residues in 
LpnE and EsiB.     
Secondary structure predictions for LpnE indicate the presence of four helices preceding 
the domain for which we have determined the structure (aa 1‐72). Of these, helices α3 and α4 
conform well to the consensus sequence of the SLR repeats in LpnE (Figure 5.8D) and we 
suggest that they indeed form an additional SLR repeat (predicted SLR0). Trypsin cleavage of 
LpnE occurs within a nine-residue linker connecting SLR0 to SLR1 (the N‐terminal repeat 
observed in our structure). The sequences of the predicted helices α1 and α2 do not correspond 
well to the consensus, and moreover, helix 1 falls within the predicted signal peptide. We, 
therefore, conclude that only helices 3 and 4 form a SLR repeat and that there are consequently 
nine SLRs in LpnE. 
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5.4.4. Ni2+ coordination by the LpnE hexa-histidine tag 
The presence of the His‐tag promoted crystallization of LpnE. The six histidines of the tag 
acquired 1.5 Ni2+ ions per tag. One Ni2+ ion rigidifies the conformation of the tag while the 
other is shared between the tags from two different molecules and helped in crystal packing. 
These two Ni2+ adopt two different coordination environments, the intratag square planar 
coordination with Ni‐N distances of 1.95 Å and the intertag octahedral coordination with Ni‐
N/O distances of 2.13 Å. The observation of two different coordination types in one protein 
crystal is rather unusual, but it appears to be serendipitous and unrelated to LpnE itself. 
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Table 5. 2 Data collection and refinement statistics for His-LpnE(73-375)  
Data collection 
Space group   P212121    
Unit cell (Å)   67.7, 84.1, 128.3   
Resolution (Å)  48.77–1.75 (1.81–1.75)  
Total reflections  1 058 671 (135 933)  
Unique reflections  74 365 (11 788)   
Completeness (%)  99.83 (98.68)   
Redundancy   14.2 (11.5)   
Mean I/σ(I)   21.12 (1.85)   
Rmerge (%)   8.3 (148.9)   
CC1/2    100 (73.4)   
Refinement  
Resolution (Å)  48.77–1.8 (1.86–1.80)  
No. of reflections  68 575 (6782)   
Rwork / Rfree (%)  18.7 / 21.4   
No. of atoms / waters  5361 / 307       
RMSD from ideal values 
Bond lengths (Å) 0.013    
Bond angles (°) 1.39    
Ramachandran plot (%) 
Favored  97.37    
Allowed  1.70    
Outlier   0.93    
PDB ID  6DEH 
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6. Crystal Structure of the Legionella Effector MavE 
 
6.1. Literature Review on MavE 
MavE (lpg2344) is one of many putative Legionella pneumophila effectors recognized as 
a substrate of the Icm/Dot T4SS.  In the study under which MavE was identified, a C-terminal 
signal sequence was found in effectors restoring LCV colocalization to a translocation 
deficient SidCΔ100 (lacking its own C-terminal 100 residues). Effectors identified in this way 
were termed either Rav (Regions allowing vacuole colocalization) or Mav (More regions 
allowing vacuole colocalization) (Huang et al., 2011). 
MavE contains a C-terminal transmembrane helix (aa 187 – 203) and lacks the E-block 
motif seen in ~50% of known translocated substrates (Huang et al., 2011). Our collaborators 
have shown that MavE localizes to a micro-domain on the cytosolic side of the LCV 
(unpublished data). This localization pattern can likely be attributed to the C-terminal 
transmembrane helix in MavE. Secondary structure predictions show MavE to be fully α-
helical with a short N-terminal helix (aa 2 – 11) flanked by an unstructured region extending 
to Ser28. Analysis of the MavE protein sequence by PsiBLAST (Position-specific iterated 
Basic Local Alignment Search Tool) (Altschul et al., 1997) shows many homologues with start 
sites corresponding to Met38. This may represent a mis-annotation of the MavE start site listed 
in UniProt, as homologues belonging to different bacteria were found to align at Met38, while 
only hypothetical proteins from L. pneumophila aligned to Met1 of MavE. 
A direct interaction between MavE and the Legionella SNARE (Soluble NSF(N-
ethylamide sensitive factor) Attachment protein REceptor) mimic (Campodonico et al., 2016; 
Shi et al., 2016) and LegC7, has been identified by yeast two-hybrid assay and the LUMIER 
assay. The latter approach allows the detection of protein-protein interactions in mammalian 
cells. Briefly, FLAG-tagged bait and Renilla luciferase-tagged prey proteins were co-
transfected into HEK293 cells. Lysates were added to anti-FLAG plates and co-precipitation 
was evidenced by luminescence. MavE was also found to suppress the growth defect observed 
in Saccharomyces cerevisiae overexpressing LegC7. These findings led MavE to be described 
as an effector of effectors (or meta-effector) (Urbanus et al., 2016). Meta-effectors promote 
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the regulatory complexity that is essential to the Legionella life cycle, although it remains 
unclear why MavE would inhibit LegC7. 
 
6.2. Experimental Procedures for the MavE Project 
 
6.2.1. Cloning of recombinant MavE 
The MavE (lpg2344) gene was amplified from Legionella pneumophila (Philadelphia) 
genomic DNA by PCR. Residues 183 – 204 are predicted to comprise a transmembrane (TM) 
region (Program Phobius). To clone only the soluble domain of MavE, we amplified the DNA 
sequence encoding residues 2 – 172. This construct terminates just after the final hydrophilic 
helical stretch and excludes the following loop and TM region. The MavE(2-172) insert DNA 
sequence was placed into pMCSG7 and pRL652 vectors by ligation independent cloning 
(LIC), incorporating an N-terminal TEV-cleavable His6- or GST-tag, respectively. His6-
MavE(2-172) expressed poorly in BL21(DE3)pLysS and GST-MavE(2-172) did not readily 
bind the glutathione resin. Running PsiBLAST on MavE showed that most homologous 
proteins have start sites corresponding to residue M38. To explore the possibility of a 
misannotated start site, we amplified MavE(39-172) from the plasmid containing MavE(2-
172). As previously described, the MavE(39-172) DNA insert was placed into pMCSG7 and 
pRL652 vectors via LIC using the extensions underlined above. This construct of MavE was 
used for expression, purification and crystallization trials. 
 
6.2.2. Protein expression and purification 
The expression of His6-MavE(39-172) was carried out as described in section 4.2.3 for 
LpnE with the following exceptions: Once purified on Qiagen NiNTA beads (Figure 6.1B), 
His6-MavE(39-172) was concentrated to 16mg/ml and digested overnight at room temperature 
with TEV protease at a 1:50 enzyme/substrate molar ratio. The extent of digestion was 
monitored by SDS-PAGE (see section 4.5.1). Untagged MavE was then loaded onto a Biorad 
SEC70 or GE SEC75 column for buffer exchange and further purification. MavE eluted from 
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the size exclusion column in a single peak corresponding to monomeric protein. Peak fractions 
were collected and concentrated to 25 mg/ml for crystallization (Figure 6.1A/C). 
A seleno-methionine derivative of MavE(39-172) was produced by inhibiting methionine 
biosynthesis immediately prior to induction. Specifically, 100 mg lysine, phenylalanine and 
threonine and 50 mg isoleucine, leucine and valine were added to 1 L of culture 15 minutes 
prior to induction. 60 mg L-seleno-methionine was also added to allow the incorporation of 
selenium atoms into overexpressed MavE during induction. 
 
Figure 6. 1 Purification of His-MavE(39-172). (A) Size exclusion chromatogram of seleno-
methionine MavE(39-172) purified on a Biorad SEC70 column. (B) Purification of His-MavE on 
NiNTA. S = soluble protein (clarified lysate), 1 – 5 = elutions 1 – 5. Protein is purified in 15 mM 
Tris, pH 8.0, 50 mM NaCl and 100 mM imidazole. (C) Peak fractions collected from size exclusion 
on His-MavE(39-172) and TEV-cleaved MavE(39-172) (depicted in A). 
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6.2.3. Crystallization of MavE(39-172) 
Both His6-MavE(39-172) and MavE(39-172) were screened for crystallization using 
Crystal Screen HT, Index (Hampton Research, Aliso Viejo, CA), JCSG Core II and Classics 
Suite (Qiagen, Toronto, Canada). His6-MavE(39-172) did not crystallize under any of the 
conditions tested, whereas MavE(39-172) produced crystals under several conditions. After 
optimization by the hanging drop vapor diffusion method, the best crystals were obtained at 
20 °C in drops containing 1 µl protein in 15 mM Tris-HCl, pH 8.0, 50 mM NaCl mixed with 
1 µl of reservoir solution (10% PEG 20000, 0.1 M Citrate, pH 3.0) and suspended over 500 µl 
reservoir solution. 
 
6.2.4. Data collection and structure determination 
The protein crystals were cryo-protected by transferring to 1 µl mother liquor containing 
20% (v/v) ethylene glycol. Diffraction data were collected to 1.8 Å at the Canadian 
Macromolecular Crystallography Facility (CMCF) 08ID beamline, Canadian Light Source, 
using a MAR300CCD Detector (Grochulski et al., 2011). Integration and scaling were carried 
out using the XDS software package (Kabsch, 2010) (autoprocess). MavE(39-172) contains 
only one methionine at position 51 and substitution of this residue for seleno-methionine 
produced enough anomalous signal to solve the structure by single anomalous dispersion 
(SAD) using the phenix.autosolve script. Refinement of the structure was carried out using 
phenix.refine (Adams et al., 2011). 
 
6.3. Results 
 
6.3.1. Overall structure 
The crystal structure of MavE(39-172) was solved by single anomalous dispersion (SAD) 
and refined to a resolution of 1.8 Å. MavE is entirely α-helical with a right-handed up-down-
down-up-down topology. These five helices, labelled A, B, C, D and E, are composed of 
residues 39 – 58, 61 – 70, 94 – 114, 120 – 141 and 150 – 167, respectively (Figure 6.1). The 
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three molecules in the asymmetric unit are designated A, B and C. Molecules B and C are 
related by twofold symmetry, and molecule A is also related by a twofold axis to an A molecule 
in a neighboring unit cell (Figure 6.2). This results in a crystal lattice comprising layers of BC 
and AA dimers. Molecules within the unit cell are arranged such that two BC layers are 
sandwiched between a single layer of A molecules (Figure 6.2). The N- and C-terminal residues 
of MavE are near one another, with Arg155 and Arg162 in helix D forming hydrogen bonds 
to Leu57 and Glu54 in helix A, respectively. Helices B and C are connected by a 22-residue 
loop, with the first 10 residues having poorly defined electron density. This loop stretches 
across a stable core of the protein formed by helices A, C, D and E.  
 
Figure 6. 2 Overall structure of MavE(39-172).Helices A, X, B, C, D are coloured in red, yellow, 
green, orange and pink (respectively). Loop regions are shown in grey.  
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Figure 6. 3 BC and AA’ interfaces in the MavE(39-172) structure. Chains A, B and C are shown in 
green, cyan and magenta, respectively. The dimer arrangement is the same for both AA’ and BC 
dimers, although two citrate molecules coordinate a sodium ion in the latter. A small molecule of 
unknown identity is present at the same region of the AA interface, as evidenced by the Fo - Fc 
map. Interacting proteins are not shown as organized in the crystal lattice.  
 
6.3.2. Crystal Contacts 
Significant intermolecular contacts in the MavE crystal occur between B and C chains or 
A and A’ from a neighboring unit cell. Each of these ~1000 Å2 interfaces 
(https://www.ebi.ac.uk/pdbe/pisa/) is formed by N- and C-terminal residues, which contact a 
kinked region of helix C in the symmetry-related molecule. Two citrate molecules at the center 
of the BC interface stabilize their association through a network of water molecules. Residues 
contributing to this interaction are Ala38, Glu42, Gln125 and Ser128 of each chain. The 
positive difference map (mFo – DFc) indicates the presence of another stabilizing element at 
the AA’ interface, although the identity of this molecule remains unclear. 
The BC and AA’ connections are likely an artifact of crystallization, as MavE is monomeric 
in solution. Furthermore, each interface relies on a stabilizing element within a solvent filled 
cavity. In BC, this stabilizing element is citrate and in AA’ it is an unknown compound. These 
compounds and their surrounding water network provide many indirect contacts stabilizing the 
BC and AA’ interfaces. In fact, only two direct contacts between MavE molecules are present 
outside this central, solvent-filled region. One of these is a hydrogen bond between the amide 
nitrogen of Ser36 and a terminal guanidinium nitrogen of Arg85. Since Ser36 is one of three 
tag residues retained after TEV cleavage, this interaction must be nonbiological. The other 
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direct contact is also a hydrogen bond, this time between Asp171 and Ser84. The limited direct 
interactions between MavE molecules, in conjunction with their monomeric state in solution, 
suggest that BC and AA’ interactions do not represent a natural state of this protein in the cell.  
Another interaction of ~283 Å2 is present between molecules A and C. This interface is 
formed predominantly by helix B of chain A and the D-E loop of chain C. The only direct 
interaction between A and C takes the form of a hydrogen bond between Oδ of Asp146 in chain 
C and Nδ1 of His69 in chain A. An additional contact mediated by a water molecule exists 
between Gln72 and Ser153 of chains A and C, respectively. This interaction angles chain A 
relative to C, such that contacts formed between rows of AA and BC dimers are weaker than 
those between the latter and itself. Consequently, our crystal exhibits layers of AA dimers 
sandwiched between double-layers of BC dimers, when viewed along the a-axis.  
 
Figure 6. 4 Packing of MavE(39-172) molecules in the crystal. AA’ molecules (green) are 
sandwiched between BC molecules (magenta and cyan) to produce a set of repeating layers, with 
each one rotated approximately 90 ° relative to its neighbor. 
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6.3.3. Comparison with the grass pollen allergen, Phlp5b 
To gain insight into MavE function, we searched for proteins with a similar fold. To this 
end, we submitted MavE(39-172) coordinates to the DALI server. The translation initiation 
factor eIF2B (α-subunit) returned the highest Z-score (PDB id 5B04, Z-score = 7.4), however, 
MavE aligned with only a small segment of this protein. We searched the literature on eIF2B 
to understand the functional relevance of its α subunit. Structural studies on eIF2B provided 
insight into its role in translation. Briefly, eIF2B is a multiprotein complex that binds and 
deactivates another complex called eIF2. In its GTP-bound form, eIF2 initiates translation by 
delivering methionyl-tRNA to the ribosome. Recent work has shown that phosphorylated 
eIF2B binds in a groove between the α and β subunits to facilitate the exchange of GTP for 
GDP on eIF2 (Kashiwagi et al., 2016). This exchange allows translation to proceed by 
promoting the dissociation of eIF2 from the ribosome. Since MavE aligns with eIF2Bα, it may 
mediate an analogous protein-protein interaction to that seen between eIF2 and eIF2B. Closer 
inspection of the MavE-eIF2Bα alignment shows that helix B and its C-terminal loop have no 
counterparts in eIF2Bα. If these features were present in eIF2Bα, they would occlude a 
significant portion of the eIF2 binding interface. Specifically, Gln63, Gln87, His95 and Val97 
in eIF2Bα are obscured by the loop connecting helix B to C in MavE. Thus, the structural 
similarity to eIF2Bα did not lead us to a functional understanding of MavE. 
Two other proteins with a similar fold to MavE are the methylthioribose-1-phosphate 
isomerase (PDB id 6A34, Z-score = 6.9) and the ribose-1,5-bisphosphate isomerase (PDB id 
5YFJ, Z-score = 6.8). Both proteins harbor an N-terminal helical bundle and a C-terminal 
catalytic domain. MavE aligns with a four-helix bundle at the N-terminus of each. These 
bundles have the same topology as MavE, with the second and fourth helix (violet and orange 
in Figure 6.5) converging at one end to form a V-shape that is interlocked with another inverted 
V from the first and third helices (red and green in Figure 6.5). Despite sharing this general 
conformation, substantial deviations can be seen in the orientation of certain helical axes. 
Specifically, helices A and E of MavE align with the ribose-1,5-bisphosphate isomerase, 
whereas helices A and C align with the methylthioribose-1-phosphate isomerase. The poor 
alignment of remaining helices may suggest weak conservation of the helical bundle 
architecture, likely arising from differences in the interhelical loop lengths. 
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Figure 6. 5 MavE and ribose-1,5-bisphosphate isomerase adopt similar conformations in their 4-
helix bundles.(A) Helices B and D (pink and orange) of MavE converge to form a < shape, which 
is interlocked with a > formed by helices A and C (red and green). (B) Ribose-1,5-bisphosphate 
has a similar organization of helices to MavE (related helices are coloured in similar shades. 
 
Helix B in MavE has no counterpart in either methylthioribose-1-phosphate- or ribose-1,5-
bisphosphate isomerase. However, both isomerases have N-terminal extensions that do not 
exist in MavE. The ribose-1-5-bisphosphate isomerase has a helical segment that is similar in 
length to helix B but does not align with it. Structural studies on the methylthioribose-1-
phosphate isomerase show an N-terminal β-sheet and neighboring helix that shields the active 
site from solvent. These structural features are present on the same face of the four-helix bundle 
as helix B. It is therefore possible that the helical bundle represents a stable core domain upon 
which functional elements are grafted. 
The most interesting result in our search for homologues was the similarity between MavE 
and the grass pollen allergen, Phlp 5b (PDB id 1L3P, Z-score = 7.1). Phlp 5b represents a core 
domain of the allergen comprised of a four-helix bundle (Rajashankar et al., 2002). Helices A, 
C, D and E of MavE(39-172) align well with the Phlp 5b core domain (Figure 6.5). This 
superposition is consistent with that seen in eIF2Bα and the two ribose-phosphate isomerases 
described above. That is, helix B has no counterpart in any of these homologues. Phlp 5b 
contains two 35-residue helix-turn-helix motifs sharing 37% sequence identity. These motifs 
adopt remarkably similar helix termination and chain reversal strategies. As such, Phlp 5b was 
described as a twinned two-helix bundle. The corresponding helix-turn-helix motifs in MavE 
 116 
 
also share several residues, with some stabilizing the core architecture. Based on these 
observations, MavE can be said to have a similar core domain to that of Phlp 5b.  
 
Figure 6. 6 Structural overlay of MavE(39-172) and the grass pollen allergen, Phlp 5b.MavE is 
coloured as in Figure 6.1. Phlp 5b is coloured wheat. Hydrophobic core residues stabilizing the 
twinned two-helix bundle are shown as sticks. Note that helix B (yellow) of MavE has no 
counterpart in Phlp 5b.  
 
Despite being alike in their overall fold, the core domains of MavE and Phlp 5b share 
limited sequence identity. Some differences in sequence arise from the structural features 
distinguishing these proteins. Specifically, helices A and C are separated by helix B and an 
extended loop in MavE, while only a tight turn is present at this region in Phlp 5b. Inspection 
of the N-terminal motif in Phlp 5b shows that chain reversal is facilitated by a proline residue 
within this loop. This method of chain reversal is repeated in the C-terminal motif, where 
another proline is present on the loop connecting helices D and E. MavE contains such a proline 
residue only in the C-terminal motif (Figure 6.7). It is possible that the evolutionary pressure 
to retain proline at the N-terminal motif has been relaxed by the extended peptide connecting 
helices A and C.  
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Figure 6. 7 Overlay of MavE(39-172) (green) and Phlp 5b (cyan) showing proline residues that 
facilitate chain reversal. Nearby loop regions are depicted as lines for clarity. Prolines are shown 
as sticks. Note the absence of a corresponding proline residue for MavE in the N-terminal motif 
(left). 
 
Another unique feature in MavE is the presence of arginine residues at the beginning of 
each motif. These residues stabilize the core domain by mediating interactions between the 
two helix-turn-helix motifs. In contrast to Phlp 5b, which has isoleucine contributing to the 
hydrophobic core at this position, MavE uses water-mediated hydrogen bond networks to 
facilitate the contact of helix A with E and helix D with C. 
Although Phlp 5b and MavE share a hydrophobic center, the contributing residues are 
different between these proteins. The hydrophobic center of Phlp 5b is comprised of positions 
1, 4, 8, 24, 31 and 35 within each twinned motif. Conversely, MavE generates a hydrophobic 
center using positions 4, 8, 11, 15, 24 and 28 of the N-terminal segment, and positions 4, 8, 12 
and 32 of the C-terminal segment. Differences between N- and C-terminal motifs in MavE 
may arise from asymmetry in the evolutionary pressures experienced by these regions of the 
protein. A possible source of this discrepancy is helix B and the residues connecting it to C, 
although it is unclear how this would affect the C-terminal motif. 
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6.3.4. Regions of functional significance in MavE 
Helix B is the only secondary structure element in our MavE model that has no counterpart 
in Phlp 5b (Figure 6.4). Inspection of residues in the extended loop connecting helix B to C 
(Figure 6.1, grey region) reveals an NPxY motif. This sequence has been found to promote 
sorting or endocytosis by interacting with phosphotyrosine-binding (PTB) domain containing 
scaffold proteins (Stolt and Bock, 2006). Some proteins containing the NPxY motif are 
directed to the basolateral membrane (Stoops and Caplan, 2014). In other cases, a C-terminal 
NPxY motif allows low-density lipoproteins to be taken up by clathrin-mediated endocytosis 
(Chen et al., 1990). Recent studies have shown the NPxY motif to have divided roles for the 
organic anion transporting polypeptide (OATP1B1), with Asn and Pro residues promoting exit 
from the Golgi apparatus and Tyr playing a role in protein stability (Wang et al., 2019). These 
varied functions make the NPxY motif in MavE an attractive sequence to investigate; by 
mediating interactions with adaptor proteins that participate in vesicular trafficking, this motif 
may drive the LCV away from lysosomes. The electron density map surrounding the NPxY 
motif is poorly resolved in our structure, suggesting conformational flexibility in this region 
of the protein. The importance of the NPxY motif is further highlighted by its presence in many 
other species of Legionella. Considering the role of NPxY motifs in binding phosphotyrosine-
binding domains (PTBs), it is possible that the twinned two-helix bundle acts as a scaffold to 
display this binding element to prospective partners. 
In addition to the NPxY motif, MavE contains a set of residues along helices B and C that 
may act as a catalytic triad. Intriguingly, helix B contains two histidines, His68 and His69, and 
two aspartates, Asp64 and Asp65. These sidechains are in close proximity to Ser102 located 
on helix C. In particular, His68 could form a hydrogen bond to Ser102 upon rotation of the 
sidechain and at the same time come into proximity of the sidechains of Asp64 and/or Asp65. 
This Ser-His-Asp arrangement is highly reminiscent of the catalytic triad observed in 
peptidases. The residues of the putative peptidase triad are conserved in all Legionella 
pneumophila sequences but are not fully present in other Legionella species.  
In summary, our MavE model contains a twinned two-helix core domain that is similar in 
fold to the grass pollen allergen, Phlp 5b. The repeated helix-turn-helix motifs comprising this 
core domain share limited sequence identity with those of Phlp 5b. These differences in motif 
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sequence give rise to alternative stabilization strategies, such as the use of arginine residues to 
facilitate intra-repeat interactions in MavE. Furthermore, MavE deviates structurally from Phlp 
5b at the connection of helices A and C. Specifically, helix B and the loop connecting it to 
helix C is absent in Phlp 5b. 
 
6.4. Discussion 
MavE is a Legionella pneumophila effector protein secreted by the Icm/Dot Type IVB 
Secretion System. It has been called a meta-effector because it directly binds and inhibits the 
SNARE mimic, LegC7. We initially attempted to reproduce this interaction in vitro using pull-
down assays. Briefly, purified His6-LegC7(142-425) and GST-MavE(39-172) was added to 
either Co2+ and glutathione resin. Proteins were competitively eluted from the column using 
either imidazole or glutathione. This pull-down experiment was repeated using His6-MavE(39-
172) and GST-LegC7(142-425). Unfortunately, neither assay implied an interaction between 
LegC7 and MavE. This absence of binding was supported by the fact that His6-LegC7(142-
425) had no effect on the size exclusion profile of His6-MavE(39-172). The biological 
significance of the MavE-LegC7 interaction has yet to be confirmed, however, and no function 
for MavE has been stated in the literature. Herein, we report the crystal structure of MavE(39-
172) solved to 1.8 Å resolution. This construct lacks the C-terminal transmembrane region and 
some N-terminal residues erroneously included in the Uniprot annotation. Our MavE model 
contains a core domain reminiscent of the grass pollen allergen, Phlp 5b. The core domain of 
MavE is distinguished from the allergen by helix B and a loop connecting it to helix B. These 
structural elements may represent a region of functional significance for MavE, as their 
absence in Phlp 5b suggests they are dispensable for protein stability.  
The twinned two-helix bundle core domain of MavE contains strikingly different motif 
sequences than those of Phlp 5b. This may be an example of evolution converging on a 
common fold. Although the reason for this convergence remains unclear, the literature on Phlp 
5b suggests that structural stability is a driving factor. That is, the Phlp 5b core domain is 
resistant to proteolysis and retains allergenicity. The stability of the twinned two-helix bundle 
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can be attributed to its hydrophobic core and conserved residues promoting intramolecular 
contacts. 
A characteristic property of the twinned two-helix core domain is proteolytic resistance. 
As such, MavE may have evolved this domain to act as a robust scaffold for displaying 
functional elements to binding partners. The fact that Phlp 5b retains allergenicity can further 
rationalize this claim, as L. pneumophila effectors must resist innate immune defences. This 
stability could be essential for effectors performing a critical function in virulence, especially 
those having no redundant counterpart. 
Structural features outside the MavE core domain may be of functional significance to this 
protein. The loop connecting helices B and C is the longest in our model and contains a region 
of conformational heterogeneity, as evidenced by high B-factors and the absence of clear 
electron density. Intriguingly, the B-C loop harbours an NPxY sequence, which is the 
canonical phosphotyrosine-binding (PTB)-domain interacting motif. The presence of this 
motif on a flexible, solvent exposed loop in MavE may suggest a role for this protein in 
recruiting PTB-domains, which predominantly exist on adaptor or scaffold proteins (Uhlik et 
al, 2005). 
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Table 6. 1 Data collection and refinement statistics of MavE(39-172)  
Data collection 
Space group    C121    
Unit cell (Å)    199.5, 42.1, 46.3   
Resolution (Å)   49.85 – 1.59 (1.6 – 1.59)    
Total reflections   313021 (20373)   
Unique reflections   80803 (5639)   
Completeness (%)   80.8 (34.8)   
Redundancy    3.87 (3.6)   
Mean I/σ(I)    12.19 (1.11)   
Rmerge (%)    7.8 (127.8)   
CC1/2     99.9 (59.3)   
Refinement  
Resolution (Å)   46.27 – 1.65 (1.71 – 1.65)  
No. of reflections   40116 (1946)   
Rwork / Rfree (%)   19.7 / 23.7   
No. of atoms / waters   3496 / 252    
RMSD from ideal values  
Bond lengths (Å)  0.01    
Bond angles (°)  1.07    
Ramachandran plot (%) 
Favored   98.47    
Allowed   1.28    
Outlier    0.26    
PDB ID   6PIR 
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7. Crystal Structure of the Legionella Effector MavL 
 
7.1. Literature Review for MavL 
MavL (lpg2526) is an L. pneumophila effector identified in the same manner as MavE (see 
section 2.4). Fusion of the MavL C-terminus to SidCΔ100 produces a hybrid protein capable 
of translocating through the T4BSS. Since SidCΔ100 is translocation deficient, MavL may 
harbor a signal sequence recognized by the T4BSS. A common motif present at the C-terminus 
of translocated effectors is a glutamate-rich stretch called the E-block. These acidic residues 
were later found to promote efficient translocation through the T4BSS by an interaction with 
DotM (see section 2.2.2.6) (Huang et al., 2011). Inspection of the MavL C-terminus reveals a 
potential E-block motif consisting of three consecutive glutamate residues, which may be 
responsible for rescuing the translocation deficit present in SidCΔ100.  
MavL export has also been found to depend on the Lsp type II secretion system (T2SS), 
which relies on the Tat- or Sec- pathway to transport effectors across the inner membrane 
(DebRoy et al., 2006). Recruitment to either of these pathways requires an N-terminal signal 
sequence. This suggests that MavL contains an N-terminal sequence targeting it to the T2SS 
and a C-terminal (E-block) motif driving export by the T4BSS. Once in the periplasm, 
substrates of the T2SS interact with an outer membrane protein called secretin, which delivers 
them from the bacterial cell. Substrates of the T2SS are targeted to the LCV lumen, while those 
of the T4BSS are exported into the host cytoplasm (DebRoy et al., 2006). MavL may therefore 
play unique roles within and outside of the LCV during infection. 
Secondary structure predictions using PsiPred show MavL to be predominantly α-helical 
with several short β-strands interspersed throughout. PsiBLAST on MavL returns several 
homologues with start sites corresponding to residue M41. As with MavE, this finding may 
point to an inaccurate start site annotation for this protein within the Uniprot database 
(https://www.uniprot.org/). Alternatively, it is possible that MavL harbors an N-terminal 
extension distinguishing it from known homologues. 
MavL homologues are present in all known L. pneumophila strains but not in L. 
longbeachae (Gomez-Valero et al., 2011). This is surprising because both organisms produce 
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severe pneumonia in patients with weakened immune systems. The presence of MavL-like 
effectors in all L. pneumophila strains implies a role for this protein in virulence, while its 
absence in L. longbeachae suggests otherwise. It is possible that MavL acts redundantly with 
another L. pneumophila effector that has homologues in L. longbeachae. Indeed, L. 
pneumophila encodes over 330 effectors and this large number arises, in part, from functional 
redundancy. This phenomenon may be a consequence of multiple hosts in the environment; if 
L. pneumophila requires a unique complement of effectors to infect each host, expansion of 
the effector repertoire is required to broaden virulence (Ensminger, 2016). The significance of 
MavL to the pathogenicity of L. pneumophila has yet to be investigated.  
Elizabeth L. Hartland and Shivani Pasricha have confirmed the Icm/Dot-dependent 
translocation of MavL into THP-1 macrophages using a fluorescence-based TEM β-lactamase 
assay. These researchers also found HA-tagged MavL to be distributed throughout the 
cytoplasm after being opsonized by Fcγ-HEK293 cells. Such findings suggest that MavL is 
exported to the cytoplasm and is not directed to membranous compartments of the host cell. 
Bioinformatic analysis using the Phyre2 server showed that 15% of the MavL sequence is 
homologous to poly-(ADP-ribose) polymerase (PARP) macrodomains. PARPs extend ADP-
ribose chains on target proteins in eukaryotes. As such, MavL may interfere with the eukaryotic 
posttranslational machinery (unpublished data).    
Another important discovery by Hartland and Pasricha is the direct interaction between 
MavL and the E2 ubiquitin conjugating enzyme, Ube2q1/Nice5. The binding event was 
initially identified by yeast two-hybrid and then in mammalian cells by co-
immunoprecipitation (unpublished data). This finding implicates MavL in the ubiquitination 
pathway, although it remains unclear how modulation of this pathway occurs. Several L. 
pneumophila effectors act as E3-ubiquitin ligase mimics, which catalyze the non-canonical 
ubiquitination of host proteins. MavL may therefore prevent the interaction of Ube2q1 with 
host E3 enzymes and promote deviation of the ubiquitination pathway at the level of ligation. 
This deviation could result in the ubiquitination of host proteins that are not otherwise destined 
for degradation. Alternatively, MavL may chemically modify ubiquitin to render it inaccessible 
to host E3s. Further experiments are needed to deduce the role of MavL in ubiquitination. 
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L. pneumophila encodes an effector called Lem26 that causes a growth defect when 
overexpressed in yeast cells. Surprisingly, co-expression of MavL with Lem26 significantly 
reduces this defect, suggesting that Lem26 is inhibited by MavL. Interaction studies by yeast 
two-hybrid and co-immunoprecipitation did not show a direct interaction between these 
proteins, however (Urbanus et al., 2016). Although Lem26 remains structurally and 
functionally uncharacterized, a quick BLASTp search predicts the presence of Vip2- and SidE-
domains at the N- and C-terminus of the protein, respectively. Vip2 domains typically play a 
role in ADP-ribosylation, while SidE domains have phosphodiesterase activity. This domain 
organization is reminiscent of SidE-family effectors, which promote the non-canonical 
ubiquitination of host proteins in an NAD+-dependent process. The mechanism by which 
MavL impairs the yeast growth defect caused by Lem26 remains unknown. 
 
7.2. Experimental Procedures for the MavL Project 
 
7.2.1. Cloning of recombinant MavL 
The gene encoding MavL (lpg2526) was cloned into pMCSG7 and pRL652 vectors by 
ligation independent cloning (LIC), as described in sections 4.2.1, 4.2.2 and 4.3.1. Initially, a 
construct consisting of residues 2-444 was designed. This construct expressed and purified 
poorly, compelling us to explore alternative constructs. As with MavE (section 4.3.1), the 
PsiBLAST algorithm indicated a start site mis-annotation for MavL; most homologues had 
start sites corresponding to the MavL residue M41. Two constructs of MavL were designed to 
investigate this putative start site, namely MavL(42-435) and MavL(42-388). Inserts 
corresponding to these sequences were amplified from the MavL(2-444) plasmid and inserted 
into pMSCG7 and pRL652 by LIC. 
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7.2.2. Protein expression and purification 
MavL(42-435) and MavL(42-388) in pMCSG7 were first transformed into 
BL21(DE3)pLysS. Protein expression and purification was then carried out as described for 
LpnE, and OCRL in section 4.2.3. Limited proteolysis on MavL(42-435) and MavL(42-388) 
showed the latter construct to have greater susceptibility to degradation than the former. 
Furthermore, crystals were obtained only for a dimer species of MavL(42-435). This longer 
MavL construct was therefore used in all downstream structural and ligand-binding studies. 
Purification of MavL(42-435) on a Biorad SEC650 or GE S200 column allowed for the 
separation of dimer from monomer species, which were then concentrated to 15 – 20 mg/ml 
for crystallization trials. Initially, MavL(42-435) eluted from size exclusion predominantly in 
the monomeric form. The dimer species became more prominent after a day at 4 °C. By the 
third day, the dimer peak was larger than that of the monomer. At this point, further incubation 
of MavL(42-435) at 4 °C no longer increased the presence of the dimer. Re-running monomeric 
MavL on gel filtration regenerated some dimer and vice versa. These findings show that 
monomer and dimer species of MavL(42-435) are in equilibrium, with the monomer favored 
initially. 
Intriguingly, only the MavL(42-435) dimer was found to crystallize. This observation 
comes in conflict with the previously reported equilibrium between monomer and dimer 
species. To account for this, it is possible that mixing purified MavL(42-435) with the 
crystallization solution stabilized the dimer. If so, rapid screening of the dimer after separation 
would have been essential to the crystallization of MavL(42-435). Consistent with this notion, 
screening of MavL was always carried out immediately after purification and any protein that 
could not be screened was flash-frozen in liquid nitrogen. In the few cases where protein was 
left at 4 °C, it gradually lost its crystallizeability.    
No phasing model for MavL(42-435) was present in the Protein Data Bank (PDB). We 
therefore opted to produce a seleno-methionine derivative for phasing by single anomalous 
dispersion (SAD). Inhibition of methionine biosynthesis was initially attempted in 
BL21(DE3)pLysS cells harboring the MavL(42-435) plasmid in pMCSG7. We found that 
growth of these cells in minimal media was prohibitively impaired. To overcome this, the 
MavL(42-435) plasmid was transformed into auxotrophic B834 E. coli competent cells. These 
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transformants grew well in minimal media supplemented with methionine, but not without it. 
Induction of protein expression was carried out as previously, using 500 µL IPTG and reducing 
the temperature to 18 °C. Importantly, the culture was resuspended in minimal media lacking 
methionine immediately prior to induction, at which point seleno-methionine was added to the 
culture. In this way, the incorporation of seleno-methionine into recombinant protein was 
ensured. Purification of seleno-methionine (SeMet) MavL(42-435) was carried out as 
described for native MavL(42-435). 
 
Figure 7. 1 Purification of His-MavL(42-435) and His-MavL(42-388). (A) Size exclusion 
chromatograms of SMet-MavL(42-435) showing the transition from monomer to dimer species. 
The early stage run (blue) shows more monomer than dimer. Later (red), nearly the same amount 
of monomer and dimer are present. After three days (green), the dimer predominates. (B) 
Purification of His-MavL(42-435) and MavL(42-388) on NiNTA. S = soluble, 1 – 3 = elutions 1 
– 3 in 15 mM Tris, pH 8.0, 50 mM NaCl, 100 mM imidazole. (C) and (D) Limited Proteolysis on 
His-MavL(42-435) and His-MavL(42-388), respectively. E = elastase, P = proteinase K, S = 
subtilisin and G = GluC. (E) Peak fractions collected from the size exclusion run of SMet-
MavL(42-435) (depicted in A). 
 
7.2.3. Crystallization of MavL(42-435) 
Initial crystals for MavL(42-435) were obtained from Crystal Screen HT (Hampton 
Research, Aliso Viejo, CA). Specifically, conditions A4 (0.1 M TRIS hydrochloride pH 8.5, 
2.0 M Ammonium sulfate) and D3 (0.1 M HEPES sodium pH 7.5, 2% v/v Polyethylene glycol 
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400, 2.0 M ammonium sulfate) gave poorly diffracting needle clusters in under three days of 
growth. Extensive efforts to optimize the morphology of these crystals using additive- and 
grid-screens were met with little success. A few months later, an improved crystal form of 
MavL(42-435) was discovered in Crystal Screen condition B3 (0.2 M ammonium sulfate, 0.1 
M sodium cacodylate trihydrate pH 6.5, 30% w/v polyethylene glycol 8,000). These slower 
growing crystals diffracted better than the initial needle-clusters. After optimization, the best 
crystals were obtained at 20 °C in drops containing 1 µL protein in 15 mM Tris-HCl, pH 8.0, 
50 mM NaCl mixed with 1 µL reservoir comprised of 0.2 M ammonium sulfate, 0.1 M citrate 
pH 6.0, 22% w/v polyethylene glycol 8,000. Both native and seleno-methionine derivative 
MavL produced optimal crystals in this condition. 
 
7.2.4. Data collection and structure determination 
Seleno-methionine derivative MavL crystals were transferred into 1 µL mother liquor 
containing 25% (v/v) glycerol. Diffraction data was collected to 2.65 Å at the Canadian 
Macromolecular Crystallography Facility (CMCF) 08ID beamline, Canadian Light Source 
(CLS), using a Pilatus3 S 6M detector (Grochulski et al., 2011). Integration and scaling were 
carried out using the XDS software package (Kabsch, 2010). Initial electron density maps were 
obtained in Phenix using the hybrid substructure search to determine heavy atom (selenium) 
sites followed by phaser EP to calculate phase estimates for all remaining structure factors. 
The autobuild script was then used to arrive at a suitable model for further refinement (Adams 
et al., 2011). Manual adjustments to this model were made in Coot (Shabalin et al., 2018) 
followed by computational refinement using phenix.refine (Adams et al., 2011). 
 
7.2.5. Isothermal titration calorimetry of MavL(42-435) with ADP-ribose 
Titrations were carried out using the Nano ITC instrument (TA Instruments, New Castle, 
DE) and analyzed with the NANOANALYZE software (TA Instruments, New Castle, DE, 
USA) as described in section 4.2.8. Briefly, 400 µM ADP-ribose was titrated into the 
calorimeter cell containing 100 µM HisMavL(42-435). Both ligand and protein were in a 
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buffer containing 15 mM Tris-HCl, pH 8.0 and 50 mM NaCl. The experiment was carried out 
at 20 °C (see section 4.5.2 for detailed explanation of ITC). 
 
7.3. Results 
 
7.3.1. MavL shares the fold of ADP-ribose binding macrodomains 
To learn more about the biochemical function of MavL, the crystal structure of His-
MavL(42-435) was solved by single anomalous dispersion (SAD) with density modification 
and refined to a resolution of 2.65 Å. There are three molecules in the asymmetric unit. They 
are nearly identical and superimpose with a root-mean-square deviation (rmsd) for Cαs of ~0.4 
Å. The core of each molecule is formed by a highly curved and twisted, ten-stranded mixed β-
sheet (Figure 7.2). Two α-helices line the concave side of the sheet and are nearly parallel to 
the β-strands, while long loops with embedded short α-helices cover the convex side of the 
sheet (Figure 7.2). Among them is a bundle of four short α-helices that are inserted between 
strands β1 and β2 and abate to one end of the β-sheet.  
 
Figure 7. 2 Overall structure of MavL(42-435). Chain is coloured blue-green-red from N- to C-
terminus. Note the α-helical bundles flanking each side of the central β-sheet. 
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A quest for proteins with similar fold conducted with the DALI server 
(http://ekhidna2.biocenter.helsinki.fi/dali/, (Holm & Rosenström, 2010) identified partial 
similarity to proteins containing  the ADP-ribose binding macrodomain fold. The region of 
similarity encompasses residues 130-340 out of the 41-404 MavL sequence. The most compact 
ADPR-binding macrodomain contains ~200 residues and is composed of a seven-stranded 
mixed β-sheet with three long α-helices on one side covering the entire face of the β-sheet, and 
two α-helices lining the end of the β-sheet on the other side. Superposition of MavL and the 
smallest macrodomain from PARP14 (PDB ID 5QHT, PanDDA analysis group depsotision, 
to be published) shows good correspondence for seven β-strands, two of the three long α-
helices on one side of the sheet and one short α-helix on the other side. However, while the 
arrangement of β-strands is conserved, their connectivity/topology differs between MavL and 
the classic ADPR-binding macrodomains. In MavL these seven strands are in order β1-β2-β7-
β3-β4-β6-β5 while in the classic fold the strand sequence is β1-β2-β7-β6-β3-β5-β4. Thus, 
MavL folds in a similar three-dimensional arrangement but with a rearranged order of β-strands 
and with special conservation of only three helices.  
The N- and C-terminal extension to the ADP-ribose binding macrodomain fold do not form 
separate domains but supplement the macrodomain fold by adding three strands to the central 
β-sheet and several α-helices. The question then arises if this modified macrodomain fold still 
recognizes ADP-ribose. Superposition of MavL with the ARTD8 macrodomain m1, m2 or m3 
containing ADP-ribose shows that the substrate binding site of all these proteins has similar 
shape and the ADP-ribose fits in this superposition neatly into the potential MavL binding site. 
To experimentally test the binding of ADP-ribose to MavL we performed isothermal titration 
calorimetry (ITC) (Figure 7.4)). The binding was easily detected and the estimated binding 
constant Kd was 13µM.  
The proteins containing ADP-ribose binding macrodomains are classified as readers, 
writers and erasers (Karlberg et al, 2013). Reader domains recognize and bind ADP-ribose 
modifications and are usually embedded within large multidomain proteins. Writers are 
components of ADP-ribosyl transferases that synthesize ADP-ribose from NAD+ and modify 
target proteins on a specific amino acid. Finally, erasers hydrolyse poly(ADP-ribose) at the 
glycosidic (1-2') linkage. We analysed in more details the structural similarity of MavL to 
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proteins with macrodomains from each of these three classes to identify which of these three 
functions is most likely for MavL. 
Structural overlay of MavL with 5KIV, 3SIH and 3VFQ shows a common ADP-ribose 
binding pocket formed by five loops. Loops I and V interact with the adenine moiety of ADP-
ribose, while loops II – IV bind the pyrophosphate and terminal ribose (ribose”) (Figure 7.3). 
Extensive contacts with the ligand are made by loop IV, which harbors a conserved 
pyrophosphate binding motif (hGTGxh) where the threonine hydroxyl hydrogen bonds with 
the 3’ oxygen of ribose’. The structurally corresponding motif in MavL, I222GTGCF227 and 
Thr224 could form the same hydrogen bond with the O3’ of ribose.  
 
Figure 7. 3 Overlay of MavL(42-435) (cyan, solid) and 3VFQ (green, transparent). ADP-ribose 
from 3VFQ is depicted as green sticks and demarcates the putative ligand-binding pocket in MavL. 
Note the similar conformation of loops surrounding ADP-ribose. 
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Figure 7. 4 Isothermal titration calorimetry (ITC) on His-MavL(42-435) and ADP-ribose. 400 µM 
ADP-ribose was titrated into 100 µM His-MavL(42-435). Top = Raw data on exothermic 
emissions for 19 successive injections (the first injection emitted negligible heat). Bottom = 
Binding curve obtained from the raw data. 
 
 
All three ADP-ribose binding homologues (5KIV, 3SIH, 3VFQ) share a set of five α-
helices flanking the substrate binding cleft. These helices are a scaffold upon which the ligand 
binding loops are grafted and numbered in the same way as the loops. Although MavL retains 
helices II – IV, it lacks helices I and V entirely. These latter helices give rise to the adenine 
binding loops, which are conformationally more variable than the pyrophosphate-binding 
counterparts (loops II – IV). This renders greater flexibility in loops I and V of MavL, as 
evidenced by conformational differences between homologues. Loop I of MavL shows the 
greatest deviation in our model, which could be attributed to the absence of bound ADP-ribose. 
The remaining helices of MavL, 5KIV, 3SIH and 3VFQ have no counterparts in the other 
models and likely play a structural role. In summary, the central β-sheet and helices II – IV 
forming the ligand binding cleft are conserved features in ADP-ribose binding macrodomains, 
likely due to their role in stabilizing the core architecture and promoting the interaction with 
the pyrophosphate of ADP-ribose.   
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Figure 7. 5 Alignment of the pyrophosphate-binding loop IV in MavL and ADP-ribose binding 
homologue, 3VFQ. Note the similar organization of proline, isoleucine and threonine residues 
along each loop. Mav2 and 3VFQ are depicted in cyan and green, respectively. The threonine 
residue in MavL adopts a different conformation than that of 3VFQ and is not positioned for ligand 
binding. 
 
The similarity of MavL to ADP-ribose binding proteins can lead to the identification of 
putative catalytic residues. For example, MavL may act as a poly-(ADP-ribose) polymerase 
(PARP) or poly-(ADP-ribose) glycohydrolase (PARG). Indeed, the MavL homologue 3VFQ 
is a PARP, while 3SIH is a PARG. Despite differing in their catalytic mechanism, the ligand 
binding loops of 3VFQ and 3SIH adopt remarkably similar conformations, with only loop V 
being distinct between them. A mechanism for the glycohydrolase activity of 3SIH has been 
proposed, where the side chain carboxyl of a glutamate (Glu115) on loop II is deprotonated by 
the glycosidic oxygen that links ribose moieties in the chain. This leads to the formation of a 
transient oxocarbenium intermediate that is neutralized by a water molecule. Prior to the 
reaction, a neighboring glutamate (Glu114) and phenylalanine (Phe227) residue orient the 
ribose moiety to facilitate cleavage (Slade et al., 2011). A cluster of three glycine residues 
interact with the pyrophosphate of a neighboring ADP-ribose moiety and are also essential for 
glycohydrolase activity in 3SIH (Patel et al., 2005). Together, these residues form a conserved 
GGG-X6-8-QEE motif that characterizes PARG enzymes. In contrast to 3SIH, 3VFQ lacks 
acidic residues on loop II. Furthermore, Phe227 in 3SIH is replaced by a Leu1137 in 3VFQ 
and no cluster of glycine residues is present in the corresponding position of 3VFQ. Thus, 
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although ADP-ribose polymerases and glycohydrolases share structurally similar ligand 
binding pockets, they can be distinguished by the GGG-X6-8-QEE motif. The ligand binding 
loops of MavL deviate slightly from the conformations observed in 3SIH and 3VFQ, with the 
largest differences being in loops I and V. Structural alignment of MavL with 3SIH reveals a 
pair of aspartate residues (Asp332, Asp333) occupying the same site as the catalytic glutamates 
in 3SIH (Figure 7.6). In addition, the phenylalanine (Phe227) residue in 3SIH (that positions 
the ribose to be cleaved) is paralleled by another Phe227 in MavL. This residue takes on 
different conformations in these proteins, with the sidechain interacting hydrophobically with 
the terminal ribose in 3SIH but not in MavL. The unique orientation of Phe227 in MavL 
suggests flexibility in loop IV, a property that is compatible with substrate binding. Thus, 
structural analysis of MavL points toward PARG activity, with Asp333 on loop II initiating 
the cleavage reaction and Phe227 stabilizing the ribose moiety. Further experimentation is 
needed to verify if such activity is truly present for MavL. 
 
Figure 7. 6 Neighboring aspartate residues in MavL (cyan) occupy a similar position to the 
catalytic glutamates of 3SIH (magenta). Coordinates for ADP-ribose (green) are taken from the 
3VFQ PDB. Note the similar orientation of Glu114 (3SIH) and Asp333 (MavL) sidechains, which 
coordinate the terminal ribose moiety. Conformational differences between remaining sidechains 
may reflect the flexibility needed to accommodate ligand. 
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7.3.2. Crystal contacts 
Despite having three molecules in the asymmetric unit, the MavL lattice consists of stacked 
dimers that are rotated to form twisted columns. These dimers are comprised of molecules A 
and B or C and C’ from a neighboring unit cell. The presence of dimers in the MavL crystal 
structure is consistent with its oligomeric state in solution. That is, only MavL fractions 
collected from the dimer peak on size exclusion could be crystallized. Each monomer is related 
to its counterpart by a twofold symmetry axis and forms a contact interface of 1067 Å2. 
Strikingly, the putative ADP-ribose binding pockets are facing one another in the dimer, with 
several interacting residues arising from the C-terminal end of loops III, IV and V. Specifically, 
Tyr232 of loop IV hydrogen bonds with backbone atoms of Asp166 and Ser167 extending 
from loop III in the neighboring dimer. The methyl groups of Asp230 in both chains are near 
one another and contribute to the hydrophobic interface connecting the molecules. Two loops 
at the C-terminal end of each chain also stabilize the interaction. Another significant 
contribution to the dimer is a stacking contact between the aromatic rings of Trp357 in each 
chain (Figure 7.8). Perhaps the most convincing evidence for the biological relevance of 
dimeric MavL is a disulfide bond joining Cys226 residues in the CC’ dimer. Although no 
disulfide is present in the AB’ dimer, superposition of the CC’ dimer reveals a similar 
orientation of Cys226 residues in both. It is possible that spontaneous reduction of the Cys226-
Cys226 disulfide contributes to the monomer-dimer equilibrium observed for MavL by 
regenerating the monomer species. This hypothesis is consistent with the dynamic presence of 
MavL monomers and dimers in solution. 
 
Figure 7. 7 Close-up of Cys226 residues in the CC’ (magenta) and AB (green and cyan) MavL 
dimers. The presence of a disulfide between C and C’ is indicated by the 2.0 Å distance between 
sulfur atoms. Slight conformational differences between Cys226 residues in the AB dimer separate 
their sulfur atoms by 3.5 Å, suggesting that these residues are nonbonded. 
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Intriguingly, electrostatic surface rendering shows a channel passing through the dimer 
interface that provides access to the putative ADP-ribose binding site (Figure 7.9). This is the 
only channel present in the dimer and may accommodate the binding of poly-(ADP-ribose) 
chains to facilitate reader or eraser activity. In addition, purified MavL gradually transitions 
from monomer to dimer species in solution, with the equilibrium favoring the dimer species. 
Taken together, these structural and biochemical insights suggest a biological significance for 
the dimeric state of MavL.  
 
Figure 7. 8 The MavL dimer interface. Molecules A and B are depicted in green and cyan, 
respectively. Binding residues are represented as wheat coloured sticks and the C-terminal stacking 
interaction between W357 of each chain is shown in magenta. 
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Figure 7. 9 Surface electrostatic rendering of the MavL dimer. A solvent filled channel passes 
through the dimer interface and exposes the active site of each monomer. 
 
In contrast to MavL, all three ADP-ribose binding homologues (5KIV, 3SIH, 3VFQ) are 
monomeric. Structural alignment shows N-terminal α-helices in both 5KIV and 3SIH that 
protrude into the MavL dimer interface where C-terminal contacts would otherwise be made. 
Although no obvious steric prevention of dimerization is present in 3SIH, this model lacks 
structural analogs to the C-terminal binding loops and Y232 in loop IV of MavL. Our data 
shows a unique mode of dimerization for ADP-ribose binding proteins. The biological role of 
this interaction has yet to be evaluated. 
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7.3.3. MavL/Ube2q1 interactions 
Our collaborators Shivani Pasricha and Elizabeth Hartland have identified an interaction 
between the MavL effector and the E2 ubiquitin conjugating enzyme, Ube2q1, by the yeast 
two-hybrid method and by co-immunoprecipitation. We aimed to reproduce this interaction in 
vitro using recombinant proteins. Two constructs of Ube2q1 were used for this purpose: (1) 
full-length Ube2q1(1-422) and (2) Ube2q1(247-414), which corresponds to a previously 
crystallized construct (PDB id 2QGX) (Sheng et al., 2012). The interaction of Ube2q1 with 
MavL was investigated using size exclusion chromatography. Initially, HisUbe2q1(1-422) and 
HisMavL(42-435) were purified on NiNTA, dialyzed in a running buffer (15 mM Tris, pH 8.0, 
50 mM NaCl) and mixed in equimolar amounts. The putative complex was incubated for a 
minimum of 30 minutes on ice. When injected onto the column together, HisUbe2q1(1-422) 
and HisMavL(42-435) produced a chromatogram that looked like an overlay of the two profiles 
representing independent proteins (Figure 7.10). Although MavL(42-435) and Ube2q1(1-422) 
have similar molecular weights, the lack of a shifted peak was taken to indicate an absence of 
binding between these constructs. Next, the putative interaction of Ube2q1(247-414) with 
MavL(42-435) was explored by size exclusion chromatography. Ube2q1(247-414) was found 
to elute in a distinct peak that did not shift in the presence of MavL(42-435), suggesting that 
this truncated construct is also unable to interact with MavL (Figure 7.11). 
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Figure 7. 10 Size exclusion chromatography on His-Ube2q1(1-422) [Blue], His-MavL(42-435) 
[Green] and the putative complex [Red] using a Biorad SEC650 column. In the complex profile, 
His-Ube2q1(1-422) elutes slightly before His-MavL(42-435) in a peak that is unshifted relative to 
the independent protein. The His-MavL(42-435) peak is also unchanged by the presence of His-
Ube2q1(1-422), indicating no interaction between these proteins. The SDS-PAGE analysis of each 
run is shown in the two gels below the chromatogram. 
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Figure 7. 11 Size exclusion chromatography (SEC) on His-Ube2q1(247-414) (PDB id 2QGX) 
[Blue], His-MavL(42-435) [Green] and the putative complex [red]. In the complex profile, His-
MavL(42-435) and His-Ube2q1(247-414) elute in distinct peaks that are unchanged relative to that 
seen for individual proteins. The SDS-PAGE analysis of each run is shown in the two gels below 
the chromatogram.  
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7.4. Discussion 
The crystal structure of MavL(42-435) reveals a similar fold to ADP-ribose binding 
proteins, with potentially catalytic aspartate residues occupying the same position as 
glutamates characterizing the PARG motif (GGG-X6-8-QEE). Aberrant ADP-ribosylation can 
have severe consequences for the host cell, including the inhibition of protein synthesis or 
overproduction of cAMP. Many species of pathogenic bacteria have exploited this powerful 
modification using secreted effectors that exhibit mono- or poly-ADP-ribosyltransferase 
(MAR/PAR) activity, leading to deleterious consequences for the host. Reversal of the PARP 
modification depends on enzymes with poly-(ADP-ribose) glycohydrolase (PARG) activity. 
Enzymes responsible for initiating or extending a poly-(ADP-ribose) chain on a protein are 
called writers, while those that hydrolyze ADP-ribose moieties from an existing chain are 
erasers. MAR- and PARylation is regulated by writers and erasers to mitigate the effect that 
would otherwise accompany unbridled modifications of this kind. If MavL does indeed have 
eraser activity, it could mitigate the effect of a bacterial or eukaryotic writer present in the host 
cell. 
A third category of proteins, called readers, recognize ADP-ribosylated proteins and 
initiate protein-protein interactions that set signaling cascades into motion. Intriguingly, MavL 
shares structural homology with ARTD8 macrodomain 2 (ARTD8m2). ARTD8m2 
distinguishes mono- from poly-ADP-ribosylated proteins and is classified as a reader. Since 
macrodomains recognize the entire ADP-ribose moiety at the site of attachment, they often 
form complexes with the modified protein. Mutations disrupting macrodomain function have 
been associated with various diseases, including cancer and neurodegeneration (Schuller et al., 
2017). The similarity to ARTD8m2 may suggest reader activity for MavL. Alternatively, it is 
possible that eraser activity of MavL is tailored for mono-ADP-ribosylated proteins, although 
it remains unclear how mono- and poly-(ADP-ribosylated) proteins are distinguished by these 
macrodomains. 
MavL was found to mitigate the growth defect observed in yeast cells expressing Lem26, 
another L. pneumophila effector containing an N-terminal Vip2 domain and a C-terminal SidE-
domain. No interaction was observed between these proteins by yeast two-hybrid or 
(LUminescence based Mammalian IntERactome) LUMIER assays in HEK293 cells. These 
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findings suggest that MavL inhibits Lem26 by an indirect mechanism. VIPs (vegetative 
insecticidal proteins) are a pair of toxins found in Bacillus cereus, where VIP1 forms a 
multimeric pore in the membrane, allowing VIP2 to enter the host cell. VIP2 has been shown 
to ADP-ribosylate actin using a Vip2 domain that has since been reported in several other 
proteins (Han et al., 1999). Meanwhile, effectors belonging to the SidE family catalyze the 
noncanonical ubiquitination of host proteins in a process that does not depend on host cell 
machinery (i.e. E1 activating, E2 conjugating and E3 ubiquitin ligases). In the first step of this 
process, ubiquitin is ADP-ribosylated by a mono-ADP-ribosyltransferase (mART) domain at 
the N-terminus of SidE-family proteins. The modified ubiquitin is then transferred to a C-
terminal phosphodiesterase (PDE), or SidE-domain, that renders phosphoribosyl-ubiquitin 
(PR-Ub), which is attached to a serine residue on the target protein. Surprisingly, the SidE 
domain of an effector called lpg1496 did not exhibit PDE activity against an array of 
nucleotides tested. This domain was found to bind ADP, however, suggesting that SidE 
domains do not exclusively cleave phosphodiester bonds in nucleotides. Although the function 
of Lem26 remains unknown, the presence of both Vip2 and SidE domains in this protein 
suggests a role in ADP-ribosylation. Thus, Lem26 may act as a bacterial writer protein. The 
indirect inhibition of Lem26 activity by MavL could be a result of opposing functions on the 
same target. That is, ADP-ribose moieties added by the Lem26 Vip2 domain are removed by 
MavL eraser activity. Alternatively, MavL might act as a reader of proteins modified by Vip2, 
initiating a signaling event that negatively regulates Lem26 activity. 
Our collaborators, Shivani Pasricha and Elizabeth L. Hartland, found MavL to interact with 
the E2 ubiquitin conjugating enzyme, Ube2q1/Nice5, by yeast two-hybrid and co-
immunoprecipitation experiments. We were unable to visualize this interaction in vitro by size 
exclusion chromatography with purified recombinant proteins. This may suggest a transient 
interaction between MavL and Ube2q1 or that some modification of either Ube2q1 or MavL 
is a prerequisite to binding. Considering the role of Ube2q1 in ubiquitination, it is possible that 
MavL only binds Ube2q1 in complex with ubiquitin. To explore this, we mutated the catalytic 
cysteine of Ube2q1 to serine and generated Ube2q1-ubiquitin complexes linked by an ester 
bond. We also used a construct of ubiquitin with its terminal glycine mutated to serine to 
generate a disulfide linked Ube2q1-ubiquitin complex. Neither of these complexes bound 
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MavL by pull-down or size exclusion chromatography. While these findings may imply that 
the MavL-Ube2q1 interaction is weak and transient, they could also suggest that additional 
modifications are required for binding. The structural studies presented here point to ADP-
ribosylation as a likely recognition determinant for MavL. Since both Ube2q1 and ADP-
ribosylation are involved in ubiquitination, it is tempting to suggest that Ube2q1/ubiquitin is 
ADP-ribosylated by Lem26 in such a way that canonical ubiquitination events are prevented. 
Further studies are needed to determine if Ube2q1 is a substrate of both MavL and Lem26. 
In summary, this study provides crystallographic and binding data that point to a putative 
role for MavL in ADP-ribosylation. Structural comparisons of MavL with ADP-ribose binding 
macrodomains suggest reader or eraser activity against mono-ADP-ribosylated substrates. 
Although the biological role of MavL remains unclear, the studies presented here will guide 
further research toward this end.  
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Table 7. 1 Data collection and refinement statistics for His-MavL(42-435) 
Data collection 
Space group    C121 
Unit cell (Å)    97.6, 138.0, 108.5 
Resolution (Å)   48.77–2.64 (2.66–2.64) 
Total reflections   572585 (85399) 
Unique reflections   82310 (13055) 
Completeness (%)   99.30 (97.7) 
Redundancy    6.96 (6.54) 
Mean I/σ(I)    15.19 (1.37) 
Rmerge (%)    7.8 (138.7) 
CC1/2     99.9 (64.9) 
Refinement  
Resolution (Å)   45.14 – 2.64 (2.74 – 2.64) 
No. of reflections   41712 (4052) 
Rwork / Rfree (%)   21.7 / 25.5 
No. of atoms / waters   8105 / 12 
RMSD from ideal values 
Bond lengths (Å)  0.003 
Bond angles (°)  0.62 
Ramachandran plot (%) 
Favored   91.14 
Allowed   8.02 
Outlier    0.84 
PDB ID   6OMI 
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8. Additional effectors investigated toward structure determination 
 
8.1. LidL 
 
8.1.1. Introduction 
LidL is a paralogue of LpnE that contains 12 Sel1-like repeats (SLRs) and disrupts vacuolar 
trafficking. We aimed to structurally characterize LidL and compare its fold to that of LpnE, 
as this may highlight conserved and functionally relevant features of bacterial SLR proteins. 
Our interest in LidL was also inspired by a methods paper showing the crystallization of a 
fragment of this protein using a microfluidic device (Lee et al., 2014). The construct of LidL 
used in this publication included residues 27-192 out of 495 residues, corresponding to the first 
four SEl1-like repeats, and diffracted to 2.76 Å. However, the structure of this fragment has 
not been reported. Considering the nonspecific interactions mediated by the SLR super-helix, 
we felt that a structural understanding of the full-length protein would be more informative 
than a truncated fragment. That is, the architecture conferred by a full complement of SLRs 
will better describe the properties of LidL than a smaller set of residues. 
 
8.1.2. Results 
At the onset of this project, our database contained a LidL construct comprising residues 
29-495. Removal of the N-terminal 28 residues eliminates a largely hydrophobic helix, which 
would likely interfere with the solubility and crystallization of this protein. Furthermore, 
analysis of LidL by the SignalP-5.0 server reveals a signal peptide at the N-terminus, with 
cleavage occurring between residues Ala25 and Leu26. Thus, LidL(29-495) was expressed 
with an N-terminal hexa-histidine tag from the pMCSG7 vector. Transformation of this 
plasmid into BL21(pLysS) led to an abundance of protein. Incubating the clarified lysate with 
Co2+ Talon beads for 1 hr at 4 °C proved to be an ineffective purification strategy, as nearly all 
recombinant protein was found in the flow-through (this was also true of the GST-tagged 
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LidL(29-495) expressed from pRL652 --this construct was not pursued further). His-LidL(29-
495) could be purified, however, if the flow-through was added to NiNTA beads and incubated 
overnight at 4 °C. The yield from affinity chromatography was ~30 mg from 1 L, although 
some precipitation occurred immediately. Removal of precipitated protein by centrifugation 
reduced the final yield to ~24 mg. This protein was concentrated to 12 mg/ml and evaluated 
by size exclusion chromatography using a Biorad SEC650 column. Several peaks were 
observed on SEC650, with many contaminants eluting in the 12 – 17 ml range. LidL(29-495) 
eluted in a final peak centered at 17.75 ml. Intriguingly, SDS-PAGE shows these purified 
fractions to contain a doublet slightly above the 50 kDa marker (Figure 8.1). This may suggest 
that a small fragment of LidL(29-495) is cleaved during the purification.  
 
Figure 8. 1 Purification of His-LidL(29-495). (A) SDS-PAGE on affinity-purified His-LidL(29-
495) after overnight incubation on NiNTA beads. From left to right, the lanes are: molecular 
weight marker, soluble protein, first elution and second elution. (B) Size exclusion 
chromatography on His-LidL(29-495) [Green] and the trypsin cleavage product [Blue] using a 
Biorad SEC650 column. (C) Fractions from the size exclusion runs depicted in B. The seven 
leftmost lanes correspond to undigested His-LidL(29-495) and the seven rightmost lanes 
correspond to the trypsin cleavage product. Note the His-LidL(29-495) doublet is no longer present 
in the digested protein. L = load. D) Limited proteolysis on His-LidL(29-495). M = marker, Uncl. 
= un-cleaved, E = elastase, P = proteinase K, T = trypsin, S = subtilisin. Incubation times are 
indicated below the enzyme abbreviations. 
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To explore the possibility of a stable proteolytic fragment for LidL(29-495), we carried out 
limited proteolysis on this construct using elastase, proteinase K, trypsin and subtilisin. 
Proteinase K and subtilisin degraded 95% of LidL(29-495) within the first three hours of 
digestion. Conversely, elastase and trypsin produced a stable cleavage product, with complete 
trypsin digestion occurring in 16 hrs. Importantly, the protein fragment obtained from trypsin 
and elastase digestion is similar in size to the smaller species observed in the LidL doublet 
(Figure 8.4B and C). It should be noted, however, that 15 % acrylamide gels were used in these 
experiments, making it difficult to distinguish proteins within the 47 – 55 kDa range. Thus, we 
cannot assume that the LidL fragment obtained from trypsin digestion is identical to that 
arising from unintended proteolysis. Still, a stable digestion fragment implies that a segment 
of LidL is accessible to trypsin and removal of this flexible region may promote crystallization.  
Inspired by our results from limited proteolysis, we pursued structural studies on the LidL 
fragment obtained from trypsin digestion. Size exclusion chromatography on this fragment 
using a Biorad SEC650 column produced a major peak at 17.5 ml with a shoulder at 18.25 ml. 
SDS-PAGE analysis of protein containing fractions revealed that many of the contaminants 
had been eliminated during digestion. The LidL fragment appeared as a single band in both the 
major and shoulder peaks, indicating the presence of two oligomeric states or conformations 
for this protein. 
LidL(29-495) was screened using CrystalScreen HT and pH Clear (Qiagen) at only 3 
mg/ml because of its tendency to precipitate at higher concentrations. Trypsin-digested LidL 
was screened with CrystalScreen HT at 16 mg/ml. The lack of initial hits for undigested 
LidL(29-495) can be attributed to low concentration since nearly all conditions were clear 
(without precipitation) in these screens. Although trypsin-digested LidL could be brought to a 
higher concentration, the SDS-PAGE analysis of these purified fractions revealed the presence 
of contaminating proteins that may prevent crystallization (Figure 8.4C, Fractions 50 – 59).  
Any number of explanations can be used to justify why a protein is recalcitrant to 
crystallization. For example, a protein-protein interaction interface may cause LidL to 
precipitate in the absence of its eukaryotic binding partner. Another issue could be the absence 
of a small molecule that stabilizes the protein in a specific conformation. One factor that 
warrants mentioning, however, is that only low concentrations (<12 mg/ml) of LidL were used 
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for crystallization. This was largely due to the tendency of this protein to precipitate, which 
may partly explain its low efficiency at binding the Ni2+ or Co2+ beads. Future efforts to address 
this issue of precipitation may include the use of alternative expression vectors and tags (eg. 
SUMO or MBP), an extensive buffer screening process or purification at low temperature (4 
°C). In addition, the trypsin cleavage product of LidL may warrant further characterization by 
mass spectrometry. This would allow the residues representing this fragment to be identified 
and cloned into an expression vector. Production of this recombinant fragment may facilitate 
crystallization if undigested protein otherwise poisons the contact interfaces.  
 
8.1.3. Discussion 
LidL is a Sel1-like repeat (SLR) protein that allows L. pneumophila to influence vacuolar 
trafficking in an infected host cell. Despite being unable to crystallize LidL(29-495), our 
studies on this protein provide some insight into purification strategies. Of note is the stable 
cleavage product we obtained from trypsin digestion. Only a small peptide fragment is cleaved 
by trypsin to render a band that migrates just below the 50 kDa marker on SDS-PAGE. Trypsin 
is known to cleave peptides on the C-terminal side of lysine and arginine residues. Secondary 
structure analysis (PsiPred) of LidL shows several potential cleavage sites within loop regions 
that would give rise to a product in the 46 – 48 kDa range. These include Lys67, Lys425 and 
Arg426, which produce LidL(68-495), His-LidL(29-425) and His-LidL(29-426), respectively. 
Since no western blot or mass spectrometry was carried out for the LidL trypsin cleavage 
product, the residue composition of this species remains unclear. 
Digestion of LidL with trypsin serves the dual purpose of eliminating (1) the doublet 
observed on SDS-PAGE for undigested His-LidL(29-495) and (2) high molecular weight 
contaminants. Removal of the doublet suggests that trypsin cleaves at, or slightly beyond, the 
original point of separation; if the original cleavage site is retained in the trypsin digested 
fragment, we should expect this product to be partially cleaved as well. It is also possible that 
trypsin degrades or inactivates the enzyme that originally cleaves His-LidL(29-495). This 
would abolish any relationship between the site of endogenous- and trypsin-cleavage. 
Importantly, our construct of LidL starts beyond the predicted signal peptide. The doublet 
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observed in the purification of LidL(29-495) is therefore unlikely to represent the cleavage of 
a signal peptide. The ability of trypsin to produce a single LidL species bodes well for 
crystallization, as homogeneity of the sample is essential for this process. Removal of the high 
molecular weight contaminants by trypsin is evidenced by size exclusion chromatography. The 
broad peak centered at 13.75 ml disappears completely in the chromatogram of trypsin digested 
LidL. SDS-PAGE analysis of these fractions confirms the removal of contaminants. 
Identifying the residue composition of the LidL trypsin cleavage product may lead to the 
rational design of new constructs that resist proteolysis and are amenable to crystallization. 
 
 
 149 
 
8.2. LirF 
 
8.2.1. Introduction 
LirF is an L. pneumophila effector protein of unknown function. We sought to determine 
the structure of this protein to learn about its function. Analysis of LirF using the PsiPred 
secondary structure prediction tool shows a combination of α-helices and β-sheets. Two 
constructs of LirF were explored at the onset of this project: LirF(2-521) and LirF(2-331). The 
C-terminal half of LirF contains several extended loops interspersed with short secondary 
structure elements (SSEs), while the N-terminal half is dominated by SSEs. We hypothesized 
that a construct of LirF lacking the C-terminal half may be more stable and therefore amenable 
to crystallization. 
 
8.2.2. Results 
Initial efforts to purify LirF(2-521) and LirF(2-331) were carried out using the pMCSG7 
vector, which confers an N-terminal hexa-histidine tag. Both constructs expressed nicely in 
BL21(DE3)pLysS, but only the full-length protein (LirF(2-521)) was soluble and could be 
purified on Ni2+ and Co2+ beads (Figure 8.1). The fact that LirF(2-331) was insoluble may 
suggest that removal of the C-terminal region exposes a hydrophobic surface giving rise to 
precipitation. Alternatively, the removed segment may support the structural integrity of LirF. 
Whatever the reason, the full-length construct (LirF(2-521)) showed promise for downstream 
structural studies and became the focus of future efforts toward this end. 
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Figure 8. 2 Purification of His-LirF(2-331) and His-LirF(2-521) on Ni2+ and Co2+. (A) SDS-PAGE 
monitoring of the His-LirF(2-331) purification. (B) SDS-PAGE monitoring of the His-LirF(2-521) 
purification. Note that His-LirF(2-331) is only present in the total lysate (yellow box) and not in 
the soluble fraction. His-LirF(2-521) is soluble and purifies on both NiNTA and Co2+. 
 
Size exclusion chromatography on His-LirF(2-521) was carried out using a GE Superdex75 
column. (Efforts to cleave the N-terminal hexa-histidine tag from LirF(2-521) were met with 
little success. Briefly, tobacco etch virus (TEV) protease was added to LirF samples at a 1:50 
ratio and incubated overnight at 4 °C. This process was repeated for three consecutive days 
with no noticeable cleavage. These findings may suggest the TEV cleavage site is occluded in 
properly folded LirF.) Consequently, tagged protein was concentrated to 10 mg/ml using a 
Millipore 30 kDa molecular weight cut-off (MWCO) centrifugal filter and a volume of 500 µl 
was injected onto the column. The protein eluted in a major peak at ~17.5 ml, with a minor 
peak preceding it that also contains some LirF and contaminating protein. Major peak fractions 
were collected and concentrated to 11 mg/ml and screened using pH Clear, MbClassI and the 
ClassicsII 96-well suites. Excess precipitation was observed in many conditions with no initial 
crystals to optimize. 
Although LirF(2-521) could be purified on affinity and size exclusion chromatography, it 
also had a tendency to precipitate during dialysis and in solution. We set up a screen at 4 °C to 
mitigate this tendency during crystal growth but observed no crystals. Increasing the final salt 
concentration to 500 mM NaCl reduced the precipitation that occurs in a concentrated LirF 
stock overnight at 4 °C. We tried to circumvent the issue of LirF precipitation using limited 
proteolysis. Our hope was to obtain a stable proteolytic fragment of LirF that would resist 
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precipitation and crystallize more readily. Elastase, proteinase K, trypsin and subtilisin were 
used to cleave LirF in an enzyme:substrate ratio of 1:1000. Trypsin was found to produce a 
stable ~42 kDa cleavage product of LirF(2-521). Elastase had no noticeable effect on LirF(2-
521), whereas proteinase K and subtilisin completely degraded the protein (Figure 8.2A). The 
stable product obtained from trypsin digestion was characterized by western blot using an anti-
His-HRP conjugated antibody (Figure 8.2B). Since the ~42 kDa band produced a signal using 
this antibody, we concluded that our N-terminal hexa-histidine tag was intact in the 
proteolyzed fragment. This implied that cleavage was occurring at the C-terminus of the 
protein. The most likely site of trypsin cleavage is Lys336, which would eliminate a peptide 
of 18.0 kDa from LirF(2-521), rendering an N-terminal fragment of 41.4 kDa. 
We then purified the trypsin cleavage product of LirF(2-521) by size exclusion 
chromatography (GE Superdex200 column). The trypsin digested LirF(2-521) eluted in a peak 
centered at 16.75 ml, which is slightly downshifted relative to the undigested protein (Figure 
8.3A, green trace; C, peak fractions). Despite extensive efforts to crystallize both full-length 
and trypsin digested LirF, no crystal hits were obtained. This project was not pursued further 
at this stage, but future efforts toward the structural characterization of LirF should consider 
the utility of a construct terminating at Arg361. Complete digestion of LirF(2-521) by trypsin 
proved difficult, and having a construct corresponding to this digested fragment may aid in 
crystallization. In addition, the six N-terminal residues of LirF are predicted to represent a re-
entrant helix, with residue eight (Thr8) being disordered altogether. Exploring N-terminal 
truncations may therefore reveal a LirF construct that resists precipitation and crystallizes 
readily. 
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Figure 8. 3 Limited proteolysis on His-LirF(2-521) reveals a stable trypsin cleavage product.(A) 
SDS-PAGE monitoring of limited proteolysis after 24 hrs at 4 °C. SM = stained molecular weight 
marker, UM = unstained molecular weight marker, E = elastase, P = proteinase K, T = trypsin, S 
= subtilisin. (B) Western blot on LirF(2-521) after being digested with various enzymes for 24 hrs 
at 4 °C. 
 
Figure 8. 4 Size exclusion chromatography of His-LirF(2-521) and trypsin digested His-LirF(2-
521) on a GE Superdex200 column.(A) Overlay of chromatograms obtained for trypsin-digested 
[Blue] and undigested [Green] His-LirF(2-521). (B) SDS-PAGE analysis of peak fraction from 
undigested His-LirF(2-521). (C) SDS-PAGE analysis of peak fractions from trypsin-digested 
LirF(2-521). 
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8.2.3. LirF Discussion 
LirF is an L. pneumophila effector protein of unknown function. Although we were unable 
to crystallize and solve the structure of this protein, we did make some discoveries to aid in 
future purification strategies. For example, our C-terminal truncation, LirF(2-331), was 
completely insoluble, while the full-length protein, LirF(2-521) was soluble and easily purified 
on Ni2+ and Co2+. This could indicate that removal of the LirF C-terminus exposes a 
hydrophobic interface giving rise to precipitation. Alternatively, proper folding of LirF may 
depend on the presence of its C-terminal half. Secondary structure analysis reveals an extended 
loop region from Asp327 to Cys376 with only a few short helices and strands predicted within 
it. This loop may connect folded N- and C-terminal domains of LirF that are represented by a 
greater length and number of secondary structure elements. Systematically exploring C-
terminal truncations of full-length LirF may help us to understand how solubility is promoted 
by C-terminal extensions beyond residue 331. In addition, the eight N-terminal and 20 C-
terminal residues of LirF are predicted to be somewhat disordered. It is therefore possible that 
removal of these residues would facilitate the crystallization of LirF. 
We found that digestion of His-LirF(2-521) with trypsin produces a stable ~42 kDa 
cleavage product that retains the hexa-histidine tag. The most likely cleavage point is Lys336, 
as this residue is not within a secondary structure element or flanked by a C-terminal proline. 
Inspection of the disorder plot generated for LirF shows that disordered residues exist in the 
125 – 150 and 450 – 521 regions. On this basis, the trypsin-digested fragment may be more 
likely to crystallize than its full-length counterpart. This limited proteolysis study can also be 
used to infer how the C-terminus affects LirF stability, because the trypsin digestion occurs at 
the C-terminus of LirF and does not impede its solubility. If trypsin does indeed cleave at 
Lys336, the short strand between Asn331 and Lys336 may be instrumental in facilitating LirF 
solubility. The intervening sequence is comprised of residues LKFKK, which may promote 
solubility via the charged lysine sidechains. It should also be noted that Lys387 is a potential 
point of trypsin cleavage, although this residue would give rise to a 47 kDa product, which 
seems a little large based on the SDS-PAGE results. Still, cleavage at this position implicates 
a greater number of residues in promoting solubility. Only one arginine and lysine residue exist 
within this intervening region and both are flanked by a proline residue at their C-terminus. 
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This is convenient, as it limits our choices for the trypsin cleavage site to Lys336 and Lys387. 
Designing constructs of LirF that terminate at Lys336 and Lys387 may verify the speculations 
presented here regarding the C-terminal affect on solubility.      
 
 155 
 
9. Conclusions and Future Directions 
Legionella pneumophila is an intracellular pathogen that is increasing in virulence by 
developing its effector repertoire. This bacterium uses a large arsenal of secreted effector 
proteins to promote replication inside a wide range of protozoan species. Many of these 
effectors are acquired from eukaryotes by horizontal gene transfer and interfere with host 
processes by molecular mimicry. Functional redundancy of L. pneumophila effectors makes 
structure determination an attractive avenue of investigation into these proteins. In this 
dissertation, crystal structures are presented for three L. pneumophila effectors that were 
functionally uncharacterized prior to this work: LpnE, MavE and MavL.  
We have found that LpnE relies on its N-terminal signal peptide to promote cis-Golgi 
localization in HEK293 cells. This same sequence likely anchors LpnE to the LCV during 
infection. Previous studies have shown LpnE to recruit OCRL to the LCV and restrict the 
intracellular replication of L. pneumophila. Our LpnE-OCRL binding studies reveal that this 
interaction occurs between a polyproline motif on OCRL and a central helix (3-αB) of LpnE. 
These findings satisfy our primary objective to explain the binding of LpnE with OCRL, 
although further studies are still needed to map this interaction in molecular detail. For 
example, co-crystallization of LpnE with OCRL or the polyproline peptide fragment would 
reveal the residues involved in this interaction. Such studies expand our appreciation of the 
strategies employed by SLR proteins to engage in protein-protein interactions and may provide 
clues to understanding how replication is inhibited by OCRL recruitment to the LCV. 
Considering the promiscuity of SLR folds, it is likely that LpnE uses unique binding partners 
to facilitate host cell entry. Screening for LpnE targets on macrophage cell membranes may 
provide insight into the process of invasion. 
The crystal structure of MavE(39-172) shares a twinned two-helix bundle core domain with 
the translation initiation factor eIF2Bα, methylthioribose-1-phosphate isomerase, ribose-1,5-
bisphosphate isomerase and grass pollen allergen Phlp-5b. A fifth helix (B) on MavE is absent 
in all four of these homologous proteins, suggesting a distinguishing functional role for this 
structural feature. Intriguingly, a surface exposed loop connecting helix B to the two-helix 
bundle harbors an NPxY motif. Considering the ability of NPxY motifs to bind adaptor 
proteins, these structural observations provide a convenient hypothesis for the role MavE plays 
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in vacuolar trafficking. For example, MavE may bind tethering factors that direct the LCV 
away from lysosomes. These observations satisfy our objective to describe structural features 
in MavE that are significant to its function. Additional efforts are required to identify the 
molecular targets of MavE and verify the role of this NPxY motif in such interactions. 
Our MavL(42-435) structure has a similar fold to that of ADP-ribose binding 
macrodomains and harbors a pair of aspartate residues in the correct position to facilitate 
glycohydrolase activity. These findings satisfy our objective to arrive at a basic functional 
interpretation of MavL using its molecular structure. Isothermal titration calorimetry (ITC) 
verified the binding of ADP-ribose to MavL(42-435), revealing a dissociation constant of 13 
µM. Although these findings offer a convenient explanation for the inhibition of Lem26 by 
MavL, it remains unclear whether MavL indeed possesses glycohydrolase activity. A better 
understanding of Lem26 functionality may explain the link between ADP-ribosylation, MavL 
and possibly its ability to bind the E2 ubiquitin conjugating enzyme, Ube2q1. 
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